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Abstract  
Background  
Coronary mortality rates amongst South Asian populations are higher than in White populations 
in the UK. The contribution of incidence and prognosis of coronary disease to the higher coronary 
mortality  rates  amongst  South  Asian  populations  is  unknown.  Incident  coronary  disease 
commonly presents as angina and non-fatal myocardial infarction rather than as fatal events. 
Aim 
This thesis sought to investigate the incidence and prognosis of differing clinical presentations of 
coronary disease such as angina and myocardial infarction in South Asian compared to White 
populations in the UK. 
Methods 
Four new prospective studies, one aetiologic (South Asian N=580 initially healthy) and three 
prognostic  (N=2189  with  suspected  new-onset  stable  angina,  N=502  undergoing  coronary 
angiography and N=3037 with acute coronary syndromes) were examined, using multi-variate 
regression analyses. A systematic review and meta-analysis of these and previously published 
studies was performed.  
Results 
•  Incidence  of  angina  was  higher  in  South  Asian  than  in  White  people  in  a  healthy 
population, and angina was similarly valid in predicting a poor prognosis in both 
ethnic groups compared to those with no chest pain.  
•  In those with chronic angina, South Asian patients did not have a higher future risk of 
myocardial infarction and death than White patients, but had a worse symptomatic 
prognosis following coronary revascularisation when compared to White patients. 
•  South Asian patients had no worse a prognosis for mortality than White patients after 
myocardial infarction  
•  On meta-analysis, incidence of fatal and non-fatal coronary disease was higher in South 
Asian  populations  compared  to  White  populations  whilst  prognosis  of  coronary 
disease in South Asian populations was not worse than in White populations.   
Conclusions 
Increased  coronary  mortality  rates  in  South  Asian  populations  compared  to  the  White 
populations are due to the higher incidence of fatal and non-fatal coronary disease in South Asian 
people, as the prognosis of manifest coronary disease in South Asian people is not worse than in 
White people. 4 
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1  Introduction 
1.1  The higher coronary mortality in South Asian compared to White 
populations 
Of  all  the  estimated  57  million  deaths  in  the  world  in  2002,  cardiovascular 
disease  was  the  largest  single  cause,  resulting  in  17  million  deaths.  Societies 
across the world experience different rates of different cardiovascular diseases, 
and within those societies, there exists differences between social class, gender 
and  ethnicity.  In  the  1950s,  studies  began  to  report  differences  in  coronary 
disease rates between ethnic groups, and in particular the South Asian group 
(predominately  people  from  India,  Bangladesh,  Pakistan  and  Sri  Lanka).1-4 
Shaper  and  Jones  in  1959  stated  that  "in  the  African  population  of  Uganda 
coronary heart disease is almost non-existent. In the Asian community on the 
other  hand  coronary  heart  disease  is  a  major  problem".1  Adelstein  in  1963 
pointed out that among the South African ethnic types, ‘Asians’ (almost entirely 
of  Indian  descent)  showed  the  most  unfavourable  mortality  rates  from 
cardiovascular  disease  and  that  these  rates  were  among  the  highest  of  the 
national rates on record.3 Walker presented similar findings from South Africa 
17 years later, having examined death certificates of members of different ethnic 
populations in Johannesburg who had died of ischaemic heart disease, and used 
them  to  calculate  age-specific  mortality  rates.  As  well  as  an  extremely  high 
mortality rate among White populations (especially among the Jewish sector), an 
equally high or higher rate was found among Indians, in the context of a lower 
rate among ‘Coloureds’ and an extremely low rate among blacks.5  
Coronary heart disease remains the most common cause of premature death in 
the UK, although mortality has been falling continuously since its peak in the 
early  1970s.6  7  However,  UK  studies  of  mortality  in  the  1970s  and  1980s 
highlighted differences in cause of death between different immigrant groups. 
Balarajan presented data based on the 1981 census showing that mortality from 
ischaemic  heart  disease  was  highest  in  men  and  women  born  in  the  Indian 
subcontinent with standardised mortality ratios of 136 and 146 respectively,8 19 
 
adding value to the data he had presented seven years earlier showing higher 
proportional mortality due to ischaemic heart disease in immigrants to England 
and Wales from the Indian subcontinent.9 
A study based on 1991 census data revealed higher standardised mortality ratios 
for those born in South Asia, of 151 (141 to 162) for women and 146 (141 to 
151)  for  men.10  This  study  further  demonstrated  that  from  1971  to  1991, 
standardised  mortality  ratios  for  ischaemic  heart  disease  in  the  general  UK 
population  fell  by  29%  for  men  and  by  17%  for  women,  whilst  South  Asian 
immigrants experienced a shallower decline (20% for men and 7% for women). 
Latest data from the 2001 UK census noted that though coronary mortality fell 
among migrants, rate ratios for coronary mortality remained higher than for men 
and women from South Asia.11-13  
Similar disparities in mortality continue to be reported internationally. Sheth et 
al reported on cardiovascular mortality among Canadians of European, South 
Asian and Chinese origin from 1979 to 1993.14 In their analysis of 1.2 million 
deaths,  rates  of  death  from  ischaemic  heart  disease  were  highest  among 
Canadians  of  South  Asian  origin  whereas  those  of  Chinese  origin  had  a 
substantially lower rate. In Palaniappan et al’s study of coronary heart disease 
mortality  for  six  ethnic  groups  in  California  between  1990  and  2000, 
proportional mortality rates were highest in Asian Indian men (161) and women 
(144).15  
1.2  Explaining ethnic differences in coronary mortality 
This thesis seeks to explain why there is a higher coronary mortality rate in 
South Asian compared to White populations. Epidemiologically, the explanation 
for this may be either as a consequence of higher incidence of coronary disease 
in South Asian populations or a worse prognosis of already-manifested coronary 
disease – or a combination of both. Evidence for the contributions of disease 
incidence  and  prognosis  requires,  respectively,  incident  events  in  ‘healthy’ 
cohort studies and examination of outcomes in clinical cohorts with coronary 
disease.  20 
 
1.3  Ethnicity 
The Department of Health’s definition of an ethnic group is ‘a group of people 
who share characteristics such as language, history, culture, upbringing, religion, 
nationality, geographical and ancestral origins and place’. In contrast, the use of 
‘race’  in  epidemiological  research  is  based  on  biological  features  principally 
centred  around  physical  factors,  and  ignores  the  wider  societal  context.16 
Ethnicity depends on a wider socio-environmental and behavioural context and 
thus makes its identification and hence use as a variable in research – of vital 
importance  in  epidemiology  –  more  difficult  than  race.    Whereas  biological 
differences between ethnic groups (e.g. in cholesterol levels) can be measured by 
a blood test, sociological and behavioural differences between ethnic groups (e.g. 
deprivation, cultural preferences for medical treatments) are more difficult to 
measure.  Advantageously, by considering the influence of such components that 
make up ethnicity, ethnicity allows the incorporation of socio-environmental and 
behavioural  factors  associated  with  differing  ethnic  groups  beyond  just  the 
genetic and biological factors that race is limited to when considering the origins 
of diseases.  
Ultimately,  such  labelling  is  only  of  importance  if  differences  between  ethnic 
groups  exist  in  the population.  Clearly,  if there  were  no  ethnic  differences  in 
disease patterns, epidemiological investigation in the field would be pointless. As 
long  as  ethnic  disparities  in  health  are  suggested  however,  then  careful  and 
critical  analyses  of  them  are  merited.  As  the  aetiology  of  disease  is  not  just 
biological but socio-environmental and behavioural, ethnicity as an exposure has 
clear advantages to race as an epidemiological variable, aside from any moral 
arguments for its use. 
The recording of ethnicity is thus of importance. The 1991 Census of Population 
was the first to collect information on the ethnic group of every individual in the 
population of Great Britain. The Office for National Statistics April 2001 census 
question  was  similar  to  the  one  asked  in  1991,  but  with  changes  in  some 
categories - in particular, people could tick "mixed" for the first time. They were 
asked “What is your ethnic group?” According to this census, South Asian people 21 
 
made up just over 3.5% of the total UK population, about 2,084,000 out of nearly 
58,800,000.  Of  these  nearly  1,054,000  (1.8%)  were  Indian,  747,000  (1.25%) 
were Pakistani and just under 283,000 (0.5%) were Bangladeshi. In comparison, 
there  were  247,403  (0.4%)  Chinese  people,  565,876  (1.0%)  Black  Caribbean 
people and 485,277 (0.8%) Black African people. The average ages of minority 
ethnic communities were younger than the White European population.17 The 
Office for National Statistics 2001 census types were:   
A.  White: British; Irish or Any other White background  
B.  Mixed: White and Black Caribbean; White and Black African; White and 
Asian or any other mixed background  
C.  Asian or Asian British: Indian; Pakistani; Bangladeshi; Any other Asian 
background  
D.  Black or Black British: Caribbean; African; Any other Black background 
E.  Chinese or other ethnic group: Chinese; Any other  
(more  detailed  data  from  The  Office  for  National  Statistics  2001  in  Appendix 
13.1) 
1.3.1  South Asian populations  
South  Asian people  are  part  of  a  heterogeneous  group  composed  of  different 
nationalities and religions (e.g. Indians and Bangladeshis, Muslims and Hindus). 
Ideally, all analyses comparing the health of this population with white majority 
populations should take this into account. However, the vast majority of studies 
that have presented results on ethnic differences between these two populations 
have used the aggregated ‘South Asian’ category, and those that collect data on 
the  constituent  peoples  often  do  not  have  the  power  required  for  statistical 
analyses between South Asian peoples.  
Hence,  the  acceptability  of  the  broader  ‘South  Asian’  group  as  a  means  of 
description of this population needs to be examined. Despite its heterogeneity, 
the term South Asian is growing in acceptance culturally among the people it 
seeks to classify because it acknowledges common interests while it allows for 22 
 
difference.18  This  also  parallels  the  gradual  acceptance  of  the  term  "Asian 
American" by peoples primarily of East and Southeast Asian ancestry, who found 
reason  to  claim  a  shared  identity  in  dealing  with  bureaucratic  matters  and 
racism.  Despite  doubts  as  to the  inclusiveness  of  such  terms  and  their  wider 
applicability,  especially  with  respect  to  health  and  disease,19  there  exist 
similarities in behaviour within the South Asian peoples. Poverty and smoking 
are more prevalent among Pakistanis and Bangladeshis whilst obesity and a lack 
of exercise are associated with all South Asian peoples, though Pakistanis and 
Bangladeshis are more likely to have higher levels of inactivity.20 21  
Furthermore,  though  differences  between  the  differing  peoples  of  the  South 
Asian category may result in different patterns of incident disease, it is unlikely 
that  such  differences  would  result  in  differential  prognoses  when  presenting 
with coronary disease. For example, the vast majority of studies have reported 
that South Asian patients of any origin (from Bangladeshis in London to Indians 
in the USA) present with coronary disease at younger ages than White patients 
and  this  younger  age.  Thus,  age  –  rather  than  the  nationality  –  will  exert  a 
stronger effect on prognosis.  
1.3.2  White populations 
Much of the work in ethnic differences has used relatively homogenous White 
populations as the comparison group. However, the heterogeneity of the ‘White’ 
group  should  be  appreciated,  for  example  the  increased  socioeconomic 
disadvantage and mortality of Irish people living in England and Wales.22 Any 
conclusions  from  analyses  on  ethnic  comparisons  should  be  applied  to  those 
specific White populations being studied, and not extrapolated to other ‘White’ 
populations outside the inclusion criteria of that study. It is of further interest 
that work from Scotland did not reveal worse coronary mortality in those born in 
South Asia compared to those Scottish-born, but that the use of England and 
Wales  as  a  comparison  group  showed  a  substantial  excess  of  coronary  risk 
among South Asians in Scotland, comparable to that reported in England and 
Wales.13 Comparisons with England and Wales showed high all-cause, coronary 
heart disease and stroke mortality among Scottish residents born in Scotland, 23 
 
Northern  Ireland,  the  Republic  of  Ireland.  Thus,  inferences  from  analyses 
between White populations in England and South Asian populations in England 
cannot then be assumed to apply to White populations in Scotland and Ireland. 
The increasing migration from Southern and Eastern Europe of ‘Whites’ adds 
further heterogeneity to the category.  
Within England itself, evidence reporting worse coronary health within deprived 
neighbourhoods  can  be  explained  away  once  individual  measures  of  socio-
demographic  status  are  adjusted  for.23  Thus,  conclusions  applied  to  White 
populations within smaller geographical areas such as England (or even within 
cities)  require  consideration  of  such  factors.  However,  Scotland’s  relative 
mortality  disadvantage compared  to  the  rest of  Great  Britain  is  not  explained 
away fully even after allowing for deprivation.24 
1.3.3  Assessment of ethnicity  
The current preference for practical reasons is for self-assessment of ethnicity25 
In a USA study, there was reasonable concordance between self-assessment of 
ethnicity and ethnicity recorded by an outside observer for some ethnic groups 
(such as blacks, White populations and ‘Asians’a, whilst other groups were less 
concordant (e.g. Hispanic and American Indian).26  
1.4  The migration history of South Asian people to the United 
Kingdom 
1.4.1  Moving to the United Kingdom 
Migration  into  the  UK  began  in  significant  numbers  after  the  1962 
Commonwealth  Immigrants  Act.  The  Moving  Here  website  and  partnership 
(http://www.movinghere.org.uk  ),  led  by  the  National  Archives,  reports  that 
before  1960  such  immigration  had  been  small  and  migrants  generally  had  a 
significant  knowledge  of  the  English  language  or  Britain,  or  both.  This  group 
comprised  seamen,  ex-Indian  army  personnel,  university  graduates,  teachers, 
doctors and other professionals. The entry of South Asian people to England was 
controlled at source by the Indian and Pakistani governments.  
                                                        
a ‘Asian’ in the USA refers to East Asians e.g. Chinese, Filipinos, Japanese 24 
 
The majority of those who entered the UK after 1960 came to fill jobs in industry, 
and  were  unskilled  in  comparison.  Most  were  literate  in  Urdu,  Punjabi  and 
Gujarati but few had much in the way of formal educational qualifications. South 
Asian  immigrants  tended  to  now  come  from  a  rural  background  and  were 
generally unfamiliar with the language and culture of Britain. They were more 
often political or economic migrants - such as the Bangladeshis who immigrated 
to  the  UK  during  the  violent  birth  of  their  country  in  1971  –  rather  than 
professional or educational. Notable exceptions were in the considerable number 
of Indian doctors who arrived to fill shortages in the National Health Service, and 
South Asian people expelled from East Africa in the 1960s and 1970s of higher 
socio-economic status, heralding from professional and mercantile backgrounds. 
1.4.2  Geographical origins of migrants  
The majority of South Asian migrants in the UK originate from only a few of the 
many communities in the sub-continent. These communities are linked to pre-
war  geographical  patterns  of  settlement  that  persist  today  within  the  UK.  
Demobbed soldiers came mostly from Punjab and Gujarat, and deserters from 
the merchant navy from Mirpur and Sylhet. Up to 90% of Pakistanis in Bradford 
and Birmingham come from the area of Mirpur. Indians who are Sikh in religion 
tend to originate from mainly the Punjab region (Southall in West London is now 
home to a large Punjabi Sikh community) whilst Hindus originate mostly from 
the  Gujarat,  Punjab  and  West  Bengal  regions.  British  Bangladeshis  largely 
originate from the north-eastern Sylhet region of their country – they were often 
employed as ship's cooks at the beginning of the century and many of them went 
on to work in the 'Indian' restaurants, which they still dominate today. In 2001 
Bangladeshis  made  up  33.4%  of  the  population  of  Tower  Hamlets  in  London 
whilst 95% of those Bangladeshis came from the rural north-eastern district of 
Sylhet. Many East African Asian people have settled in London in areas such as 
Wembley and Harrow. Thus, these pockets of relative social homogeneity exist 
within the heterogeneous category of the ‘South Asian’.  25 
 
1.5  The pathology of the stages of coronary disease underlying its 
differing clinical presentations  
Atherosclerosis can be staged into a complex series of molecular and cellular 
processes  in  the  circulatory  system  leading  ultimately  to  arterial  thrombosis. 
These stages correlate with differing clinical presentations relevant to this thesis. 
Many presentations of coronary disease exist, but atheroma within the coronary 
artery  itself  results  in  specific  clinical  presentations  such  as  angina  and 
myocardial ischaemia.  
1.5.1  Asymptomatic coronary atheroma 
The first stage in atherogenesis is the formation of the fatty streak. Firstly, there 
is  infiltration  and  entrapment  of  low  density  lipoprotein  (LDL)  in  the  blood 
vessel  wall.  Once  entrapped  in  the  vessel  wall,  LDL  undergoes  modification 
which  results  in  the  secretion  of  a  chemotactic  substance  that  attracts 
monocytes.  These  cells  then  migrate  through  the  vessel  wall,  transform  into 
macrophages which then digest the LDL particles. The cytoplasm of the cell is 
increasingly packed with lipid forming the fatty streak. Fatty streaks are smooth 
raised plaques located beneath the endothelium and have been observed in the 
coronary arteries of asymptomatic young adults.27 This stage of atheroma is ‘sub-
clinical’ as it is not associated with symptoms of angina, i.e., the symptom of chest 
discomfort or pain associated with reduced myocardial arterial blood supply as a 
result of increasing arterial luminal stenosis.  
1.5.2  Exertional angina and the fibrous plaque 
The  fibrous  plaque  represents  the  next  phase.  With  progression  of  the  fatty 
streak, smooth muscle cells (not normally present in the sub-endothelial space) 
migrate from the media to the sub-endothelial space where they proliferate and 
produce  connective  tissue  to  form  a  fibrous  cap.  Increasing  diameter  of  the 
plaque increasingly obstructs the blood flow through the lumen of the coronary 
artery,  progressively  restricting  blood  supply  to  the  myocardium,  causing 
clinically apparent exertional angina, or ‘chronic stable angina pectoris’, in the 26 
 
patient.b  Non-invasive  tests  such  as  exercise  electrocardiography  may  reveal 
electrical changes indicative of ischaemia.  
1.5.3  The acute coronary syndrome and the ruptured plaque 
The next stage is the development of a lesion which can calcify, haemorrhage, 
ulcerate and thrombose. It is the progression of the stable atherosclerotic fibrous 
plaque (that results in exertional angina) into this vulnerable and unstable lesion 
(the  rupture  of  which  results  in  thrombosis)  that  leads  to  the  clinical 
presentation of unstable angina (recurrent episodes of angina on minimal effort 
or  at  rest).  If  coronary  blood  supply  is  sufficiently  reduced,  infarction  of  the 
myocardium can then result as a result of a total or a sub-total occlusion of the 
coronary artery. 
 
Figure 1 Stages of atherosclerosis and correlation with clinical presentations 
(adapted from Abrams 200528)                
   
 
                                                        
b The term angina in this thesis will henceforth imply chronic stable angina pectoris rather than 
unstable angina (described on next page) 27 
 
1.5.4  Prediction of outcomes at differing clinical presentations of coronary 
disease 
To  understand  the  relative  contributions  of  incidence  and  prognosis  that 
underlie  the  epidemiology  of  coronary  death,  stages  within  coronary  disease 
need to be considered. Though incidence itself implies first event, this can be 
non-fatal or fatal, correlating with different stages of coronary disease. The sub-
clinical coronary plaque can cause both the gradual encroachment of coronary 
blood  flow  causing  angina  as  an  incident  clinical  event,  and  can  also  present 
directly as thrombosis leading to unstable angina or myocardial infarction or 
death.  Incident  angina  can  itself  progress  to  myocardial  infarction  or  death. 
Hence, knowledge of non-fatal and fatal incidence is of importance to overall 
coronary  disease  epidemiology.  Most  incident  coronary  disease  is  non-fatal 
rather  than  fatal,29  30  and  of  these  non-fatal  presentations,  the  prognosis  of 
presentations  such  as  angina  and  myocardial  infarction  are  different.  Factors 
that  affect  prognosis will  also  be  different  in  angina  compared  to  myocardial 
infarction.  
1.5.5  Other presentations of ischaemic heart disease 
Many presentations of ischaemic heart disease exist, and have been measured 
both  in  epidemiological  studies  and  by  clinical  means.  The  International 
Classification of Diseases (ICD 10th Revision, Version for 2007, appendix 13.2) 
lists angina pectoris (I20) and myocardial infarction (I21, I22) as three of the five 
categories making up the ischaemic heart diseases category (I20-I25). Further 
clinical  presentations  of  ischaemic  heart  disease  exist  within  the  ICD 
classification  –  such  as  coronary  failure  (within  I24)  and  ischaemic 
cardiomyopathy  (within  I25),  end-results  of  the  infarcted  myocardium  or 
extensive atherosclerosis. Furthermore, the complications listed within I23 often 
result in sudden cardiac death, another clinical presentation of ischaemic heart 
disease. Other categories within I25 include those that do not present clinically 
but are often found fortuitously, such as silent ischaemia and ECG changes such 
as q waves (I25.2) and arrhythmic sudden cardiac death, which previous clinical 
and epidemiological studies have used as measures to assess the incidence and 
prevalence of ischaemic heart disease. 28 
 
Coronary failure, cardiomyopathy and arrhythmias strictly refer to pathological 
processes arising from the myocardium (as a result of coronary insufficiency) 
rather than the coronary artery, whilst ECG changes may not be associated with 
symptomatic  disease.  This  thesis  seeks  to  examine  symptomatic  clinical 
syndromes that require the patient where possible to have presented themselves 
to the healthcare service, and focuses on events within the lumen of the coronary 
artery  and  are  hence  the  primary  clinical  presentations  of  the  pathological 
process of coronary atherosclerosis. This thesis hence will focus on angina and 
myocardial infarction in its study of incidence and prognosis, whilst appreciating 
that coronary disease may also present as silent ischemia, coronary failure and 
arrhythmias. 
1.6  Angina 
Angina  is  a  common  initial  manifestation  of  coronary  heart  disease,29  a 
significant burden in primary care31 and has considerable economic implications. 
A  UK  study  conservatively  estimated  that  angina  accounted  for  1.3%  of  the 
annual health expenditure.32  
1.6.1  Definition of angina 
Angina is diagnosed from a clinical constellation of symptoms from the patient 
history.  Descriptions  of  symptoms,  articulated  by  patients  to  their  doctors, 
remain a cornerstone of diagnosis in clinical medicine. The clinical history is the 
first step in assessing chest pain or discomfort in order to ascertain whether or 
not it represents angina. The history also allows the doctor to identify patients in 
whom additional investigation is necessary and in whom it may be spared,33 34  
and  whether  additional  therapy  including  coronary  revascularisation  through 
percutaneous  coronary  intervention  (PCI,  using  balloon  angioplasty  and 
stenting) or coronary artery bypass surgery (CABG) is needed. 
1.6.1.1 Diamond and Forrester definition 
One of the most widely used definitions of chronic stable angina pectoris was 
presented in 1979 by Diamond and Forrester who analysed 4952 patients with 
chest  discomfort.  They  showed  that  typicality  of  symptoms  correlated  with 29 
 
angiographic  coronary  disease.34  The  authors  described  three  types  of  chest 
pain: nonanginal, atypical, and typical.  
The pain was assessed with these questions: 
1) Is the pain retrosternal?  
2) Is the pain precipitated by stress?  
3) Is the pain relieved by rest or nitroglycerin? 
Patients who answer yes to all three questions were determined to have typical 
chest pain, those who answered yes to two of the questions to have atypical chest 
pain and those who answered yes to only one question were deemed to have 
nonanginal chest pain. 
1.6.1.2 European Task Force definition 
The Task Force on the Management of Stable Angina Pectoris of the European 
Society  of  Cardiology  defined  angina  as  follows  in  its  2006  consensus 
document:35  
Stable angina is a clinical syndrome characterized by discomfort in the chest, jaw, shoulder, back, or 
arms, typically elicited by exertion or emotional stress and relieved by rest or nitroglycerin. 
It continued: 
The  characteristics  of  discomfort  related  to  myocardial  ischaemia  (angina  pectoris)  have  been 
extensively described and may be divided into four types: location, character, duration and relation to 
exertion, and other exacerbating or relieving factors. The discomfort caused by myocardial ischaemia 
is usually located in the chest, near the sternum, but may be felt anywhere from the epigastrium to 
the lower jaw or teeth, between the shoulder blades or in either arm to the wrist and fingers. The 
discomfort  is  usually  described  as  pressure,  tightness,  or  heaviness,  sometimes  strangling, 
constricting, or burning. The severity of the discomfort varies greatly and is not related to the severity 
of the underlying coronary disease. Shortness of breath may accompany angina, and chest discomfort 
may also be accompanied by less specific symptoms such as fatigue or faintness, nausea, burping, 
restlessness, or a sense of impending doom.  
The duration of the discomfort is brief, not more than 10 minutes in the majority of cases, and more 
commonly  even  less.  An  important  characteristic  is  the  relation  to  exercise,  specific  activities,  or 30 
 
emotional stress. Symptoms classically deteriorate with increased levels of exertion, such as walking 
up an incline or against a breeze, and rapidly disappear within a few minutes, when these causal 
factors abate. Exacerbations of symptoms after a heavy meal or first thing in the morning are classical 
features of angina. Buccal or sublingual nitrates rapidly relieve angina, and a similar rapid response 
may be observed with chewing nifedipine capsules.  
Finally, to classify, it presented the following classification: 
Typical angina (definite)  - Meets three of the following characteristics  
•  Substernal chest discomfort of characteristic quality and duration  
•  Provoked by exertion or emotional stress  
•  Relieved by rest and/or GTN (glyceryl trinitrate) 
Atypical angina (probable)  - Meets two of the above characteristics  
Non-cardiac chest pain   - Meets one or none of the above  
This  definition  outlined  what  constitutes  typical  characteristics  of  angina 
pectoris, and framed it into the categories of location, character, duration and 
relation to exertion, and other exacerbating or relieving factors. What constitutes 
typical characteristics of angina was not specified in the Diamond and Forrester 
definition.  
1.6.1.3 The Rose angina questionnaire 
The  Rose  angina  questionnaire  (RQ)  is  a  widely-used  survey  tool  for  the 
measuring of angina in populations (see appendix 13.3).36 The questionnaire was 
introduced  in  1962  and  defines  angina  as  chest  pain  that  limits  exertion,  is 
situated over the sternum or in the left chest and left arm, and is relieved within 
10 minutes by rest. It is highly specific when compared against a medical record 
of doctor-diagnosed angina,37 and is strongly associated with subsequent risk of 
coronary  events  in  European  populations.38  This  definition  outlines  typical 
characteristics of angina pectoris within the categories of location, duration and 
relation to exertion.  31 
 
1.6.2  Measuring angina 
The  early  and  appropriate  identification  of  angina  will  result  in  early  and 
appropriate investigation and treatment.33 34 
1.6.2.1 Typicality of angina 
While laboratories standardise assays for biomarkers in the measurement of a 
myocardial infarction, angina is a clinical constellation of symptom descriptors, 
rendering  quantitative  measurement  difficult.  There  are  no  large  studies 
comparing the diagnostic and prognostic value of chest pain descriptors between 
ethnic groups, as symptoms have been predominately investigated in White male 
populations.  Furthermore,  there  is  a  perception  that  all  South  Asian 
populations39-41 and other ethnic minorities42 43  with suspected ischaemia are 
more  likely  to  report  atypical  symptom  descriptors  of  pain.  This  has  been 
attributed  to  cultural  differences  in  the  experience,  interpretation  and 
understanding of pain,39 whilst biologically,  there is evidence to suggest that 
there are ethnic differences in the interpretation of cutaneous pain (to a series of 
thermal stimuli in a study of 27 White participants and 24 African Americans 
participants),44 implying that similar differences may occur in the interpretation 
of visceral pain such as angina although this is far from proven. 
Most studies have been performed in those presenting with the acute chest pain 
of  a  suspected  myocardial  infarction.40  45  Teoh  et  al  studied  symptom 
distribution between Asian and Caucasian patients at presentation with acute 
coronary syndromes at a London hospital. They concluded that ‘Asian patients 
were younger, more likely to be diabetic and tended to report a higher intensity 
of pain and over a higher area of their body, and more frequent discomfort over 
the rear of their upper thorax than Caucasian patients’. In a study examining first 
myocardial infarctions in South Asian and White patients who had presented to 
the coronary care unit of a district general hospital,46 chest pain was deemed 
atypical in 26 (51%) of the Asian and 30 (39%) of the White patients. 
Fewer studies have examined the typicality of chronic angina symptoms. The 
reliability  of  the  Rose  angina  questionnaire  was  reported  in  a  2001  cross-
sectional study to be inconsistent in South Asian populations  when compared to 32 
 
self-reported  doctor-diagnosed  angina  and  independently  coded 
electrocardiogram (ECG) abnormalities.39 The capacity of RQ ‘definite angina’ to 
identify  doctor-diagnosed  angina  was  lower  in  South  Asian  populations 
compared to European populations. 
Beyond  these  cross-sectional  studies,  the  prospective  validity  of  angina 
measures in comparing prognosis between ethnic groups is also unknown. Thus, 
ethnic differences in angina prognosis may not be apparent if ethnic differences 
in the description of symptoms are not taken into account. 
1.6.2.2 Severity of angina 
Ambulatory patients reporting a significant deterioration in their angina over the 
preceding month have been found to have a higher one-year mortality rate than 
those with more stable symptoms.47 Furthermore, a higher burden of symptoms 
is  associated  with  higher  physical  and  role  functioning.48    As  angina  has 
potentially adverse prognoses both in terms of mortality and morbidity if not 
adequately  managed,  accurate  measurement  of  its  severity  is  of  clinical 
importance.  
The Canadian Cardiovascular Society (CCS) classification system has been used 
as an epidemiological tool to measure the severity of angina.49 Worse severity of 
angina  on  the  CCS  score  is  associated  with  a  more  adverse  prognosis  as 
measured by rates of myocardial infarction and death.50 This measure is a scale 
ranging from I, when angina is mild and does not limit physical activity, through 
to IV, when angina severely restricts activities (box below). 
Canadian Cardiovascular Society Functional Classification of Angina 
Class  Activity Evoking Angina        Limits to Physical Activity 
I  Prolonged exertion        None 
II  Walking > 2 blocks or > 1 flight of stairs    Slight 
III  Walking < 2 blocks or < 1 flight of stairs    Marked 
IV  Minimal or at rest        Severe 33 
 
1.6.3  Prevalence of angina  
Around 2 million women and men in the UK have angina and about 1% of the 
population visit their general practitioner at least once yearly with symptoms of 
angina.30 National surveys have produced data on the prevalence of angina in the 
UK,  as  tabulated  below  (Table  1).  In  a  meta-analysis  on  the  international 
prevalence of angina, angina varied from 0.73% to 14.4% in women (population 
weighted mean, 6.7%) and 0.76% to 15.1% in men (population weighted mean, 
5.7%).29  
      Prevalence of angina (%) 
      Ages 55-64  Ages 65-74 
Study, year  Study 
population 
Definition of angina  Women  Men  Women  Men 
Health 
survey for 
England, 
2006* 
Random 
sample of 
addresses - 
14,142 adults 
interviewed 
Rose Angina 
Questionnaire/Self-
reported doctor-
diagnosed angina 
3.3/3.2  3.6/8.0  5.0/8.3  4.9/14.2 
The Scottish 
Health 
Survey, 
2003** 
Random 
sample of 
addresses - 
8,148 adults 
interviewed 
Rose Angina 
Questionnaire/Self-
reported doctor-
diagnosed angina 
4.0/7.4  5.1/11.2  16.8/14.2  6.7/20.8 
* http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-surveys/health-survey-for-england/health-
survey-for-england-2006:-cvd-and-risk-factors-adults-obesity-and-risk-factors-children  
**http://www.scotland.gov.uk/Publications/2005/11/25145024/50253  
Table 1 Prevalence of angina in UK adults from survey data 
The  incidence  of  diagnosed  angina  appears  to  be  increasing  when  examining 
secular trends from 1978 to 2000. This is in contrast to a decline in rates of all 
other  types  of  major  coronary  events  among  British  men.51  General  practice 
morbidity survey data from England and Wales also indicates that angina may be 
increasing,31 with the rate of consultation for angina among men and women in 
the  1990s  higher  than  in  the  1980s,  the  comparable  statistic  for  myocardial 
infarction having fallen during this time. Contrasting evidence from the British 
Regional Heart Study reported that the prevalence of angina symptoms fell from 
1978-1996, among men with and without a diagnosis of coronary heart disease.52 34 
 
This was a study in which angina was defined in a standardised way throughout 
follow-up. However, this reported finding is limited by the authors’ technique of 
determining overall population prevalence of angina through the use of a series 
of  cross  sectional  studies  nested  within  what  is  a  prospective  cohort  study. 
Though  analyses  were  age-adjusted,  the  presented  ‘trend’  in  prevalence  of 
angina  should  be  interpreted  cautiously.  Their  findings  of  a  decline  in  age-
specific angina prevalence are more robust among the men aged between 55 and 
64 years, who contributed to at least three of the cross sectional studies. Data 
from successive Health Surveys  for England can provide information on such 
trends and overall show no evidence of any significant change in the prevalence 
of self reported symptoms as assessed by the Rose Questionnaire between 1991 
and 1994 and only a small, non-significant decline in men between 1994 and 
1998.53  Thus,  a  valid  measurement  of  chest  pain  is  important  for  the  true 
assessment of prevalence.  
1.6.3.1 Prevalence of angina by minority ethnic group 
Clinical  trials  of  angina  have  largely  recruited  male,  White  patients  from 
secondary and tertiary centres,54-57 rendering conclusions on the prevalence of 
angina in ethnic groups difficult. Furthermore, the definitions and measures of 
angina have been largely derived and validated in White male populations. The 
prevalence of angina was reported to be higher in some South Asian peoples 
compared to the majority White population (self-reported ‘ever diagnosed by the 
participant’s doctor’) in the Health Survey for England in 2004 (Table 2).58 
  Caribbean  Indian  Pakistani  Bangladeshi  Chinese  Irish  General 
population 
Men               
Observed %  3.4  4.9  6.9  3.1  1.6  4.0  4.8 
Standardised 
risk ratio 
0.73  1.26  2.85  1.24  0.60  0.73  1 
Women               
Observed %  1.5  3.2  2.5  2.0  1.2  2.5  3.4 
Standardised 
risk ratio 
0.61  1.79  2.19  2.22  1.00  0.87  1 
Table 2 Prevalence of angina in minority ethnic groups, Health Survey for England in 2004  
However, when angina was assessed in this survey by the Rose questionnaire, 
the differences between minority ethnic groups and the general population were 35 
 
smaller than those assessed by the self-reported diagnosis. Hence, the finding 
that the Rose questionnaire seemed to produce different responses to the self-
reported  diagnoses  thus  questions  the  validity  of  methods  used  to  measure 
angina in South Asian populations. If the accurate measurement of angina is of 
importance  in  determining  prevalence  and  prognosis,  this  assumes  a  higher 
importance  if  ethnic  differences  are  apparent  as  a  result  of  usage  of  these 
measures.  
1.6.4  Treatment of angina 
The management of angina comprises two main strategies: 
•  Anti-anginal  medication  -  β-blockers,  calcium-channel  antagonists, 
nitrates and potassium-channel activators like nicorandil 
•  Coronary revascularisation (following investigation by invasive coronary 
angiography)  –  percutaneously  by  balloon  angioplasty/stenting,  or 
surgically through bypass grafting.  
Many patients with angina are not investigated through coronary angiography, 
as symptoms may settle on medication alone. As the risk of death from coronary 
angiography is around 1 in 1000,59 the purpose of coronary angiography is to 
plan  a  management  strategy  beyond  medication  alone  that  will  improve  the 
patient’s quality of life or prognosis.  American College of Cardiology/American 
Heart Association Guidelines for Coronary Angiography60 recommend invasive 
investigation in patients with CCS class III and IV angina despite being on anti-
anginal medication. 
In patients with angina, those of South Asian origin have been reported to be less 
likely to undergo coronary revascularisation than those of White origin.61 This 
may not be solely explained by access to specialist services, as general practices 
with a higher proportion of South Asian patients have been reported as having 
higher rates of coronary angiography.57 South Asian populations have also been 
shown to have higher rates of angiography than White populations in studies of 
healthy individuals.62 Furthermore, South Asian people were more likely to seek 
immediate care for (hypothetical) anginal symptoms than White people41 in a 36 
 
survey on attitudes to health seeking behaviour and have been reported to have 
had more consultations with a general practitioner in the year before coronary 
angiography than White people.61 It has been proposed that differences in the 
description of symptoms might contribute to inequalities in medical care,40 63 as 
the  diagnostic  validity  of  symptoms  plays  an  important  role  in  deciding 
appropriate  further  clinical  investigation  and  hence  management.47  This  may 
explain  ethnic  differences  in  the  loss  of  patients  between  getting  a  coronary 
angiogram and ultimately receiving the treatment, coronary revascularisation, 
after it.  
1.6.5  Prognosis of angina  
In patients with a diagnosis of angina, it has been reported that 17% will have 
died from coronary heart disease or been admitted with a non-fatal myocardial 
infarction or unstable angina within three years.29 
Prognosis of angina can be investigated both in terms of: 
•  the  future  risk  of  serious  manifestations  of  coronary  disease  such  as 
unstable angina, myocardial infarction and coronary death; 
•  as an outcome itself, as those who suffer angina and undergo treatment to 
allay  their  symptoms  may  have  their  symptoms  return  (symptomatic 
prognosis). 
1.6.5.1 Risk of future myocardial infarction and coronary death  
In those patients with exertional angina, prognosis for myocardial infarction and 
death is not improved by coronary revascularisation: 
•  A meta-analysis of randomised controlled trials in 2000 comparing PTCA 
(percutaneous  trans-luminal  coronary  angioplasty,  balloon  angioplasty 
alone without stenting) with medical treatment alone in chronic coronary 
heart disease concluded that PTCA led to a reduction in angina (relative 
risk (RR) 0.70 (95% confidence interval (CI) 0.50-0.98)) but conferred no 
beneficial effects on risk of myocardial infarction or death.64  37 
 
•  In the Second Randomized Intervention Treatment of Angina (RITA-2),65 
death or myocardial infarction occurred in 73 (14.5%) PTCA patients and 
63 (12.3%) medical patients (p=0.21).  
•  A 1994 meta-analysis compared CABG with medical treatment and found 
that surgery conferred a survival advantage only in those patients with 
severe  left  main  stem  coronary  disease,  three-vessel  disease,  or  two-
vessel disease with a severely stenosed proximal left anterior descending 
artery.66  However,  only  10%  of  trial  patients  received  an  internal 
mammary artery graft in addition to their vein grafts, routine practice in 
current surgery now. Only 25% received anti-platelet drugs whilst use of 
statins was similarly low compared to current standards.  
Secondary prevention medical therapy (aspirin, statins) on the other hand plays 
a role in the stabilisation of the atherosclerotic process, as shown in studies such 
as the REVERSAL study, where intensive lipid-lowering treatment with statins 
reduced  the  progression  of  coronary  atherosclerosis  as  measured  by 
intravascular  ultrasound.67  The  effect  of  cholesterol  lowering  with  statins  on 
mortality and morbidity in patients with coronary heart disease is well-known, 
first muted on a large scale by the 4S study,68 and subsequently shown on meta-
analysis of 4S and four subsequent trials.54  
1.6.5.2 Risk of future recurrent angina  
The  importance  of  revascularisation  in  improving  symptomatic  outcomes  has 
been shown in both meta-analyses64 and large clinical trials.47 However, studies 
have  documented  that  many  patients  undergoing  revascularisation  still  have 
angina  after  1  year69  70  and  ethnic  disparities  in  clinical  outcomes have  been 
reported in African-American patients who reported higher rates of angina than 
White  patients  at  six  months  following  coronary  angiography.71  A  study  on 
outcomes following coronary bypass surgery revealed that medical management, 
length of stay and hospital morbidity in Indo-Asian patients was no different 
from that of their White Caucasian counterparts, though numbers were small 
(n=194  in  both  arms)  and  follow-up  short,  limited  to  in-patient  stay  post-
operatively.72  If  South  Asian  patients  do  have  higher  long-term  symptomatic 38 
 
outcomes however, this would increase the size of the prevalent pool of angina in 
South Asian populations. This is of importance to public health as angina places a 
significant  burden  on  both  morbidity  and  health  service  usage,  with  angina 
patients constituting up to two thirds of the patients that undergo PCI in Western 
countries.64 73  
1.7  Myocardial infarction 
The arrival of sensitive and specific serologic biomarkers has led to a change in 
the  definitions  of  myocardial  infarction.  The  World  Health  Organisation  had 
defined myocardial infarction as a combination of two of three characteristics: 
typical  symptoms  (i.e.,  chest  pain/discomfort),  enzyme  rise  and  a  typical 
electrocardiogram pattern involving the development of Q waves.74 The arrival 
of biomarkers has led to the introduction of the term ‘acute coronary syndrome’ 
which now includes all those with ST-segment elevation myocardial infarction 
(STEMI),  non-ST-segment  elevation  myocardial  infarction  (NSTEMI)  and 
unstable angina.c 
1.7.1  Definition of myocardial infarction 
The ability to detect very small infarcts that would not previously have been 
considered a myocardial infarction has resulted in many individuals, who were 
formerly diagnosed as having unstable angina, being diagnosed today as having 
had  a  myocardial  infarction.  This  has  resulted  in  a  change  of  definition  of 
myocardial  infarction  as  presented  in  the  consensus  document  of  the  Joint 
European  Society  of  Cardiology/American  College  of Cardiology  committee  in 
2000.75  Creatine  phosphokinase-MB  isoenzyme  (CK-MB),  a  previously  widely-
used biomarker for myocardial infarction, has now been shown to be unsuitable 
as a diagnostic gold standard for the diagnosis of myocardial infarction76 and the 
use of cardiac troponins are now widespread. Troponins are integrally involved 
in the process of myofibril contraction and relaxation within the cardiac myocyte 
and  troponin  T  and  troponin  I  are  highly  sensitive  and  specific  markers  of 
myocardial injury.  
                                                        
c The term acute coronary syndrome in this thesis will henceforth imply the inclusion of 
myocardial infarction within it  39 
 
The new definition of a myocardial infarction now requires a raised troponin 
level,  after  which  electrocardiogram  changes  indicative  of  ischaemia  allow 
further classification into clinically-relevant types which determine appropriate 
clinical management. These types include STEMI with ST segment elevation on 
ECG  representing  total  occlusion  of  a  coronary  artery  and  NSTEMI  with  ST 
segment depression representing sub-total occlusion of a coronary artery. The 
term ‘unstable angina’ still represents the initial presenting clinical syndrome of 
recurrent episodes of angina on minimal effort or at rest, and a raised troponin 
consequently redefines it as a NSTEMI. 
A  troponin  value  of  0.05  µg/l  has  been  proposed  as  the  most  appropriate  to 
define  an  acute  coronary  syndrome,76  though  what  constitutes  a  myocardial 
infarction  remains  unclear,  the  most  recent  consensus  document  (Joint  Task 
Force  for  the  Redefinition  of  Myocardial  Infarction)  simply  stating  that  ‘an 
increased value for cardiac troponin is defined as a measurement exceeding the 
99th  percentile  of  a  normal  reference  population’.77  Many  hospitals  define  a 
NSTEMI as a troponin above a certain level, such as 0.05 µg/l or above, and thus 
use the term ‘troponin-positive acute coronary syndrome’ for those with a raised 
troponin, but which is less than 0.05 µg/l. There is no consensus however for 
this, and the troponin cut-point is often used simply to allocate those who would 
have cardiac rehabilitation. In practice, the treatment of NSTEMI and ‘troponin-
positive acute coronary syndrome’ are broadly similar. 
1.7.2  Prevalence of myocardial infarction 
National  surveysd  report  a  prevalence  of  myocardial  infarction  in  the  UK  of 
around  14%  in  men  and  3-7%  in  women  aged  65-74.  The  prevalence  of 
myocardial infarction in men aged 55-64 is between 6-9%, whilst for women the 
figures are 2-4%. However, the situation is complicated by the heterogeneous 
                                                        
dHealth Survey for England 2006 http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-
related-surveys/health-survey-for-england/health-survey-for-england-2006:-cvd-and-risk-factors-adults-obesity-and-
risk-factors-children  
The Scottish Health Survey 2003 http://www.scotland.gov.uk/Publications/2005/11/25145024/50253  
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nature  of  myocardial  infarction  as  described  above.  Furthermore,  from  a 
predominance of STEMI in the past, STEMIs are declining in prevalence,78 with 
the overall proportion of NSTEMI increasing.79  
The  multinational  Global  Registry  of  Acute  Coronary  Events  (GRACE)  project 
reported data from its first 11543 patients in 2002.80  Of these patients included, 
38% had a final diagnosis of unstable angina, 30% had STEMI, and 25% had 
NSTEMI. The ENACT study in 1999 on patients hospitalised with acute coronary 
syndromes  in  390  hospitals  in  29  European countries  reported  that  unstable 
angina was the most frequent cause of hospitalisation (46%), followed by acute 
myocardial  infarction  (39%).81  In  a  prospective  survey  of  the  characteristics, 
treatments and outcomes of patients with acute coronary syndromes in Europe, 
the  Euro  Heart  Survey  of  Acute  Coronary  Syndromes  reported  an  initial 
diagnosis  of  STEMI  in  42.3%,  NSTEMI  in  51.2%,  and  ‘undetermined 
electrocardiogram acute coronary syndrome’ in 6.5%.82 
1.7.2.1 Prevalence of myocardial infarction by minority ethnic group 
With  regard  to  ethnicity,  the  age-standardised  risk  ratios  of  myocardial 
infarction for South Asian men and women did not differ significantly from men 
and women in the general population in the Health Survey for England in 2004 in 
all aged above 16 years.58 There is a trend towards a younger age of presentation 
in South Asian patients.8 83 
1.7.3  Treatment of myocardial infarction  
Treatment of patients with an acute coronary syndrome who present with ST-
segment elevation on the ECG (STEMIs) is principally aimed at restoration of 
myocardial  perfusion  (reperfusion)  using  fibrinolysis  (thrombolytic  drugs)  or 
increasingly  primary  percutaneous  coronary  intervention  (PCI, 
angioplasty/stenting).  However,  NSTEMIs  and  unstable  angina  are  more 
heterogeneous in their presentation and are associated with a higher variation in 
diagnosis  and  treatment.84  Variations  in  receipt  of  medical  treatment  such  as 
statins  as  well  as  access  to  angiography  and  subsequent  receipt  of  coronary 
revascularisation are widely present in such patients.85 The wide range of clinical 41 
 
manifestations and hence treatments will result in variable prognoses. Reasons 
behind these variations may include:  
-  the use of different definitions for ‘unstable angina’ and ‘NSTEMI’84 
-  differences in the characteristics of presenting patients 
-  geographical  practice  variation,81  which  is  influenced  by  the  incidence  of 
coronary  heart  disease  in  the  local  population,  the  type  of  resources 
available, and doctors’ perceptions of existing therapies.  
It  is  conceivable  that  ethnic  differences  will  exist  in  treatment  and  hence 
prognosis  and  explaining  reasons  behind  such  differences  will  entail 
consideration of not only biological differences but also socio-demographic and 
clinical management variables. 
1.7.4  Prognosis of acute coronary syndromes  
The hospital death rate for patients with STEMI in the GRACE study was 7%,85 
whilst those patients with NSTEMI and unstable angina had a rate of death at 
seven days of 6% and 3% respectively. Longer-term follow-up has shown that 
within five years of first admission with an acute myocardial infarction, around 
40% of  patients will have died, principally of a repeat myocardial infarction or 
other coronary cause.86 
However, it has been reported that 70% of those with ‘unstable angina’ can have 
detectable  elevated  troponin  levels.76  These  patient  would  have  had  CK-MB’s 
reported as within the normal range. The importance of this is more than just to 
categorise.  These  patients  with  elevated  troponin  levels  are  subject  to  a 
significant risk of adverse cardiac events. 50% of these patients will experience 
recurrent  ischaemia  and  10%  will  die  or  re-infarct  within  30  days  despite 
optimum  medical  management.  This  has  prompted  investigation  into  better 
pharmacological therapy and the role of invasive procedures.87 Patients with the 
highest  risk  of  adverse  complications  are  most  likely  to  derive  the  greatest 
benefit  from  invasive  therapy  and  the  release  of  troponin  identifies  high-risk 
patients  where  early  coronary  intervention  significantly  reduces  adverse 
coronary outcomes, as those without a troponin release have similar outcomes 42 
 
with either a pharmacological therapy approach or an invasive revascularisation 
approach.88  
Using troponin testing as a means of improved discrimination of those at risk, 
inequalities  in  the  clinical  management  of  acute  coronary  syndromes  may  be 
reduced. Prior to the widespread introduction of troponin testing, a considerable 
difficulty  in  clinical  practice  was  in  identifying  those  at  risk  within  the  wide 
spectrum of patients that presented with acute chest pain.  
1.8  Factors determining prognosis of angina and myocardial 
infarction  
Aetiological factors that predict incidence, both biological and social, may also 
influence  prognosis.  Prognosis  will  also  be  affected  by  strategies  of  clinical 
management and level of disease severity at time of presentation of coronary 
disease. Furthermore, prognostic outcomes should include not only the risk of 
future death and other serious clinical presentations but also those that measure 
morbidity,  i.e.,  in  patients  with  angina,  the  study  of  symptomatic  outcomes 
(improvement of angina).  
1.8.1  Risk factors 
In White populations, aetiologic risk factors for myocardial infarction such as 
hypertension, diabetes and smoking are in addition prognostic factors.89  90 In 
patients  diagnosed  with  coronary  heart  disease  who  smoked,  a  systematic 
review  of  cohort  studies  showed  a  36%  reduction  in  crude  relative  risk  of 
mortality for patients who quit compared with those who continued smoking.91 
However, such patterns may not be as simple in South Asian populations. In a 
prospective cohort study conducted of 828 South Asian and 27,962 non South 
Asian patients in the UK with insulin-treated diabetes diagnosed at ages under 
50 years, standardised mortality ratios for South Asian patients (mainly of Indian 
or Pakistani descent) diagnosed with diabetes under age 30 years were 3.9 (95% 
CI 2.0-6.9) in men and 10.1 (5.6-16.6) in women, and in the corresponding non 
South  Asian  patients were  2.7  (2.6-2.9)  and  4.0  (3.6-4.3),  respectively.92  That 
diabetes mellitus may have a worse prognosis in South Asian patients  for future 
adverse  coronary  outcomes  and  diabetes-related  complications  has  been 43 
 
proposed  by  others,93  and  the  finding  that  South  Asian  patients  have  poorer 
knowledge and understanding of diabetes94 may play a role in this. 
The prevalence of risk factors also differs by ethnic groups, and prevalence is not 
necessarily  higher  in  South  Asian  populations,  with  lower  levels  of  total 
cholesterol  and  smoking  prevalence  than  the  White  majority  population.95 
Furthermore, South Asian patients, from Bangladeshis in London to Indians in 
the USA, present with coronary disease at younger ages than White patients,96 97 
age being the most important non-modifiable risk factor in the aetiology and 
prognosis  of  coronary  disease  from  large  population  studies  such  as 
Framingham98  and  the  World  Health  Organisation  MONICA  Project 
(multinational  monitoring  of  trends  and  determinants  in  cardiovascular 
disease).99 
1.8.2  Disease severity 
Within the coronary disease phenotypes of angina and myocardial infarction, the 
severity of disease at presentation will affect prognosis.  Severity of disease can 
be classed as anatomical, functional and symptomatic.  
1.8.2.1 Anatomical severity  
The degree of coronary disease at coronary angiography predicts future risk of 
adverse outcomes in those presenting with myocardial infarction.100 Previously 
reported ethnic differences in degree of coronary disease between South Asian 
and White populations may therefore be a factor in prognosis, as South Asian 
patients  have  been  reported  to  have  more  severe  coronary  disease  at 
angiography than White patients when presenting with coronary disease.101 
The breakdown of acute coronary syndrome by degree of coronary occlusion 
(e.g.  STEMI/NSTEMI)  and  whether  an  effect  modification  of  this  on  the 
relationship between ethnicity and prognosis exists is not known. Furthermore, 
it is not known whether South Asian patients present with differing severity of 
myocardial  infarction  (levels  of  troponin,  left  ventricular  function)  to  White 
patients and whether this in turns affects prognosis.   44 
 
1.8.2.2 Functional severity 
The degree of myocardial ischaemia associated with coronary artery disease can 
be measured by exercise ECG testing, which remains the most widely accessible 
and  relatively  inexpensive  method.  Prediction  of  future  coronary  events  and 
mortality is also an important use of the exercise ECG.102  
1.8.2.3 Symptomatic severity 
That the South Asian population is more likely to report atypical features of pain 
require prognostic analyses to take this into account. Typical pain is suggestive 
of more severe coronary disease than atypical pain.103 Comparing the prognostic 
validity  of  typical  against  atypical  chest  pain  descriptors  for  severe  adverse 
outcomes  such  as  myocardial  infarction  and  coronary  death  is  therefore  of 
importance. Furthermore, severity of angina predicts higher physical and role 
functioning  and  hence  prognosis  in  terms  of  symptomatic  outcomes 
(improvement in angina) needs studying.  
1.8.3  Social environment 
The  comparative  prognosis  of  acute  coronary  syndromes  in  South  Asian  and 
White patients may be affected by a range of factors that are not only biological 
but social. Previous research has shown the association between individual-level 
socioeconomic  characteristics  and  coronary  heart  disease,  a  higher 
socioeconomic status associated with a lower coronary mortality,104 and that the 
social deprivation of areas influences the aetiology and prognosis of coronary 
disease.105  
1.8.3.1 Deprivation 
South Asian populations are more likely to live in areas with relative social and 
economic deprivation.106 Studies that report that South Asian patients receive 
worse clinical management suggest this may be associated with the deprived 
areas they live in.29  
1.8.3.2 Access to care 
The relationship between social environment and minority ethnic group health 
need not necessarily be a negative one. Distance from hospital is a prognostic 
factor – in a study examining ambulance journeys to hospital of patient with 
potentially  life-threatening  conditions,  increased  distance  from  hospital  was 45 
 
associated with increased risk of death (odds ratio 1.02 per kilometre; 95% CI 
1.01  to  1.03;  p<0.001).  This  association  was  not  changed  by  adjustment  for 
confounding  by  age,  sex,  clinical  category  or  illness  severity.107  This  is  of 
relevance  to  prognostic  analyses  in  acute  coronary  syndromes  considering 
minority ethnic groups in the UK tend to live close to acute hospitals.108 It has 
long  been  recognised  that  access  to  coronary  revascularisation  services  may, 
paradoxically, be increased in deprived areas in the UK, probably as a result of 
their proximity to specialist cardiac centres such as teaching hospitals.109 
1.8.4  Clinical management 
1.8.4.1 Secondary prevention drugs 
Cross-sectional  studies  have  reported  in  ecological-type  analyses  that  general 
practitioner prescribing rates of statin prescription were lower in primary care 
trusts with a higher percentage of South Asian people.110 However, more recent 
studies using data from the 2001 Census and Quality and Outcomes Framework 
data  suggest  that  such  medical  therapy,  which  plays  an  important  role  in 
improving prognosis,68  111 is on the contrary more highly prescribed in South 
Asian  and  more  deprived  communities.112  Hence,  taking  into  account  such 
differences in clinical management is of importance in prognostic analyses. 
1.8.4.2 Specialist investigation and treatment  
Some studies report an underuse of coronary revascularisation amongst South 
Asian patients deemed appropriate to receive it.61 In acute coronary syndromes, 
an elevated troponin level subjects that patient to a significant risk of adverse 
cardiac  events  such  as  death,  and  hence  access  to  early  coronary 
revascularisation  that  reduces  the  risk  of  premature  death  is  of  higher 
importance.  Thus,  any  underuse  in  a  particular  ethnic  group  will  potentially 
worsen their prognosis.  
In those patients with exertional angina, access to clinical management strategies 
which provide symptomatic relief for the patient will be of higher importance.  46 
 
1.9  Relationship between healthy individuals and those with 
coronary disease, and factors affecting incidence and prognosis  
Understanding  the  relationship  between  healthy  individuals  and  those  with 
coronary disease, and of how factors affecting incidence also affect prognosis 
requires  the  disaggregation  of  the  coronary  disease  entity.  The  figure  below 
(Figure 2) highlights the complexity of these relationships, and serves as a model 
for the prospective analyses of my thesis. It outlines the relationships within the 
umbrella  of  coronary  disease  of  the  primary  clinical  presentations  of  the 
pathological  process  of  coronary  atherosclerosis,  angina  and  myocardial 
infarction.  It  demonstrates  the  possible  pathways  a  healthy  individual  may 
present  themselves  to  healthcare  services  with  coronary  disease,  and  the 
relationships of these coronary phenotypes with ensuing death.  
This thesis seeks to compare if these relationships vary between South Asian and 
White populations, to investigate ethnic differences in incidence and prognosis of 
angina  and  myocardial  infarction,  and  factors  determining  prognosis  of  these 
differing clinical presentations of coronary disease.  47 
 
 
 
Figure 2 Relationship between healthy individuals and those with coronary disease, and factors affecting incidence and prognosis  48 
 
 
2  Aims and objectives 
2.1  Aim 
This thesis seeks to investigate the contribution of incidence and prognosis of 
differing  clinical  presentations  of  coronary  disease  such  as  angina  and 
myocardial infarction to the higher coronary mortality rates observed in South 
Asian compared to White populations in the UK. 
2.2  Specific research objectives  
1.  To determine the incidence and prognosis of angina in healthy South Asian 
and White populations. 
2.  To  determine  in  those  presenting  with  incident  chest  pain  whether 
differences exist in the description of symptoms between South Asian and 
White  populations,  and  the  association  of  symptom  descriptors  with 
prognosis  and  receipt  of  management  strategies  for  chronic  coronary 
disease. 
3.  To  determine  impact  on  symptomatic  prognostic  outcomes  (change  in 
angina  severity)  in  South  Asian  and  White  populations  from  different 
management strategies for chronic angina.  
4.  To  compare  fatal  prognostic  outcomes  of  acute  coronary  syndromes  in 
South  Asian  and  White  populations  and  assess  factors  underlying 
prognosis. 
5.  To  assess  the  contribution  of  incidence  and  prognosis  to  the  higher 
coronary  death  rates  in  South  Asian  compared  to  White  populations 
through meta-analysis of the four cohorts and previously reported studies. 49 
 
 
3  Systematic literature review 
3.1  Summary of chapter 
 
Background The higher coronary mortality in South Asian compared to White 
populations may be either due to a higher incidence of coronary disease in South 
Asian populations or a worse prognosis in them. A review in 2000 reported no 
evidence for a higher incidence of coronary disease in South Asian populations 
and the overall prognosis of coronary disease in South Asian compared to White 
populations was not known. 
Methods A systematic review was conducted on MEDLINE and Embase from 
January  1966  to  November  2008  to  identify  eligible  prospective  studies  that 
compared incidence and prognosis of coronary artery disease in South Asian and 
White  populations.  Backward  citation  tracking  through  hand-searching  of 
reference  lists  of  eligible  studies  and  forward  citation  tracking  of subsequent 
articles that cited eligible studies were conducted. 
Results Of six studies on incidence, five reported that South Asian populations 
have a higher incidence of coronary disease. There were few data on non-fatal 
incidence.  When  considering  the  seven  studies  on  prognosis,  event  numbers 
were  low  in  South  Asian  participants  (221  recorded  in  total,  they  were 
heterogeneous in their methods and adjustment for confounders was lacking. 
Studies  focussed  more  on  fatal  rather  than  non-fatal  outcomes,  and  on 
presentation with myocardial infarction rather than angina. 
Conclusions  The  literature  on  incidence  of  coronary  disease  in  South  Asian 
populations  suggests  a  higher  incidence  of  fatal  coronary  disease  in  them 
compared  to  White  populations,  but  the  literature  on  non-fatal  incidence  is 
sparse.  When  considering  prognosis,  the  literature  is  unable  to  definitively 
answer  whether  prognosis  is  worse  in  South  Asian  compared  to  White 
populations. 50 
 
 
3.2  Introduction 
A higher coronary mortality in South Asian compared to White populations has 
been reported from census data in the UK. Whether this is a consequence of 
higher incidence of coronary disease or a worse prognosis of already-manifested 
coronary disease in South Asian compared to White populations is not known. 
Furthermore,  incidence  itself  can  be  non-fatal  or  fatal  and  the  prognoses  of 
differing  clinical  presentations  such  as  angina  and  myocardial  infarction  are 
different. Prognostic outcomes should also examine not only the risk of future 
death but also non-fatal outcomes for the overall assessment of prognosis. 
A  systematic  review  published  in  2000  examining  the  evidence  of  coronary 
disease in South Asian compared to White populations reported that of the 19 
studies retrieved, none reported incidence, and highlighted the higher number of 
cross-sectional  studies  measuring  prevalence  of  coronary  disease  phenotypes 
such as self-reported angina.113 No prospective studies were reported. There was 
also  wide  heterogeneity  in  case  definitions  of  ethnic  grouping,  and  in  the 
measurement  of  differing  clinical  presentations  of  coronary  disease  such  as 
angina and myocardial infarction. The overall picture of incidence and prognosis 
of coronary disease in South Asian compared to White populations is thus not 
known. 
3.3  Research objective to be investigated 
This chapter sought to systematically identify and critically evaluate published 
literature relating to all five specific research objectives of this thesis.  
3.4  Specific research questions 
i.  What is the current knowledge from peer-reviewed published literature 
on the incidence of coronary disease (fatal and non-fatal) in healthy 
South Asian and White populations?  
ii.  What is the current knowledge from peer-reviewed published literature 
on the comparative prognosis of the coronary disease presentations of 51 
 
angina  and  myocardial  infarction  in  South  Asian  and  White 
populations? 
3.5  Methods 
3.5.1  Search strategy  
MEDLINE 1966-2008 was searched without any language restriction and using 
the following Medical Subject Heading terms: 
(India or Pakistan or Bangladesh or Sri Lanka or Ethnic Groups or ethnology or 
Asian  Continental  Ancestry  Group  or  Asia)  AND  (coronary  or  myocardial 
infarction or myocardial ischaemia or cardiovascular disease)  
Studies were identified for incidence or prognosis by adding these as text word 
search terms. To focus further on longitudinal studies and incidence, the search 
was expanded using a combination of all the Medline Clinical Queries filters for 
incidence,114 and including ‘follow-up studies’ and ‘treatment/disease-outcome’ 
as terms as well. The  search was  repeated in Embase. Hand-searching of the 
reference list of eligible studies was conducted to identify further relevant work 
(backward citation tracking). Science Citation Index was used to identify all the 
subsequent  papers  that  cited  any  of  the  eligible  studies  (forward  citation 
tracking) using ISI Web of Science.  
This search was undertaken prior to commencement of this PhD and updated in 
November 2008. 
3.5.2  Inclusion criteria  
The titles and abstracts and, where not clear, full manuscripts of all identified 
studies were examined and eligibility for inclusion was defined if:  
•  The study compared South Asian and White ethnic groups.  
•  For incidence:  
o  The  study  was  prospective  in  populations  without  clinically 
manifested coronary disease, or presented data on relative risk of 
coronary mortality from cross-sectional analysis. 52 
 
o  Outcomes were defined as death and incident non-fatal myocardial 
infarction or angina. 
•  For prognosis:  
o  The  study  was  prospective  in  a  population  with  the  coronary 
disease phenotypes of angina (stable or unstable) or myocardial 
infarction/acute coronary syndrome.   
o  Outcomes were defined as mortality from coronary disease or non-
fatal angina/myocardial infarction. 
3.5.3  Data extracted 
The full manuscripts of the papers remaining were obtained and the following 
data extracted from each paper 
•  setting of study 
•  number of participants by ethnic group 
•  the terminology used for the ethnic groups (retained in describing eligible 
studies in this chapter) 
•  age (mean or median) 
•  numbers of women/men and diabetics 
•  outcome and duration of follow-up 
•  risk factors that were adjusted for in prospective analyses. 
3.5.4  Incidence of coronary disease  
The MEDLINE search strategy for incidence is outlined in appendix 13.4. 137 
relevant publications were found. 
3.5.4.1 Papers excluded after reviewing titles and abstracts 
Of  the  137  results  obtained,  after  scanning  the  titles  and  abstracts,  46  were 
excluded on the basis that the study focussed on an ethnic group other than 53 
 
South Asian (such as Black, Far Eastern), or used a comparison group other than 
White.115  e 
Four  studies  within  these  46  presented  mortality  data  by  splitting  the  South 
Asian population into their constituent peoples. As this thesis aims to study the 
South Asian population as a whole group, these studies were not comparable to 
the  planned  analyses  for  this  thesis.11  13  116  12  As  outlined  earlier,  many 
similarities exist between South Asian peoples, and differences between South 
Asian peoples are less likely to affect prognosis than incidence. 
However, these studies are of broader relevance and are outlined in the table 
below. The study by Harding et al11 examined trends for coronary heart disease 
mortality among migrants in England and Wales from 1979–2003. Most South 
Asian  populations  remained  at  higher  risk  of  death  in  all  three  time  periods. 
Wild’s study of 2001 census data12 utilised the ability of this latest census to code 
the  South  Asian  population  by  their  constituent  peoples.  Mortality  rates 
remained higher in all South Asian peoples. The group were unable to provide a 
standardised mortality ratio for the South Asian population as a whole (personal 
communication,  Sarah  Wild).  Hippisley-Cox  et  al116  examined  incidence  of 
cardiovascular  disease  and  found  a  higher  incidence  of  combined  non-fatal 
events in all South Asian peoples. Fischbacher et al’s13 comparisons within the 
Scottish population did not report excess coronary mortality in all South Asian 
peoples. However, the authors commented that when using England and Wales 
as a comparison group, the excess of coronary mortality risk among the South 
Asian population in Scotland was comparable to that reported in England and 
Wales. 
                                                        
e An example of the latter showed that Asian Indian male migrants were more prone to suffer 
from a myocardial infarction or coronary death than the majority populations of Chinese and 
Malays in Singapore.  
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Study  
(year of 
publication) 
 
Methods  Outcomes  Results  
Harding 
(2008) 
From Office for 
National Statistics 
anonymised death 
records 1979-83, 1989-
93 and 1999-2003. 
Cross-sectional age-
standardised and sex-
specific death rates and 
rate ratios 
In all three time periods, compared with men 
born in England and Wales, men born in East 
Africa, India, Pakistan, Bangladesh, Scotland, 
Northern Ireland, Republic of Ireland or Poland 
had higher mortality.  
Among women, consistently higher mortality 
was seen for those born in India, Scotland, 
Northern Ireland or Republic of Ireland in all 
time periods compared to women born in 
England and Wales. Rate ratios in Pakistan-
born women in 1999–2003 were more than 
twice that of England and Wales born women. 
Hippisley- 
Cox 
(2008) 
Prospective open 
cohort study with 
routinely collected data 
from general practice 
and linked Office for 
National Statistics 
death certificates, 1 
January 1993 to 31 
March 2008 
Incident diagnosis of 
cardiovascular disease 
(coronary heart disease, 
stroke, and transient 
ischaemic attack)  
Adjusted risk is 45% higher (29% to 63%) 
among Indian men, 67% higher (40% to 101%) 
among Bangladeshi men, and 97% higher (70% 
to 129%) among Pakistani men 
Fischbacher 
(2007) 
Census data for Scottish 
residents aged 25 years 
and over between 
January 1997 and 
March 2003. 
Standardised mortality 
ratios by country of birth 
High all-cause, coronary heart disease (CHD) 
and stroke mortality among Scottish residents 
born in Scotland, Northern Ireland, the 
Republic of Ireland, India and Hong Kong.  
Wild 
(2007) 
Population data from 
the 2001 Census and 
mortality data for 2001-
2003.  
All-cause and circulatory 
disease sex-specific 
standardised mortality 
ratios (SMRs) and 95% 
confidence intervals (CI) 
people aged 20 years 
and over in England and 
Wales by country of 
birth 
SMRs for circulatory disease were as follows: 
people born in Bangladesh 167 (136–204); 
India 149 (142–157); Pakistan 174 (159–192).  
Table 3 Studies examining mortality and incidence of coronary disease within South Asian 
peoples compared to White majority populations  
 
Two  studies  within  these  46  were  North  American  studies  which  used 
proportional mortality ratios and did not present direct comparisons between 
South Asian and White populations and hence were not included.14 15  
77 were excluded as the study was not on coronary disease and 11 on the basis 
that  the  study  examined  cross-sectional  associations  of  cardiovascular  risk 
factors rather than coronary disease. The systematic review on the subject by 
Bhopal was in itself not an original study.113  55 
 
Expanding the search traced a further six studies to add to the two from the 
initial search leaving eight in total for which manuscripts of the papers were 
obtained for full inspection. 
3.5.4.2 Papers excluded after review of full text 
The following were excluded: 
A study which had originally recruited participants with hypertension from a 
time  period  between  1979  to  1993  used  a  combined  outcome  that  made 
comparison with other studies’ outcomes impossible.117 Khattar et al published a 
longitudinal comparison of morbidity and mortality among White, South Asian 
and Afro-Caribbean participants with hypertension, originally recruited between 
1979 to 1993 at a North-West London district general hospital, and followed-up 
at  five  years  for  the  risk  of  non-cardiovascular  death,  coronary  events, 
cerebrovascular  events,  and  peripheral  vascular  death.  Coronary  events 
consisted  of  a  combined  coronary  death  (myocardial  infarction  or  ischaemia, 
ventricular  fibrillation,  and  cardiac  failure),  nonfatal  myocardial  infarction, 
coronary artery bypass graft surgery, and percutaneous transluminal coronary 
angioplasty. South Asian participants had the highest all-cause event rate of the 
ethnic groups, the high event rate because of an excess of coronary events (2.86 
in South Asian participants compared to 1.32 events/100 participant-years in 
White  participants,  p  <  0.01).  Cox  proportional  hazards  regression  analysis 
(adjusting for age, sex, diabetes, previous cardiovascular disease and 24 hour 
systolic blood pressure) revealed that South Asian origin was an independent 
predictor of time to a first event (South Asian v White participants: p = 0.008). 
Patel  et  al’s  study  followed  up  participants  with  hypertension118  to  compare 
rates  of  myocardial  infarction  amongst  South  Asian  participants  compared  to 
White European Caucasian participants. On comparison of baseline risk factors, 
Caucasian participants with hypertension were older, more likely to smoke, more 
obese and more hyperlipidaemic than South Asian participants, who had more 
diabetes. The use of antihypertensive therapies was more common amongst the 
Caucasian participants compared to South Asian participants. During the 5-year 
follow-up period the rate of myocardial infarction was double in South Asian 56 
 
participants to that observed in European Caucasian participants. This increased 
incidence of myocardial infarction was fully accounted for by diabetes, and the 
group could not provide a multivariate-adjusted incidence rate ratio (personal 
communication, Jeetesh Patel).  
This left six eligible studies comparing the incidence of coronary disease in South 
Asian alongside White populations, of which two were cross-sectional studies on 
mortality.  57 
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Figure 3 Literature search flow diagram for the comparison of incidence of coronary disease 
between South Asian and White populations 
 
3.5.5  Prognosis of coronary disease 
The MEDLINE search strategy is outlined in appendix 13.5. Using the clip-board 
facility on Search 2.0 to collate the articles found from searches numbered 28, 
29, 30, 37, 43, there were 426 relevant publications.  
3.5.5.1 Papers excluded after reviewing titles and abstracts 
Of the 426 results obtained, after scanning the titles and abstracts, 100 were 
excluded on the basis that the study focussed on an ethnic group other than 
South Asian (such as Black, Far Eastern), or used a comparison group other than 
Potentially relevant publications on incidence from MEDLINE search history (n=137) 
Excluded as study covers an ethnic group other than South Asian (n=46) 
 
Studies on South Asian and White populations (n=91) 
Excluded as study not on coronary disease (n=77) 
Studies on coronary disease in South Asian and White populations (n=14) 
Excluded as examining cross-sectional associations of risk factors or review (n=12) 
Excluded (n=2) 
Potentially relevant publications on incidence from Medline Clinical 
Queries,‘follow-up studies’ and ‘treatment/disease-outcome’ and Embase (n=6) 
 
6 satisfied inclusion criterion of comparison of incidence of coronary disease between 
South Asian and White populations 58 
 
White.119 f 246 were excluded as the study was not on coronary disease and 72 
on  the  basis  that  the  study  examined  cross-sectional  associations  of 
cardiovascular  risk  factors  rather  than  coronary  disease  or  was  a  review 
(Bhopal).113 This left eight studies.  
Expanding the search traced a further study (appendix 13.6) to add to the eight 
from the initial search leaving nine in total for which manuscripts of the papers 
were obtained for full inspection. 
3.5.5.2 Papers excluded after review of full text 
The following were excluded: 
Lane  et  al  compared  cardiovascular  and  all-cause  mortality  among  White 
European,  African-Caribbean  and  South  Asian  populations  through  an 
observational follow-up study in Birmingham. However, the dataset had serious 
limitations, given that significantly fewer South Asian men could be traced by the 
Office for National Statistics, and there were no data on follow-up for the South 
Asian women in the study at all.120 
Shaukat et al had in 1997 presented results in the BMJ that patients of Indian 
subcontinent origin were at substantially higher risk of mortality and of further 
coronary  events  than  patients  of  European  origin  after  first  myocardial 
infarction.  However,  this  work  was  subsequently  retracted  due  to  research 
fraud.121 
This left seven eligible studies comparing the prognosis of coronary disease in 
South Asian and White populations. 
                                                        
f An example of the latter is of Mak et al, who reported on myocardial infarction mortality event 
rates and mortality among Chinese, Malay and Indian residents of Singapore.  In comparison with 
the Chinese population, the Malay population had the highest case-fatality. 59 
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Figure 4 Literature search flow diagram for the comparison of prognosis of coronary disease 
between South Asian and White populations 
 
3.6  Results  
3.6.1  Studies included on incidence of coronary disease  
These are described below, and further details tabulated after (Table 4). 
3.6.1.1 Fatal outcomes 
Two studies presented census data on the increased coronary mortality in South 
Asian compared with White populations. Balarajan’s study based on the 1981 
census,8  and  Wild  and  McKeigue’s  study  based  on  1991  census  data10  have 
already both been discussed in chapter 1. 
Potentially relevant publications on prognosis from MEDLINE search history (n=426) 
Excluded as study covers an ethnic group other than South Asian (n=100) 
Studies on South Asian and White populations (n=326) 
Excluded as study not on coronary disease (n=246) 
Studies on coronary disease in South Asian and White populations (n=80) 
Excluded as examining cross-sectional associations or review (n=72) 
Excluded (n=2) 
7 satisfied inclusion criterion of comparison of prognosis of coronary disease between 
South Asian and White populations 
Potentially relevant publications on prognosis from Medline Clinical 
Queries,‘follow-up studies’ and ‘treatment/disease-outcome’ and Embase (n=1) 60 
 
One prospective cohort study that examined coronary death as a longitudinal 
outcome in healthy individuals comparing South Asian and White populations 
was  found.  Forouhi  et  al  (2006)122  was  designed  to  prospectively  assess  the 
survival of 1787 European and 1420 South Asian men recruited in West London 
in  1988.  Ethnicity  was  identified  on  the  basis  of  name,  country  of  birth  and 
appearance,  supplemented  by  direct  enquiry  in  cases  of  doubt.  Follow-up, 
flagged for death notification from the Office for National Statistics, was 99.4%.  
Multi-variate Cox regression models were developed, and analyses adjusted for 
age and coronary risk factors. The results showed that South Asian men in this 
study  had  higher  coronary  mortality  than  European  men,  and  this  remained 
significantly higher in multi-variate models. 
3.6.1.2 Non-fatal outcomes 
3.6.1.2.1  Healthy individuals  
Fischbacher  et  al’s123  2007  paper  examined  incidence  of  fatal  and  non-fatal 
myocardial infarction. It was a record-linked retrospective cohort study of 4.6 
million people. It linked information on individual ethnic group from the 2001 
census  to  Scottish  hospital  discharge  and  mortality  data.  94%  of  the  census 
records  were  matched  to  a  unique  national  health  identifier,  the  Community 
Health  Index  record.  Myocardial  infarction  was  as  recorded  by  a  clinician  at 
hospital  discharge  or  recorded  as  the  underlying  cause  of  death  on  a  death 
certificate. The South Asian population comprised people who were designated 
as the head of household at the 2001 census as Pakistani, Indian, Bangladeshi 
and other South Asian. The paper reported that the incidence rate ratio for acute 
myocardial  infarction,  fatal  combined  with  non-fatal,  was  1.45  (95%  CI  1.17-
1.78) for South Asian compared to non-South Asian men and 1.80 (95% CI 1.31-
2.48) for South Asian women compared to non-South Asian women. Age, sex and 
previous admission for diabetes were adjusted for in the analyses. Out of the 126 
incident myocardial infarctions in South Asian people, 21(17%) were fatal; in 
non-South Asian people, 9672(31%) of the 30978 events were fatal. 
3.6.1.2.2  Individuals with coronary disease risk factors but no coronary disease 
The UK Prospective Diabetes Study 32124  sought to estimate the incidence of 
myocardial infarction (fatal and non-fatal combined) by ethnicity in participants 61 
 
with diabetes (4974 patients, aged 25-65 years, 82% White, 10% South Asian). 
General practitioners referred 7,108 newly diagnosed participants with diabetes, 
aged 25–65 years, to 23 clinical centres throughout the UK between 1977 and 
1991. The participant defined his or her own ethnicity. The median follow-up 
was  8.7  years.  This  study  reported  that  the  hazard ratio  for  the  South  Asian 
compared to the White population of myocardial infarction was 1.2 (95% CI 0.9-
1.7), after adjusting  for age, sex, year of study entry, systolic blood pressure, 
smoking,  social  class,  total  cholesterol,  and  high  density  lipoprotein  (HDL) 
cholesterol.  
The  11-year  follow-up  on  the  Southall  Diabetes  Survey125  was  undertaken  in 
1984. All subjects who could be traced for follow-up were sent a questionnaire 
which enquired about a history of heart attack requiring hospital admission. A 
100%  concordance  was  noted  between  self-reporting  of  morbid  events  and 
hospital  case-notes.  The  study  used  the  term  European  for  the  reference 
population.  Completed  questionnaires  were  obtained  from  89%  of  the  South 
Asian participants and 93% of European participants still alive. The method of 
ascertainment of ethnicity was not specified in the paper. A history of myocardial 
infarction  requiring  hospital  admission  (hence  allowing  ascertainment  of 
incidence for solely non-fatal events) was 2.5 times more common in South Asian 
participants as in European participants and adjustment for the younger age of 
South  Asian  participants  further  increased  the  odds  ratio  for  a  history  of 
myocardial  infarction  to  3.8  (95%  CI  1.8–8.0,  p=0.001).  The  study  did  also 
examine the coronary mortality rate ratio for the South Asian population versus 
the  European  population,  though  due  to  the  age  difference  between  ethnic 
groups,  age-stratified  analyses  rather  than  an  age-adjusted  mortality  was 
presented in the paper. This made it difficult to compare incidence of fatal events 
with other studies retrieved earlier with fatal outcomes. In those aged 30-64, risk 
of death from circulatory disease for ischaemic heart disease was twice as high in 
South Asian participants than in European participants, whereas coronary death 
rates  in  more  elderly  (age  above  75)  South  Asian  participants  with  diabetes 
appeared better than elderly European participants with diabetes. 62 
 
Table 4 Literature search for the comparison of incidence of coronary disease between South Asian and White populations 
Study (year of 
publication) 
 
Design, setting and 
recruitment time 
N (men/women)  Percentage diabetic  
(S. Asian/White) 
Age  
 
Length of follow-up in 
years/outcome 
Number of events  
(S. Asian/White) 
Results   Variables adjusted for 
in analyses 
CROSS-SECTIONAL 
Wild (1997)  Cross-sectional census 
data, England and 
Wales, 1989-92 
SA: 318,805/ 315,382 
W: 15,634,589/ 
16,070,270 
-  -  -/coronary death  4230/177327  SMRs for those born in 
South Asia of 151 for 
women and 146 for 
men 
Age  
Balarajan (1991)  Cross-sectional census 
data, England and 
Wales, 1979-83 
SA: 3410/798 
W: 207,936/6248 
-  -  -/coronary death  4208/277184  SMRs for those born in 
South Asia of 146 for 
women and 136 for 
men  
Age  
COHORT 
Forouhi  (2006)  Cohort study of healthy 
men aged 40-69  from 
general practice lists in 
West London, 1988  
SA: 1420/- 
W: 1787/- 
35.4/ 19.6  South Asian 51.2 (7.0) 
White 52.9 (7.1) 
Mean (SD) 
16.2/Coronary death  108/95  Adjusted coronary 
mortality higher in 
South Asian men  
(HR 1.68 (1.21,1.94) 
Age, smoking, blood 
pressure, diabetes, 
lipids 
Fischbacher (2007)  Census data, Scotland, 
2001-2003 
SA: 9706/9285 
W: 1,464,458/ 
1,709,148 
 
-  -  2/fatal or first nonfatal 
MI 
126 (38 women)/ 
30978 
 (13276 women) 
Incidence rate ratios in 
South Asian compared 
to non-South Asian 
1.45 (1.17, 1.78) in 
men, 1.80 (1.31, 2.48) 
in women 
Age, sex, previous  
admission for diabetes  
U.K. Prospective 
Diabetes 
Study 32 (1998) 
Prospective cohort 
study of patients with 
new type 2 diabetes, 
aged 25–65 years, from 
23 UK clinics, 1977-91  
SA: 336/154 
W: 2367/1734 
All  South Asian 47.0 
White 52.2 
Mean 
8.7/ fatal or first 
nonfatal 
MI 
490/4101  Adjusted hazard ratio 
for MI in South Asian 
compared to White 
participants 
1.2 (0.9-1.7). 
Age, sex, systolic blood 
pressure, smoking 
history, lipids, HbA1c 
 
Mather (1998)  Prospective cohort 
study of patients with 
diabetes, aged 30 years 
and over, from 
community survey, 
1984 
SA: 730 (m+w) 
W: 304 (m+w) 
All  South Asian 55.0 
White 67.0 
Mean 
11/nonfatal MI  82/9  myocardial infarction 
requiring hospital 
admission 2.5 times 
more common in South 
Asian as in White 
participants 
Age 
HbA1c - haemoglobin A1C (glycosylated haemoglobin); MI – myocardial infarction 63 
 
3.6.2  Studies included on prognosis of coronary disease 
These are described below, and further details tabulated after (Table 5). 
3.6.2.1 Outcomes from myocardial infarction  
Six studies that compared prognosis between South Asian and White populations 
following  presentation  with  myocardial  infarction  were  found.  All  of  these 
studies  examined  fatal  outcomes,  with  none  of  them  examining  non-fatal 
outcomes. 
The most recent paper was Fischbacher et al’s study,123 described above within 
the incidence search, which had also examined prognosis following myocardial 
infarction. After adjustment for age, sex and any previous admission for diabetes, 
the  hazard  ratio  for  death  following  myocardial  infarction  reflected  better 
survival among the South Asian population. 
Liew et al126 reported on case fatality rates for acute myocardial infarction in 
South Asian and White patients admitted to a single centre coronary care unit. 
This study examined short-term (in-hospital) outcomes of patients over a period 
of  15  years.  Hence  the  design  of  the  study  was  to  examine  cross-sectional 
outcomes of patients with acute myocardial infarction treated in an inner city 
coronary  care  unit  over  a  specific  time  period  rather  than  specifically  the 
outcomes  of  one  cohort.  Analysis  of  the  records  of  all  coronary  care  unit 
admissions of patients with acute coronary syndromes during 2002 at the unit 
was used to record ethnicity and this showed that 38% (196 of 521) were South 
Asian, which approximated well to the proportion of South Asian people (33%) 
living in the catchment area of the hospital at the time. Myocardial infarction was 
defined as any two of typical chest pain, 0.1 mV ST elevation on ECG and a rise in 
serum  CK.  The  study  concluded  that  the  rate  of  in-hospital  mortality  was  in 
progressive decline and that these improvements were observed in both South 
Asian  and  White  patients.  No  difference  in  case  fatality  rates  between  South 
Asian and White patients was observed. Analyses were not designed to adjust for 
potential confounders.  
Gupta et al published127 a follow-up study of Canadian South Asian patients with 
myocardial infarction, albeit based on a retrospective review of charts from two 64 
 
hospital  sites,  and  only  looking  at  in-hospital  outcomes.  Participants  were 
matched for age, sex, hospital and discharge date. A list of all patients with a 
discharge diagnosis of myocardial infarction  between January 1994 and April 
1999 was obtained from the two hospitals in the study (n=4180). They identified 
South  Asian  patients  by  their  surnames  and  first  names,  and  by  using  self-
reported  ethnicity  and  country  of  birth  when  available.  Of  the  734  patients 
identified as probably from the South Asian population, 553 were matched to 
non-South Asian patients by age within five years, sex, hospital and discharge 
date within six months. Most of the remaining 181 South Asian patients were 
excluded because of inability to find a matched control subject or missing charts. 
Anterior infarctions occurred more frequently among the South Asian patients 
than  among  the  control  subjects  but  infarct  size  as  measured  by  creatine 
phosphokinase  did  not  differ  significantly  between  the  two  groups.  They 
reported  similar  in-hospital  outcomes  between  the  South  Asian  patients  and 
matched control groups (in a logistic regression model using age, smoking status 
and diabetes, the risk-adjusted death rate was similar for the two ethnic  groups 
(9.1% and 7.7% respectively, p=0.20). 
Wilkinson et al compared mortality in South Asian and White patients in the six 
months  after  hospital  admission  for  acute  myocardial  infarction  in  the  east 
London borough of Newham.96 They recorded ethnic group in all patients from 
their response to a direct question. South Asian patients were younger, a higher 
proportion  of  them  did  not  smoke  and  a  substantially  higher  proportion  had 
diabetes (38.3% v 10.9%). After adjustment for age, sex, previous myocardial 
infarction,  and  treatment  with  thrombolysis  or  aspirin,  or  both,  South  Asian 
patients had a poorer survival over the six months from myocardial infarction 
(HR  (95%CI)  2.02  (1.14-3.56)).  Additional  adjustments  for  diabetes,  and  also 
clinical symptoms and signs of left ventricular failure were performed, and this 
resulted in the excess risk disappearing (HR (95%CI) 1.44 (0.79-2.61)). 
Mukhtar  and  Littler  compared  outcomes  after  myocardial  infarction  in  South 
Asian patients with those of White patients in a prospective case-control study 
undertaken in Birmingham, UK.128 All patients of South Asian ethnic origin aged 65 
 
69 or less who were admitted with chest pain to the coronary care units of five 
hospitals  in  Birmingham  between  1  July  1986  and  30  June  1987  were 
documented. Details of ethnic origin were recorded on the original admission 
and confirmed before discharge. All South Asian patients were matched for age 
and sex with White patients who were admitted to the same hospital during the 
same period of time and discharged alive with a confirmed diagnosis of acute 
myocardial  infarction.  There  was  no  significant  difference  between  the  two 
groups with regard to the main risk factors for coronary artery disease. There 
was also no difference in the range of cardiac medication taken by the South 
Asian  and  White  patients  in  the  follow-up  period.  Information  as  to  whether 
patients  were  alive  or  dead  was  obtained  from  their  general  practitioners. 
Patients  with  a  confirmed  myocardial  infarction  were  invited  for  a  follow-up 
interview 18 months after the original infarct. Four South Asian patients could 
not  be  traced.  The  paper  reported  no  significant  difference  in  survival  or 
complications during the four years after an acute myocardial infarction in South 
Asian and White patients.  
Hughes et al46 compared the natural course of first myocardial infarction in Asian 
and White patients who had presented to the coronary care unit of a district 
general hospital in north-west London. The primary aim of the paper was to 
present  data  on  the  prevalence  and  characteristics  of  myocardial  infarction 
between the two ethnic groups. Over two years from June 1985 to June 1987, 
128 men (77 White, 54 Asian) presenting consecutively with a first myocardial 
infarction were recruited into the study. Myocardial infarction was diagnosed in 
the presence of any two of a clinical history compatible with infarction, a serial 
rise and fall in creatine phosphokinase activity and typical electrocardiographic 
changes persisting for a minimum of 24 hours. All patients were followed up for 
one year. Patients lost to follow up (seven White, eight Asian) were assumed to 
have followed a similar clinical course to the remainder of their ethnic group. 
Data  on  one-year  follow-up  for  all-cause  death  showed  that  14%  of  Asian 
patients had died compared to 10% of White patients (numbers of deaths being 
respectively six and seven in Asian and White groups). No account was taken for 
confounders such as diabetes and age.  66 
 
3.6.2.2 Outcomes from angina  
One study compared prognosis between South Asian and White patients of any 
other presentation of coronary disease bar myocardial infarction. This was an 
earlier report from one of the cohorts for this thesis. It examined South Asian and 
White patients with chronic angina undergoing coronary angiography and found 
no  differences  in  mortality  between  South  Asian  and  White  patients  (age-
adjusted HR 1.05 (95% CI 0.68 to 1.63)) nor in rates of combined death and non-
fatal myocardial infarction (HR 1.07, 95% CI 0.78 to 1.47) at median follow-up 
for 30 months.61 The paper’s remit was not a focus on outcomes but more on 
appropriateness of care, and further adjustments for confounding variables were 
not performed. 
3.6.2.3 Non-fatal outcomes 
There  were  no  studies  retrieved  that  examined  non-fatal  outcomes  such  as 
angina.67 
 
 
Study (year of 
publication) 
 
Design, setting and 
recruitment time 
N (men/women)  Percentage diabetic 
(South Asian/White) 
Age  
 
Length of follow-up 
/outcome 
Number of events 
(South Asian/White) 
Results   Variables adjusted for 
in analyses 
Fischbacher et al 
(2007) 
Retrospective myocardial 
infarction cohort from 
census data (Scotland) 
2001-2003 
SA: 88/38 
W: 17,696/13,276  
-  -  2 years/all-cause death  40/17,075  Risk of death 0.59 (95% 
CI 0.43-0.81), reflecting 
better survival among 
South Asian patients. 
Age, sex and any 
previous admission for 
diabetes  
Liew et al (2003)  Myocardial infarction 
cohort (London, UK)  
1998–2002 
SA: 303 
W: 469 
-  -  days/all-cause death  19/56  No ethnic difference in 
in case fatality rates  
 
Nil 
Feder et al (2002)  Coronary angiography 
cohort (London, UK) 
1996-1997 
SA: 391/111 
W: 2112/862 
33/9  South Asian patients 
older (presented as age 
categories) 
30 months/death or 
non-fatal MI 
50/386  No ethnic differences 
in outcomes  
Age  
Gupta et al (2002)  Matched myocardial 
infarction cohort (Canada) 
1994-1999 
SA: 381/172 
W: 381/172 
 
43.4/28.2  South Asian 62.6 
White 63.0 
Mean age 
6 days/Coronary death  45/39  Similar in-hospital 
mortality (9.6% and 
7.8%, p = 0.27) 
Age, sex, smoking, 
diabetes 
Wilkinson et al (1996)   Myocardial infarction 
cohort (London, UK) 
1988-1992 
SA:129/20 
W:259/54 
38.3/10.9  South Asian 54 (49-59)      
White 57 (50-60) 
Median (inter-quartile 
range) 
0.5 years/ all-cause 
death 
49/78  South Asian population 
had poorer survival 
accounted for by 
diabetes 
Age, sex, previous  
admission for diabetes, 
impaired left ventricle 
Mukhtar et al (1995)  Matched myocardial 
infarction cohort 
(Birmingham, UK) 
1986-1987 
SA:102 
W:102 
23.5/14.7  South Asian 54.0(8.6)  
White 53.9 (68.5) 
Mean age (SD) 
8.7 years/ fatal or first 
non-fatal MI 
12/10  No significant 
difference in survival  
Age, sex  
Hughes et al (1989)  Myocardial infarction 
cohort (London, UK) 
1985-1987 
SA:23/20 
W:50/20 
 
-  South Asian 50.2 (9.0) 
White 55.5 (6.7) 
Mean age (SD) 
1 year/all-cause death 
 
6/7 
 
14% of South Asian 
compared to 10% of 
the White population 
had died  
Nil 
Table 5 Literature search for the comparison of prognosis of coronary disease between South Asian and White populations68 
 
3.7  Discussion 
From the systematic review of this chapter, there were some prospective studies 
on  incidence  of  coronary  disease,  whilst  still  few  in  numbers,  whilst  the 
literature  on  prognosis  in  South  Asian  compared  to  White  populations  was 
heterogeneous  and  focussed  mostly  on  fatal  outcomes  following  myocardial 
infarction.  The  review  of  Bhopal  in  2000  had  concentrated  on  incidence  and 
prevalence. It found no evidence was available on incidence of coronary disease 
in  South  Asian  compared  to  White  populations,  and  did  not  report  any 
prognostic studies.  
3.7.1  Incident disease  
There were few studies examining incidence of solely non-fatal events and no 
studies on the incidence of angina in South Asian and White populations. There 
were only two prospective studies in healthy individuals, Forouhi et al122 and 
Fischbacher  et  al123  both  showing  that  South  Asian  populations  had  a  higher 
incidence  of  coronary  disease  compared  to  White  populations.  Of  the  other 
studies in individuals with risk factors but no manifest coronary disease, all but 
one reported a higher incidence of coronary disease in South Asian compared to 
White populations. Hence, though few studies exist on incidence, there are at 
least  some  and  this  represents  an  improvement  on  Bhopal’s  review  in  2000 
which retrieved none. 
3.7.2  Prognosis of disease  
When considering prognosis, the literature was heterogeneous in terms of length 
of follow-up, with three of the studies on participants with myocardial infarction 
focussing  solely  on  short-term,  in-hospital  events.  Participant  numbers  were 
small,  resulting  in  small  numbers  of  outcomes.  In  total,  across  seven  studies 
spanning recruitment from 1989-2003, there were only 221 events recorded in 
South Asian populations. Over half of these, 114 in total, were within one month 
of the index event. Adjustment for confounders was lacking – though all studies 
that recorded diabetes prevalence reported a higher prevalence in South Asian 
compared  to  White  populations,  multi-variate  regression  analyses  were  not 
consistently performed to account for this. None of the studies fully took into 
account  ethnic  differences  in  clinical  management,  social  environment  and 69 
 
disease  severity.  Studies  tended  to  focus  mostly  on  fatal  outcomes  following 
presentation  with  myocardial  infarction,  and  there  was  only  one  study 
examining  prognosis  of  angina,  and  none  on  non-fatal  outcomes.  Finally, 
throughout all these studies, the method of recording of ethnic group was not 
consistent. 
3.7.3  Implications 
3.7.3.1 Incidence of coronary disease  
The lack of studies examining incidence of solely non-fatal events such as angina 
between South Asian and White populations is significant. If incidence of non-
fatal events such as angina is higher among South Asian populations than White 
populations, then the appropriate identification and management at this initial 
presentation  may  prevent  progression  to  more  serious  later-phase 
manifestations of coronary disease such as myocardial infarction and ultimately 
coronary death. Therefore, knowledge of the incidence of angina is important to 
the overall picture of coronary disease epidemiology between South Asian and 
White populations. 
3.7.3.2 Prognosis of coronary disease  
Studies  retrieved  were  heterogeneous  in  their  methods  and  thus  makes  it 
difficult to render a conclusion on the prognosis between South Asian and White 
populations.  No contemporary studies have examined prognosis between South 
Asian  and  White  populations  using  the  newer  definitions  of  myocardial 
infarction taking into account troponin level. Furthermore, few studies exist that 
have compared prognosis between South Asian and White populations of any 
other presentation of coronary disease bar myocardial infarction such as angina.  
3.8  Conclusion 
The literature on incidence of coronary disease in the South Asian population is 
sparse but suggests overall a higher incidence of fatal coronary disease in South 
Asian  compared  to  White  populations.  There  are  few  studies  on  non-fatal 
incidence.  When  considering  prognosis,  the  literature  is  heterogeneous  and 
focussed mostly on myocardial infarction and thus is unable to answer whether 
prognosis is worse in South Asian compared to White populations. 70 
 
 
4  Data in four cohorts used for this PhD 
4.1  Summary of chapter 
The purpose of this chapter is to present the four studies chosen to span the 
natural history of coronary disease and prognostic risk. The methodology of the 
datasets is compared and contrasted, and in particular the quality and validity of 
the data examined for those variables essential for the analyses of this thesis 
such  as  ethnicity  and  chest  pain.  This  is  of  greatest  importance  in  the  acute 
coronary syndrome registry (MINAP), as the other three  cohort studies were 
designed for research.  71 
 
 
4.2  The cohorts 
To answer the specific objectives of the thesis, four cohort studies were chosen 
to span the natural history of coronary disease.   
4.2.1  Healthy population cohort  
The Whitehall-II study was set up to examine reasons behind the social gradient 
in health and disease found in the original Whitehall study of the 1960s.129 The 
target population for the Whitehall-II study was all civil servants aged 35–55 
years working in the London offices of 20 Whitehall departments in 1985–88. 
10308  people  were  recruited,  3413  women  and  6895  men.  The  participants 
included  all  grades,  from  clerical  and  office  support  grades  through  middle-
ranking executive grades up to senior administrative grades, differing widely in 
salary. The whole cohort was surveyed at the research clinic at 5-year intervals, 
and a postal questionnaire was sent out to them between clinic phases.130 131  
Ethical approval for the study was obtained from the University College London 
Medical School Committee on the ethics of human research.  
4.2.2  Chest pain clinic cohort  
The Chest Pain Clinic study recruited participants, all with suspected new-onset 
stable angina, in six rapid access chest pain clinics in the United Kingdom from 2 
January 1996 to 31 December 2002. The participating centres were:  
￿  Newham General Hospital  
￿  Oldchurch Hospital 
￿  Manchester Royal Infirmary 
￿  Blackburn Royal Infirmary 
￿  Burnley General Hospital 
￿  Kingston General Hospital 
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The rapid access chest pain clinic at Newham General Hospital (now University 
Hospital) in east London was the first of these to be established in January 1996. 
It was one of the first nationally and four years later became the service model 
for the National Service Framework.132  g The National Service Framework for 
coronary  artery  disease  recommended  rapid  access  chest  pain  clinics  for 
cardiological assessment of recent onset chest pain within two weeks of referral 
from  primary  care.  This  compressed  timeframe  from  generalist  to  specialist 
could not be achieved in the conventional outpatient cardiology clinic with its 
referrals for a wide range of other cardiac conditions. Rapid access chest pain 
clinics  concentrate  cases  of  chest  pain  and  thus  can  model  revascularisation 
requirements  by  measuring  the  population  frequency  of  the  indications  for 
which  revascularisation  confers  benefit.  Such  an  "incidence  of  indications" 
approach has been applied in other conditions (for example, the need for total 
hip replacement133).  
At  the  time  the  rapid  access  chest  pain  clinic  was  established,  an  electronic 
database was developed in which registry baseline data on consecutive patients 
attendances were recorded. The success of the database led to its utilisation in 
five  other  rapid  access  chest  pain  clinics  around  the  country,  all  of  which 
recorded data in identical fields to those used at Newham.  
Ethical approval for the multi-centre study was obtained from a multiregional 
ethics  committee  (Multi-centre  Research  Ethics  Committee  /02/04/095).  The 
National  Patient  Information  Advisory  Group  gave  permission  to  link 
anonymised data sets without obtaining individual patient consent.  
4.2.3  Coronary angiography cohort  
The  Appropriateness  of  Coronary  Revascularisation  (ACRE)  Study  was  a 
prospective  study  investigating  clinical  outcomes  in  patients  undergoing 
coronary angiography at two hospitals within one NHS Trust – The London Chest 
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and St Bartholomew’s Hospitals. It was set up in 1995 to assess the appropriate 
use of coronary angiography, as wide variations in practice existed. The resident 
population  of  the  combined  catchment  area  was  2,833,000  with  89%  of  the 
angiography procedures performed in this population being performed at this 
NHS Trust. Patients were referred from five different health authorities (East 
London  and  the  City,  Barking  and  Havering,  Redbridge  and  Waltham  Forest, 
North  or  South  Essex)  and  13  hospitals  as  well  as  approximately  700  GP 
practices.   
Coronary  angiography  is  defined  by  the  American  Heart  Association  as  the 
‘radiographic visualization of the coronary vessels after injection of radio-opaque 
contrast media’.60 A sheath is inserted percutaneously into a peripheral artery 
(most  commonly  the  femoral  artery  in  the  groin)  under  local  anaesthesia 
through  which  a  fine  hollow  coronary  catheter  is  manipulated,  under  x-ray 
guidance, into the origin of the coronary arteries. It is a relatively safe procedure, 
the risk of major complications being ~1 in 1000.59  Complications include death, 
myocardial infarction, stroke, aortic or coronary dissection, cardiac rupture, air 
embolus, cardiac arrhythmia and peripheral arterial injury.  
In  ACRE,  all  consecutive  patients  undergoing  elective  (more  than  90%)  and 
emergency coronary angiography admitted between April 15th 1996 and April 
14th 1997 were recruited at the time of their coronary angiogram.  4120 patients 
were identified from ward admission and catheter laboratory log books.  There 
were no exclusion criteria. 54% of the ACRE cohort went on to revascularisation 
at 2.5 years. Ethical approval for the study came from the five local research 
ethics committees.  
4.2.4  Acute coronary syndrome cohort 
The Myocardial Infarction National Audit Project (MINAP) is a registry which 
contains data from patients with an acute coronary syndrome who have been 
admitted  to  all  230  hospitals  in  England  and  Wales.134  The  use  of  medical 
registries  to  audit  clinical  practice  has  sharply  increased  due  to  progress  in 
information  technology  and  increasing  demands  for  accountability.  A  medical 
registry has been defined as ‘a systematic collection of a clearly defined set of 74 
 
health  and  demographic  data  for  patients  with  specific  health  characteristics, 
held in a central database for a predefined purpose’.135 Beyond their role as tools 
to  monitor  and  improve  quality  of  care,  registries can  also be  a  resource  for 
epidemiological research.  An advantage of such databases is that they include 
all-comers,  and  therefore  have  no  exclusion  criteria  as  in  the  case  of  clinical 
trials. Thus, conclusions from research from them are potentially applicable to all 
with the condition under study. Exclusion criteria within trials often exclude for 
example high-risk patients.  
The degree of the population coverage within MINAP cannot be matched by the 
national register in the USA (which selects 20% of hospitals)136 or elsewhere in 
Europe.137   Each  month,  MINAP  accrues  over  7000  acute  coronary  syndrome 
events. MINAP records 108 data fields, covering acute coronary syndrome type 
and  severity  (such  as  ECG  changes  and  markers  of  myocardial  necrosis)  risk 
factors, drugs and invasive management. Such data are not available in routinely 
collected Hospital Episode Statistics data, the national statistical data warehouse 
for England of the care provided by NHS hospitals and for NHS hospital patients 
treated elsewhere.h Large-scale data on admission rates with ACS with respect to 
ethnicity, or by specific sub-types of ACS cannot be provided by Hospital Episode 
Statistics  because  there  is  no  coding  of  ethnicity  or  of  STEMI,  ACS  (troponin 
positive or negative) or NSTEMI.  The database thus has the potential, through its 
large numbers of participants, to examine in detail hypotheses pertaining to the 
differing types of the acute coronary syndromes. Furthermore, it has the ability 
to  take  into  account  the  multitude  of  confounding  factors  that  operate  when 
considering the prognosis of acute coronary syndromes. The MINAP dataset is a 
collection  of  terms  and  definitions  which  allows  national  consistency  when 
comparing or describing any aspect of care of acute coronary syndromes. Not 
every  data  item  is  relevant  for  every  patient,  as  those  with  STEMI  will  for 
example have a different clinical management strategy to those with NSTEMI.  
However, the value of such clinical registration datasets to research depends on 
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the  quality  of  the  data  as  the  validity  of  registry  data  is  most  threatened  by 
incomplete and incorrect data entry. 
Between 1 January 2004 to 31 December 2004, 91684 patients were entered 
onto  the  database  of  which  27573  had  an  ST-elevation  myocardial  infarction 
(STEMI),  42281  had  a  non  ST-elevation  myocardial  infarction  (NSTEMI)  and 
7318 had a troponin-negative acute coronary syndrome. 2003 was the first year 
in which a full  dataset was available using all 230 hospitals, as prior to this, 
hospitals  were  being  increasingly  recruited  into  the  registry.  The  patients  in 
MINAP  have  been  followed  up  for  their  vital  status,  linked  to  the  Office  of 
National Statistics. MINAP has National Patient Information Advisory Group and 
Central Office for Research Ethics Committees approval for individual patient 
anonymous  linkage  for  mortality.  No  patient  identifiers  are  given  out  to 
researchers. MINAP is funded by the Healthcare Commission. 
4.3  Assessment of data quality in each cohort 
4.3.1  Data checking  
The cohorts for study in this thesis were selected on account of the coverage they 
provide across the different stages of the natural history of coronary disease. The 
populations and methodology of the studies varied.  
The  following  checks  were  performed  on  the  data  (definitions  from  Last’s 
Dictionary of Epidemiology138): 
•  Selection  bias  –  “Error  due  to  systematic  differences  in  characteristics 
between those who take part in a study and those who do not.” 
o  At the start-point of data collection within a research study is the 
recruitment process at which point such a bias can exist 
•  Information bias – “A flaw in measuring exposure or outcome data that 
results in different quality (accuracy) of information between comparison 
groups.” Within this category are: 76 
 
￿  Recall  bias  –  “Systematic  error  due  to  differences  in 
accuracy or completeness of recall to memory of past event 
or experiences.” 
￿  Observer bias – “Systematic difference between a true value 
and that actually observed, due to observer variation.”  
o  Cohort  studies  rarely  suffer  from  recall  bias  due  to  their 
prospective nature, and observer bias was minimised in all these 
studies  as  classification  of  exposure  status  (e.g.  ethnicity)  was 
done prior to onset of disease.  
•  Measurement  bias  –  “Systematic  error  arising  from  inaccurate 
measurements of subjects on study variable(s).”  
o  This can result from missing data and also is the extent to which an 
instrument  (such  as  a  questionnaire)  actually  measures  the 
characteristic that is of interest, its validity. 
The table below outlines the data sources and methodology of the four datasets 
used, and potential areas where biases and errors may result. 77 
 
 
Page 1/2  Aetiologic study  Prognostic studies (patients with coronary disease) 
Cohort   Whitehall-II  Chest pain clinic  ACRE   MINAP 
Population   Healthy  population,  as  yet 
having  no  diagnosis  of 
coronary disease 
People  with  chest  pain  of 
recent  onset  referred  from 
primary care  
Patients  undergoing  coronary 
angiography for chronic angina 
who have been reviewed by a 
cardiologist 
Patients  presenting  as 
emergencies  with  acute, 
severe chest pain at rest 
Location  London  offices  of  20  civil 
service departments 
Six  rapid  access  chest  pain 
clinics across England 
Two hospitals within one NHS 
Trust, London 
230  hospitals  across  England 
and Wales  
Dates  of  baseline  data 
collection 
1985–8   2  January  1996  to  31 
December 2002. 
15 April 1996 to 14 April 1997.  Full national recruitment from 
2003  onwards.  Continuous 
registry  and  data  accrue  year 
on year.  
Recruitment method  Epidemiological  research 
study, consented participants, 
with clinical examinations and 
questionnaires  administered 
at  baseline  by  designated 
research staff. 
Clinical  database  within  an 
NHS clinic. Data recorded by a 
cardiologist  using  identical 
databases.  
Clinical  research  study, 
consented  participants,  with 
baseline  questionnaire 
administered  and  review  of 
case  notes  by  designated 
research staff.  
Clinical  database,  with  data 
recorded  by  coders  at 
individual hospitals and sent to 
a collating centre.  
Total  numbers/response  rate 
at baseline  
10308 recruited/73%  11185/100%  consecutive 
patients 
4020/100%  consecutive 
patients 
91687/100%  consecutive 
patients (in 2004) 
Baseline data completeness   99.9%  92.5%  98.0%  Variable  
Collection  of  ethnicity 
variable  
 
 
 
Ethnicity  was  defined 
according  to  the  Office  for 
National Statistics 1991 census 
types.  Participants  self-
reported  their  ethnicity  at 
Cardiologist ascribed ethnicity 
as Asian, White, Black or other 
during the consultation. 
Self-assigned  ethnicity  was 
based  on  the  1991  census 
classification by questionnaire 
The patient's ethnic group was 
determined  by  the 
clinician/health  care  worker. 
Ethnicity was coded as Asian, 
Caucasian,  Black,  Oriental  or 78 
 
Page 2/2  phase  5  (1997–1999), 
observer-assigned  ethnicity  at 
baseline.  
other. 
Completeness  of  data  for 
ethnicity  
99.9%  81.2%   89.7%   80.2% (in 2004) 
Number of South Asians  580  2900  502  3236  
Main  exposures  used  for 
analyses of thesis 
Rose questionnaire angina   Chest pain descriptors  
(typical/atypical) 
 
Canadian  Cardiovascular 
Society  classification of angina 
severity  
Diabetes,  disease  severity 
(troponin) and acute coronary 
syndrome type 
Follow-up   Seven  follow-up  phases  over 
18  years  by  post  and  by 
interview/examination.  Office 
for National Statistics 
 
Office  for  National  Statistics, 
Hospital Episode Statistics 
Six-year  follow-up  by  post. 
Office  for  National  Statistics, 
Hospital  Episode  Statistics. 
Case  notes  and  Patient 
Administration Systems 
Office for National Statistics  
Outcomes   Chest pain 
Non-fatal MI 
Death 
Angiography/Revascularisation 
Non-fatal MI 
Death 
Change in angina  
Non-fatal MI 
Death 
one-year all-cause mortality 
Completeness of follow-up   99%  of  participants  were 
flagged  for  mortality.  Follow-
up  for  the  whole  cohort  by 
questionnaire was 67%. 
99.5%  of  participants  were 
flagged for  mortality, hospital 
admissions,  coronary 
angiography  and 
revascularisation. 
99%  of  participants  were 
flagged for mortality, all-cause 
hospital  inpatient  admissions, 
and on hospital admission for 
revascularisation and non-fatal 
myocardial infarction  
85.6%  of  South  Asian  and 
91.2%  of  White  populations 
were followed up for all-cause 
mortality.   
Thesis  objectives  to  be 
answered (thesis chapter) 
1,5 
(5) 
2,5 
(6) 
3,5 
(7) 
4,5 
(8) 
Cohort   Whitehall-II  Chest pain clinic  ACRE   MINAP 
Table 6 The four cohorts used for the thesis – data sources and methodology79 
 
4.3.2  Recruitment at baseline 
Of the four studies, MINAP differed in being a database where individual consent 
is  not  sought  at  baseline  admission  and  data  entry  is  undertaken  by  the 
individual different hospitals, rather than dedicated members of a research team 
-  hence  checking  the  quality  of  baseline  data  variables  was  of  particular 
importance.  
Selection  bias  within  cohort  studies  can  occur  if  the  exposed  and  unexposed 
groups  differ  in  a  fixed  way.  In  an  occupational  cohort  for  example,  the 
unexposed control group may be healthier than an exposed group of workers 
simply  because  they  are  healthy  enough  to  stay  in  work.  In  the  four  studies 
chosen for this thesis, the exposed (South Asian population) and the unexposed 
(White population) groups were chosen from within the same study populations, 
prior to the development of the outcome (e.g., myocardial infarction, death) of 
interest. Thus, selection bias is reduced, and the checks undertaken for baseline 
recruitment  and  data  collection  revolved  predominantly  around  data 
completeness.  
4.3.2.1 Whitehall-II 
This study initially recruited by inviting all non-industrial civil servants aged 35-
55  working  in  the  London  offices  of  20  departments.  The  overall  original 
response  rate  at  recruitment  (Phase  1)  was  73%,  high  for  such  a  study,139 
reducing the possibility of selection bias. A further 4% of the civil servants on the 
lists provided by the civil service had moved before the study and were therefore 
not eligible for inclusion.140 Completeness of data in those recruited was high at 
baseline  in  Whitehall-II  as  all  participants  were  interviewed  in  person  by 
research staff.  
4.3.2.2 Chest pain clinic 
As  a  prospectively  recruited  clinical  cohort,  all  patients  who  consecutively 
attended to the clinics over the recruitment phase were included. The nature of 
the chest pain clinic is such that recent-onset chest pain is keenly sought, and 
referral  guidelines  to  the  clinic  were  agreed  following  discussions  between 
general practitioners and the department of cardiology. The clinic is relatively 
easy to access in terms of logistics (appointments given within days rather than 80 
 
months)  and  there  are  few  hurdles  to  assessment  in  clinic  presented  to  the 
general practitioner. Among patients fulfilling eligibility criteria, the cohort has 
previously  reported  that  the  chest  pain  clinic  substituted  for  conventional 
cardiology  out-patients  clinic  in  all  but  3%  of  cases.29  Thus,  significant 
differential referral by ethnicity to chest pain clinic is unlikely thus reducing the 
chance of selection bias. Consent was not sought at baseline due to the nature of 
the database as an on-going clinical database and completeness of baseline data 
in chest pain clinic was high at 92.5%.  
Though data entry for smoking status, history of hypertension and diabetes and 
medication were 100% complete, history of hypercholesterolemia was unknown 
in 68.49% of the cohort and 78.4% did not have a cholesterol level. Data were 
available on the whole cohort for statin therapy - 1.9% of those with no data on 
hypercholesterolemia were on a statin, compared to 5.9% defined as not having 
hypercholesterolemia  and  40.6%  of  those  defined  as  having 
hypercholesterolemia. Thus, it is likely that among those in whom cholesterol 
was not known, a high cholesterol level was unlikely judging by their low statin 
prescription rates.  
A previously published sensitivity analysis showed that the rates of coronary 
deaths and non-fatal events for patients with missing baseline data were not 
significantly different from those complete baseline data.29 
4.3.2.3 ACRE 
As  a  prospectively  recruited  clinical  cohort,  all  patients  who  consecutively 
attended  for  angiography  over  the  recruitment  phase  were  included  –  this 
eliminates selection bias in following up those selected for angiography, though 
it  can  not  take  into  account  selection  bias  in  the  actual  selection  process  for 
angiography.  On  the  day  of  coronary  angiography,  eligible  patients  were 
identified by examination of ward admission and catheter books. Trained nurses 
extracted  data  (e.g.  on  smoking,  history  of  hypertension,  diabetes,  results  of 
exercise  electrocardiography,  blood  pressure)  from all  4020  case  notes  using 
standardised  forms.  Furthermore,  patients  completed  a  questionnaire  about 
their general health, coronary heart disease risk factors and angina symptoms 81 
 
(data  available  for  3301/4020,  82%  response  rate).  Within  those  case  notes 
searched and questionnaires completed, completeness of data was high at 98%.  
4.3.2.4 MINAP 
MINAP  is  a  continuous  registry  and  data  accrue  year  on  year.  Longitudinal 
patterns were investigated in a number of important fields to test the year-on-
year consistency of data field entry and thus the quality of its measurements. 
Disease patterns in one year are likely to be comparable to the next if definitions 
of that disease have not changed.  
Secular  data  entry  patterns  in  percentages  of  electrocardiogram  findings  and 
diagnosis of acute coronary syndrome type were examined. MINAP has available, 
from 2003, four years of full data from all 230 hospitals in England and Wales. 
These years were also compared to pre-2003 data, during which time hospitals 
were being progressively recruited and hence data would be incomplete.  
The results are shown in the table below. 
Year  Pre-03  2003  2004  2005  2006 
N  2769  92,252  93,469  89,635  77,255 
ECG           
  ST segment elevation  27.99  32.15  31.86  31.50         29.58 
  LBBB  7.87  4.98  5.29  5.53         4.90 
  ST segment depression  14.12  11.92  13.28  15.11         14.95 
  T wave changes  13.69  12.33  13.08  14.59         14.09 
  Other abnormality  24.63  13.44  14.52  14.98         14.08 
  Normal  6.36  8.88  8.97  9.11         8.16 
  Unknown   5.34  11.25  13.0  9.18  14.24 
           
ACS type           
  STEMI  28.17  29.65  29.50  29.58  27.59 
  NSTEMI  27.01  41.85  45.24  47.48  50.29 
  Troponin negative  0.22  4.45  7.83  8.25  7.0 
  Unknown  44.60  24.04  17.44  14.69  15.12 
Figures are percentages apart from N 
Table 7 MINAP - Proportions of ECG abnormalities and ACS type in successive yearly datasets  
 
The data showed a consistency from 2004-2006. STEMI’s constituted around 28-
29% of acute coronary syndromes, and percentages for the breakdown of the 
other types of acute coronary syndrome and within ECG were also consistent 82 
 
across  the  years.  The  percentage  of  ST  segment  depression  remained 
consistently around 13-15 across 2004-1006.  
These results were suggestive that, year on year, a degree of consistency was 
found, and a pattern of changing data entry over the years was not seen.  
4.3.3  Ethnicity 
As  the  main  exposure  of  interest  to  this  thesis  was  ethnicity,  the  validity  of 
measures of ethnicity within the four cohorts was checked. 
4.3.3.1 Whitehall-II 
Ethnicity  was  defined  in  Whitehall-II  according  to  the  Office  for  National 
Statistics 1991 census types. Though ethnicity was observer-assigned at phase 1, 
at  phase  5,  participants  self-reported  their  ethnicity.  This  was  then  used  to 
validate  the  ethnicity  data  collected  at  phase  1.  There  was  strong  agreement 
between  data  on  observer-assigned  ethnicity  from  phase  1  and  self-reported 
ethnicity  at  phase  5  -  93%  of  ascribed  South  Asian  participants  described 
themselves  South  Asian,  99.3%  of  self-ascribed  White  participants  described 
themselves as White. Hence, Whitehall-II had a high degree of completeness of 
data for ethnicity, and the data appeared valid. 
4.3.3.2 Chest pain clinic 
In  the  chest  pain  clinic  study,  the  cardiologist  ascribed  ethnicity  as  “Asian”, 
“White”, “black” or “other” during the consultation. In a validation study within 
the Newham chest pain clinic, I found that of 34 consecutive patients (25 South 
Asians), 88% self-assigned their ethnicity using the 2001 census classification in 
line  with  the  assessment  of  the  cardiologist  (kappa  statistic  0.766).  Those 
patients who self-assigned their ethnicity as Bangladeshi, Indian, Pakistani or Sri 
Lankan I refer to as ‘South Asian’.  Hence, data on ethnicity in this study appeared 
valid. 
4.3.3.3 ACRE 
Self-assigned  ethnicity  was  based  on  the  1991 census  classification  by 
questionnaire  on  the  day  of  index  coronary  angiography  and  identified 
424 South Asian patients. For patients with missing data, given and family names 
were cross matched on a database of 15 000 names used to identify South Asian 83 
 
patients in routine data from east London.141 This database identified a further 
78 South  Asian  patients.  This  system  was  considered  valid  because  the  name 
database is highly specific (99%); the name assigned and self assigned methods 
identified  similar  proportions  of  South  Asian  people  (15.6%  and  12.8%, 
respectively) and confining the analyses to those with self-assigned ethnicity did 
not affect the results. Overall, 3607/4020 (89.7%) patients on the database had 
data available for ethnicity, with 57 being coded black, 74 other.  
Baseline  ethnic  profiles  of  this  cohort  have  been  previously  reported  in  the 
literature.61  The  risk  factor  profile  between  White  and  South  Asian  patients 
revealed  patterns  consistent  with  previous  literature  in  South  Asian 
populations58 142 such as their younger age (6% of South Asian patients aged 70 
or over compared to 20% in White patients), the high percentage of diabetics 
(33%  in  South  Asian  compared  to  9%  in  White  patients)  and  the  lower 
percentage of smokers (8% in South Asian compared to 13% in White patients).  
Hence, ACRE had a high degree of completeness of data for ethnicity, and the 
data appeared valid. 
4.3.3.4 MINAP 
In MINAP, the patient's ethnic group was determined by the coder assessing the 
case notes and patient computer records. Ethnicity within case notes or on the 
hospital computer system can be entered in a number of ways. The patient can 
themselves complete an administration form asking for personal details which 
can include other items such as address and next of kin details, or can verbally 
offer  their  ethnicity  when  asked.  The  ethnic  group  may  also  have  been 
determined by the healthcare professional entering administrative data on the 
patient,  and  this  information  may  come  from  self-assessed  ethnicity  from 
another source such as letter from the general practitioner, or be assigned by the 
healthcare professional. Ethnicity was coded Caucasian, Black, Asian, Oriental, 
Other and Unknown in the database. 
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I sought to:  
•  investigate the degree to which coding ethnic group was missing, and to 
examine  admission  characteristics  between  those  with  an  ethnic  code 
present and those without to assess the possibility of selection bias.  
•  examine whether the coronary risk profile of the Asian patients in the 
database was consistent with coronary risk profiles previously reported 
in the South Asian population, such as their high prevalence of diabetes. 
19.8% of the entries for 2004 did not have a coding of ethnic group entered. 
When analysing admission characteristics between those with an ethnic code 
present  and  those  without,  there  were  similar  patterns  in  characteristics 
between  the  groups  (Table  8),  although  many  were  rendered  statistically 
significant  as  a  consequence  of  the  large  numbers  involved.  Importantly, 
percentages of diabetics were similar between those with an ethnic code present 
and  those  without,  as  a  bigger  percentage  in  the  missing  group  may  have 
suggested that the South Asian patients, who would be expected to have more 
diabetes, had more missing data for ethnic code than the White patients. 
                    Ethnic code  P 
Data  Present  Missing   
N  79906  19666   
Age (mean, years)  68.86  68.32  <0.001 
Men  63.64  63.08  <0.001 
Infarct pattern       
 STEMI  31.97  31.56 
 NSTEMI/troponin positive   59.30  55.51 
  troponin negative  8.73  12.93 
<0.001 
Smoking ex/current  70.67  72.41  <0.001 
Hypertensive  45.21  43.01  <0.001 
Diabetes  19.09  18.33  0.022 
Hyperlipidaemia treatment  30.03  27.94  <0.001 
Previous heart failure  7.19  6.41  <0.001 
Previous chronic renal failure  3.56  3.85  0.082 
Previous peripheral vascular disease   5.07  5.28  0.271 
Previous revascularisation       
  PCI  6.80  8.07  <0.001 
  CABG  6.23  6.98  <0.001 
Figures are percentages apart from N and age 
Table 8 MINAP - Admission characteristics, comparing availability of ethnic group data, in 
2004 85 
 
Analyses  on  risk  factor  profile  between  White  and  Asian  patients  revealed 
patterns consistent with previous literature in South Asian populations58 - the 
high  percentage  of  diabetics,  the  lower  percentage  of  smokers  (especially  in 
Asian women) and similar percentages of hypertensives (Table 9).143 The MINAP 
study  is  primarily  focussed  on  outcomes  as  opposed  to  expected  patterns  of 
health  when  presenting  with  acute  coronary  syndromes.  Hence,  it  is  of 
reassurance that the patterns of risk factors at baseline by ethnicity conform to 
previously reported patterns.  
  Men  Women 
  Asian  White  Asian  White 
N  2374  46829  849  27387 
Current smokers   28.7  28.3  3.7  20.2 
Hypertensive   44.3  38.1  58.8  46.9 
Hyperlipidaemia treatment  35.9  26.3  35.2  25.0 
Diabetes         
   Oral medication  19.4  6.9  22.9  7.0 
   Insulin  11.8  4.7  7.2  5.3 
Figures are percentages apart from N 
Table 9 MINAP - Risk factor profile, comparing White and Asian patients, by sex, in 2004 
Hence,  data  on  the  ‘Asian’  patients  in  this  study  appeared  to  be  valid  in 
measuring the true South Asian population.  
4.3.4  Follow-up  
The  most  important  source  of  selection  bias  in  cohort  studies  is  when 
completeness of follow-up data differs between exposure categories. This loss 
can reduce the statistical power of the study (through a reduction in sample size) 
and, if selective, can cause bias as the remaining sample may not represent the 
population it was originally selected from.  
4.3.4.1 Whitehall-II 
The study maintained good follow-up through its procedures. The methodology 
of interviewing participants in person at alternate stages (invited to the research 
clinic  at  5-year  intervals,  and  a  postal  questionnaire  between  clinic  phases) 
ensured a low attrition rate. Furthermore, home visits by nurses were offered for 
the first time to participants unwilling or unable to travel to the Phase 7 clinic 
and a brief telephone questionnaire was administered to those who decline clinic 
and full questionnaire participation at each phase.  86 
 
Follow-up  for  death  and  myocardial  infarction  was  99.9%  complete.  In 
particular, this thesis sought prospective data on chest pain as measured on the 
Rose  questionnaire.  I  found  that  that  loss  to  follow-up  for  South  Asian 
participants  in  answering  questions  on  chest  pain  was  higher  than  in  White 
participants. However, there were no differences in baseline risk factor profile 
(smoking,  hypertension  and  total  cholesterol)  between  those  South  Asian 
participants with follow-up for chest pain and those without at phase 7. 9% of 
non-response in South Asian participants and 11% in White participants were 
accounted for by death. Subjects in both ethnic groups with missing follow-up 
were more likely to be in a lower grade of work. Those that are more likely to 
drop out completely are also more likely to have more health problems and be of 
lower socio-economic status144 which may result in an underestimate of angina 
in a South Asian population, as significantly more South Asian participants were 
in a lower grade of work in Whitehall-II. With 18-year phase 7 follow-up for the 
whole cohort being a reasonable 67%, the biggest cause of loss to follow-up for 
chest pain data was loss of overall questionnaire follow-up rather than chest pain 
non-response. 
4.3.4.2 Chest pain clinic 
The study was able to monitor mortality among patients by use of data from the 
Office  for  National  Statistics  and  monitor  hospital  admissions,  coronary 
angiography  and  revascularisation  by  use  of  the  national  Hospital  Episode 
Statistics, supplied by the National Health Service Wide Clearing System, using 
unique National Health Service numbers. Successful matching was achieved for 
99.5% of the cohort.  
4.3.4.3 ACRE 
The  major  variable  of  study  within  ACRE  was  angina,  and  its  change  from 
baseline  to  follow-up.    Analyses  on  whether  significant  differences  existed 
between  ethnic  groups  in  those  with  data  on  angina  and  those  without  are 
presented in section 4.3.5.2. Follow-up for death and myocardial infarction was 
99% complete. 87 
 
4.3.4.4 MINAP 
Follow-up in MINAP was in the form of all-cause mortality, at one year. Using 
2004 data, follow-up for all-cause mortality was 85.6% complete in South Asian 
patients, 91.2% in White patients.  Examining admission characteristics stratified 
by availability of follow-up data, both South Asian and White patients without 
data for follow-up were younger and more likely to have had a troponin-negative 
ACS, but there were no significant differences in the other categories (Table 10).  
  South Asian  White 
Data available for one-
year follow-up 
Yes  No    Yes  No   
N  2769  467    p  57109  13016   p 
             
Age  (mean, years)  61.87  60.32  0.027  69.66  66.02  <0.001 
Men  73.37  73.45  0.904  62.99  63.68  <0.001 
Infarct pattern 
 STEMI  32.20  40.26  0.004  31.37  36.22  <0.001 
 NSTEMI/trop +ve  52.11  43.64    60.78  49.30   
 troponin -ve  15.69  16.10    7.85  14.48   
             
Smoking ex/current  46.33  51.30  0.072  71.72  72.19  0.449 
Hypertensive  45.23  41.44  <0.001  53.64  46.32  0.005 
Diabetes  42.48  37.59  0.067  29.36  30.13 
 
0.214 
Hyperlipidaemia 
treatment 
39.46  31.00  0.001  14.38  12.25  <0.001 
Previous heart failure  6.96  4.67  0.086  7.55  5.02  <0.001 
Previous chronic renal 
failure 
4.76  3.47  0.250  3.65  2.42 
 
<0.001 
Previous  peripheral 
vascular disease  
3.03  2.45  0.519  5.23  4.90  0.267 
Previous revascularisation 
  PCI  12.51  11.03  0.400  6.47  7.53  0.002 
  CABG  9.31  7.04  0.136  5.95  8.47  <0.001 
             
Figures are percentages apart from N and age 
Table 10 MINAP - Admission characteristics, comparing status (dead/alive) at 1 year, in 
South Asian and White patients, in 2004 
I  performed  further  checks  on  the  data.  Among  those  lost  to  follow  up  (i.e., 
unknown  vital  status  from  the  Office  for  National  Statistics),  a  number  were 
retrieved from information on in-hospital death that was present in the database. 
233 of the 5462 with missing one year follow-up had died in hospital from the 
2004 cohort and hence were recorded as death. Overall figures for follow-up at 
one year were now 87.7% complete in South Asian patients, 95.6% in White 
patients.   88 
 
4.3.5  Cohort-specific data field checks  
4.3.5.1 Chest pain in Whitehall-II 
Chest pain as recorded by the Rose questionnaire was an important variable for 
planned analyses. Of the 9775, 577 (99.5%) South Asian participants and 9184 
(99.9%) White participants had data available on chest pain at phase 1. By 18 
year  follow-up  at  phase  7,  41  South  Asian  participants  and  525  White 
participants had died, and data on chest pain were available on 317 South Asian 
and 6268 White participants.  No differences in baseline risk factor profile were 
found between those South Asian participants with follow-up for chest pain at 
phase 7 and those without, and the rate of chest pain non-response on those who 
filled in the questionnaire was low.  
4.3.5.2 Angina in ACRE 
The major variable of study within ACRE was angina and its improvement from 
baseline to follow-up. There were a greater proportion of South Asian patients 
with  missing  data  for  angina,  and  I  examined  whether  significant  differences 
existed  in  baseline  characteristics  in  risk  factors,  past  coronary  history  and 
management, socio-economic characteristics, the CCS as defined by the doctor on 
admission and angiographic findings within ethnic groups between those with 
data on angina (at both baseline and follow-up) and those without. This analysis 
revealed that no significant differences existed (Table 11).   89 
 
Table 11 ACRE - Comparison of baseline factors between those with data and those missing data for angina at baseline and follow-up, in South Asian and 
White patients 
Ethnic group                                      SOUTH ASIAN  p  WHITE   p 
Data for angina  Missing  Not missing    Missing  Not missing   
N  306 (60.96)  196    1466 (49.29)  1508   
Age (mean, (SD) in years)  56.33 (9.98)  54.19 (9.10)  0.016  61.38 (10.74)  60.46 (9.34)  0.013 
Men  244 (79.74)  147 (75.00)  0.212  1061 (72.37)  1051 (69.69)  0.107 
Ever smoked   90 (47.87)  88 (46.56)  0.799  889 (76.77)  1048 (70.86)  0.001 
Hypertensive   117 (38.24)  74 (37.76)  0.914  445 (30.35)  444 (29.44)  0.587 
Total cholesterol (mean, (SD, 
range)) in mmol/l 
5.56 (1.17)  5.61 (1.17)  0.673  5.59 (1.12)  5.61 (1.13)  0.708 
Diabetes   108 (35.29)  48 (24.49)  0.011  149 (10.16)  139 (9.22)  0.383 
Body Mass Index (mean (SD))  26.01 (4.08)  25.89 (3.94)  0.767  27.24 (4.45)  27.56 (4.50)  0.077 
Family history of coronary heart 
disease  
54 (31.03)  73 (40.11)  0.074  503 (45.48)  654 (45.54)  0.974 
Lower social class   70 (32.41)  68 (35.42)  0.521  557 (39.76)  669 (45.17)  0.003 
Left school < 16 yrs   75 (42.37)  74 (44.85)  0.645  1104 (85.85)  1242 (86.37)  0.694 
Heart failure   40 (13.07)  18 (9.18)  0.184  237 (16.17)  157 (10.41)  <0.001 
Previous myocardial infarction   129 (42.16)  71 (36.22)  0.185  651 (44.41)  599 (39.72)  0.010 
Doctor-defined angina status CCS 
III-IV  
129 (47.78)  72 (41.38)  0.186  534 (40.45)  542 (39.50)  0.615 
Previous PCI   21 (6.86)  19 (9.69)  0.253  112 (7.64)  133 (8.82)  0.242 
Previous CABG   22 (7.19)  15 (7.65)  0.846  151 (10.30)  146 (9.68)  0.574 
>1 diseased coronary vessel   229 (75.58)  138 (70.77)  0.234  1128 (77.74)  1189 (79.27)  0.313 
Impaired left ventricular function   67 (22.11)  31 (15.90)  0.089  347 (23.91)  216 (14.40)  <0.001 
 
Data are (n, (%)) unless specified 
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4.3.5.3 Diagnosis of acute coronary syndrome type in MINAP 
A major variable for analysis within MINAP was the final (discharge) diagnosis. 
This coded types of acute coronary syndrome, beyond the previously narrow 
category  of  myocardial  infarction,  which  now  exist  as  a  result  of  troponin 
measurement. Only 3.5% of entries for 2004 had missing data. I then sought to 
check the data validity within this field - the extent to which the category final 
diagnosis measured the specific ACS types within it. The data collection form, 
available on the website of MINAP,i stipulated that all hospitals use the following 
types:  
Discharge 
diagnosis 
1. Myocardial Infarction (ST elevation) 
2. Myocardial Infarction (non ST 
elevation) 
3. Threatened MI 
4. Acute Coronary Syndrome (troponin 
positive) 
5. Acute Coronary Syndrome (troponin 
negative) 
6. Chest pain of uncertain cause 
7. Myocardial Infarction (unconfirmed) 
8. Other diagnosis 
10 Acute Coronary Syndrome (troponin 
unspecified) 
 
The definitions of the most relevant types of acute coronary syndrome to this 
thesis were defined in MINAP thus: 
•  ST  elevation  myocardial  infarction  required  the  presence  of 
electrocardiographic changes of ST elevation consistent with infarction of 
=>2mm  in  contiguous  chest  leads  and/or  ST  elevation  of  =>1  mm  ST 
elevation in 2 or more standard leads. 
                                                        
i http://www.rcplondon.ac.uk/CLINICAL-
STANDARDS/ORGANISATION/PARTNERSHIP/Pages/MINAP-.aspx  91 
 
•  Non-ST  elevation  myocardial  infarction  required  electrocardiographic 
changes  including  new  ST  or  T  wave  changes  (except  ST  elevation) 
and/or cardiac enzyme or troponin elevation (CK twice the upper limit of 
the reference range; locally accepted cut off value for troponin).  
•  Acute  coronary  syndrome  (troponin  positive)  was  defined  when  there 
were symptoms consistent with cardiac ischaemia with troponin release 
with dynamic ECG changes consistent with fluctuating ischaemia.  
•  Acute coronary syndrome (troponin negative) was defined when there 
were  symptoms  consistent  with  cardiac  ischaemia  without  troponin 
release with dynamic ECG changes consistent with fluctuating ischaemia.  
I sought to check whether data in these types had been collected as stipulated 
within the whole MINAP database.   
I sought to do this by: 
•  cross-tabulation of the diagnoses with ensuing treatment strategy, which 
are specific to each type of acute coronary syndrome; 
•  cross-tabulation  with  data  on  biochemical  markers  of  myocardial 
infarction, such as troponin, on which the definitions partly rely on. 
Thus, the validity of types of acute coronary syndrome within the category of 
final diagnosis could be achieved by comparison to other clinical assessments.  
4.3.5.3.1  Final diagnosis and reperfusion strategy  
I compared final diagnoses to final reperfusion strategy, as the vast majority of 
STEMIs  would  have  had  thrombolytic  treatment  with  a  fibrinolytic  drug  to 
reperfuse a completely occluded artery.  
The  table  below  (Table  12)  shows  that  the  majority  of  STEMIs  received 
thrombolytic therapy. Of those without a diagnosis of STEMI or NSTEMI, both 
those with positive and negative troponins appropriately had very low numbers 
of thrombolytics administered. An appropriately low percentage of NSTEMI had 
reperfusion,  though  numbers  were  higher  than  in  acute  coronary  syndrome 92 
 
(troponin  positive),  probably  as  a  result  of  inadvertent  reperfusion,  which  is 
more common in this group as their ECG changes may resemble STEMIs. 
Final diagnosis  Reperfusion 
    
STEMI  21275 (86.4) 
NSTEMI  2853    (11.6) 
Acute Coronary Syndrome (trop+ve)  200      (0.81) 
Acute Coronary Syndrome (trop-ve)  311      (1.3) 
Percentages in brackets  
Table 12 MINAP - Final diagnosis against reperfusion treatment, in 2004 
4.3.5.3.2  Final diagnosis and biochemical markers 
I then examined troponin levels with the final diagnosis. I expected that STEMIs 
would  have  the  highest  levels  of  troponin,  followed  by  NSTEMIs,  Troponin 
positives and then troponin negative diagnoses to have a level near to zero. This 
was confirmed in the following table: 
Final diagnosis  Mean troponin (SD) in ng/ml 
STEMI  24.36 (22.8-26.0) 
NSTEMI  10.50 (9.48-11.52) 
Acute Coronary Syndrome (trop+ve)  2.91 (2.58-3.24) 
Acute Coronary Syndrome (trop-ve)  0.11 (0.05-0.17) 
   
Table 13 MINAP - Final diagnosis against troponin levels, in 2004 
Thus, overall I found no significant measurement errors in the coding of ACS type 
under the variable ‘final diagnosis’. 
4.3.5.4 Cardiac biomarkers in MINAP 
I sought to investigate the quality and validity of data on troponin, vital to the 
types  of  ACS  diagnosis,  and  which  also  allows  quantification  of  severity  of 
disease, allowing further disaggregation of the heterogeneous entity that is ACS. 
Data on biomarkers were collected as ‘elevated cardiac markers’ as well as actual 
troponin level in the MINAP database. 
I sought to:  
•  examine the degree of missingness for entry of the troponin field; 
•  test  validity  by  tabulating  peak  troponin  against  the  ECG  findings 
recorded on arrival. 93 
 
Analyses showed that prior to 2003, there was a low rate of entry for troponin 
which then improved 2004 onwards (Table 14) - this is most likely attributable 
to the increasing use of troponin in hospitals. The field ‘elevated markers’ had 
only 11.71% missing data, as pre-2003 entries would have included elevated CK. 
The usage of CK started to diminish post-2003 to be replaced increasingly by 
troponin. There was consistency observed in the levels of data entry in the fields 
on troponin and also in the field elevated markers across years 2003-2006 (table 
below). 
  Pre-03  2003  2004  2005  2006 
N  2769  92,252  93,469  89,635  77,255 
Troponin  39.11  18.69  18.52  19.71  16.18 
Elevated markers   11.71  14.18  11.73  11.11  13.82 
Figures are percentages apart from N 
Table 14 MINAP - Proportions of data fields for cardiac marker with missing entries in 
successive yearly datasets  
I then tabulated peak troponin against the ECG findings recorded on arrival, as 
higher troponin levels would be seen in those with ischaemic ECGs, and this was 
confirmed in the table below:  
ECG findings on arrival  Peak troponin (mean, SD) in ng/ml 
ST/T changes  17.8 (227) 
normal/other  6.7 (229) 
Table 15 MINAP - ECG findings on arrival against troponin levels, in 2004 
4.4  Statistical power 
The primary outcome for prognosis in this thesis was the comparative risk of 
risk  of  death  and  non-fatal  myocardial  infarction  between  ethnic  groups. 
Examination  for  other  outcomes  (receipt  of  investigations,  improvement  in 
symptoms) was exploratory and there is a lack of prior data in these outcomes 
from other studies. Hence, as the magnitude and direction of difference (if any) 
between  the  two  ethnic  groups  were  unknown  for  such  outcomes,  power 
calculations using estimated relative risks were not possible.   
On the combined endpoint of death and non-fatal myocardial infarction, there is 
80% power at the P=0.05% level to detect a relative risk of at least 1.30 between 
South Asian and White participants (chest pain clinic study), and 1.26 (ACRE 94 
 
study)  and  1.59  (Whitehall  II)  between  South  Asians  and  White  participants, 
assuming the annual event rates shown in Table 16. In MINAP, there is 90% 
power  at  the  P=0.05%  level  to  detect  a  relative  risk  of  at  least  1.3  between 
between  South  Asian  and  White  participants  for  death.  Statistical  power  is 
largely  determined  by  the  number  of  events  occurring  in  South  Asian 
participants and this exceeds 100 for each study. 
  Aetiologic study  Prognostic studies 
  Whitehall I  Chest pain clinic  ACRE   MINAP 
Follow up until   2002 (14 yrs)  2004 (3 yrs)  2003 (7 yrs)  1 year  
Estimated N events 
in South Asians 
121  174  181  300 
Estimated  annual 
risk  death  /  MI  in 
South Asians 
1.5%  2%  6%  3%  (risk  of  death 
only) 
 
Table 16 Estimated risk of outcomes in South Asian participants in the studies of this thesis 
4.5  Conclusions 
The  four  studies  chosen  to  span  the  natural  history  of  coronary  disease  and 
prognostic risk, though different in their methodologies, stood up to scrutiny in 
terms of data quality in order to examine the specific objectives of this thesis.   95 
 
 
5  Incidence and prognosis of suspected angina in a healthy 
population   
5.1  Summary of chapter 
 
Background  The  incidence  of  symptoms  of  stable  angina  in  South  Asian 
populations is not known and the consistency of measurement of angina in them 
has  been  questioned. This  work  sought  to  determine the  incidence  of  typical 
angina,  exertional  and  non-exertional  chest  pain  and  subsequent  coronary 
prognosis in South Asian compared to White populations.  
Methods A cohort study of 9775 (9195 White participants and 580 South Asian 
participants) civil servants aged 35–55 years in 1985–8 with seven phases of 
community  follow-up  over  18  years.  Chest  pain  was  categorised  as  typical 
angina,  exertional  chest  pain  and  non-exertional  chest  pain  using  the  Rose 
questionnaire. The prognostic outcome was a measure of coronary death and 
non-fatal myocardial infarction at phase 7 (2003-2004). 
Results  The  South  Asian  participants  had  higher  cumulative  frequencies  of 
typical angina by phase 7 (17.0% vs 11.3%, chi2=16.93, p<0.001) and exertional 
chest  pain  (15.4%  vs  8.5%,  chi2=  31.06,  p<0.001)  compared  to  White 
participants  but  less  non-exertional  chest  pain  (24.6%  vs  31.3%,  chi2=11.76, 
p=0.001).  In both ethnic groups, typical angina and exertional chest pain were 
associated with increased rates of coronary events when compared to those with 
no chest pain. Within those with any pain at baseline, South Asian participants 
had a worse long-term prognosis than White participants (typical angina HR 2.56 
(1.36-4.84)). 
Conclusions South Asian participants had a higher incidence of typical angina 
and exertional chest pain than White participants, and this was associated with 
an  increased  subsequent  rate  of  coronary  death  and  myocardial  infarction 
compared to those with no chest pain. However, South Asian participants had a 
worse long-term prognosis than White participants within all types of chest pain. 96 
 
5.2  Introduction  
Prospective  studies  in  healthy  individuals  comparing  South  Asian  to  White 
populations  report  a  higher  incidence  of  fatal  outcomes122  and  non-fatal 
outcomes  such  as  myocardial  infarction.123    There  are  no  studies  comparing 
incidence  of  angina  among  South  Asian  compared  to  White  populations.145  
Appropriate  identification  and  management  at  early,  incident  symptomatic 
presentations of coronary disease such as angina may prevent or at least delay 
progression to more serious later-phase manifestations of coronary disease such 
as myocardial infarction and ultimately coronary death. 
However, South Asian people may report atypical features when presenting with 
chest pain39 40 45 and angina measurement is reported to be inconsistent in South 
Asian people using questionnaires.39 The comparative incidence of chest pain 
symptoms in South Asian and White populations and subsequent implications on 
prognosis has not been investigated in population-based studies.   
5.3  Research objective to be investigated 
This chapter sought to investigate specific research objective 1. 
To determine the incidence and prognosis of angina in healthy South Asian and 
White populations. 
 
5.4  Specific research questions 
 
i.  What is the cumulative incidence of typical angina symptoms, exertional 
chest pain, and non-exertional chest pain in South Asian compared to 
White populations? 
ii.  What is the association with coronary risk factors with different forms of 
chest pain in South Asian and White populations? 
iii.   What are the rates of subsequent prognostic outcomes (coronary death 
and non-fatal myocardial infarction) of chest pain in South Asian and 
White populations? 97 
 
5.5  Methods 
5.5.1  Population 
The Whitehall-II study is a prospective cohort of non-industrial civil servants 
aged  35–55  years  who  worked  in  the  London  offices  of  20  civil  service 
departments at baseline (1985–1988). Clinical examinations and questionnaires 
were administered at baseline, 1991–1993 (phase 3), 1997–1999 (phase 5), and 
2003–2004 (phase 7), with questionnaires in 1989 (phase 2), 1995 (phase 4), 
and 2001 (phase 6). By 18 years at phase 7, follow-up for the whole cohort was 
67%.  10308  people  were  recruited,  3413  women  and  6895  men.  The 
participants  were  all  grades,  from  clerical  and  office  support  grades  through 
middle-ranking  executive  grades  up  to  senior  administrative  grades,  differing 
widely in salary. 
5.5.2  Ethnicity 
Ethnicity was defined according to the Office for National Statistics 1991 census 
types (appendix 13.1). Participants self-reported their ethnicity at phase 5, and 
where  this  was  missing,  observer-assigned  ethnicity  from  phase  1  was  used. 
There was strong agreement between data on observer-assigned ethnicity and 
self-reported ethnicity - 93% of ascribed South Asian participants self-described 
themselves  South  Asian,  99.3%  of  self-ascribed  White  participants  described 
themselves as White. Of the participants, 9195 were ascribed as White at phase 1 
and 580 participants were grouped as South Asian.  
5.5.3  Chest pain 
At each of the seven phases over 18 years follow-up, symptoms of stable angina 
pectoris were assessed using the Rose questionnaire (appendix 13.3). Chest pain 
was defined in three mutually exclusive groups:   
•  “typical angina” if the pain was located over the sternum or in both the left 
chest and the left arm, was precipitated by exertion, caused the person to 
stop and went away in 10 minutes or less;  
•  ‘exertional chest pain”, based on the ‘possible’ classification as originally 
proposed by Cook et al,146  being chest pain brought on by exertion but 98 
 
not satisfying the additional criteria, such as location and relation to rest, 
necessary for a diagnosis of typical angina;  
•  ‘non-exertional  chest  pain”  was  defined  as  those  complaining  of  chest 
pain that had no relation to exertion.  
STATA do-file– generation of chest pain groups at phase 1  
 
gen  rosedefinite=1  if  chpuph==1  &  (chpact==1|chpact==2)&  chpstop==1  &  chptime==1  & 
(chploc==1|chploc==2) 
recode rosedefinite .=0 
replace rosedefinite=. if chpuph==.  
label variable rosedefinite "new phase 1 typical" 
 
gen rosepossible=1 if chpuph==1 & rosedefinite==0  
recode rosepossible .=0 
replace rosepossible=. if chpuph==.  
label variable rosepossible "new phase 1 exertional" 
 
gen atypicalpain=1 if chpain==1 & rosepossible==0 & rosedefinite==0 
recode atypicalpain .=0  
replace atypicalpain=. if chpain==.  
label variable atypicalpain "nonexetional phase 1" 
 
gen chestpain=1 if atypicalpain==1  
replace chestpain=2 if rosepossible==1  
replace chestpain=3 if rosedefinite==1  
replace chestpain=0 if chpain==2  
label variable chestpain "0 none 1 non-exertional 2 exertional 3 typical" 
 
9184 White participants and 577 South Asian participants had data on chest pain 
at phase 1. By 18 year follow-up at phase 7, 41 South Asian participants and 525 
White participants had died, and data on chest pain were available on 317 South 
Asian participants and 6268 White participants.  No differences in baseline risk 
factor profile were found between those South Asian participants with follow-up 
for chest pain at phase 7 and those without. The rate of chest pain non-response 
on those who filled in the overall study questionnaire was low, inferring most of 
loss to follow-up for chest pain response was as a result of those not filling in the 
study questionnaire rather than not filling in the Rose angina section.  
Baseline was defined as phases 1-3, as multiple reports of Rose angina are more 
likely  to  indicate  the  presence  of  disease,147  and  angina  may  come  and  go 
depending on concomitant control of symptoms at time of assessment. Those 
with typical angina at either phase 1, 2 or 3 were defined as baseline typical 
angina.  Baseline  exertional  chest  pain  was  similarly  defined  using  exertional 99 
 
chest pain at either phase 1,2 or 3, having excluded those who had complained of 
typical  angina,  and  baseline  non-exertional  chest  pain  again  was  similarly 
defined,  having  excluded  those  who  had  complained  of  typical  angina  or 
exertional chest pain at one of the phases 1, 2 or 3. 
STATA do-file– generation of baseline categories of chest pain, where z=phase 2, x=phase 3 
 
gen earlytypical=1 if (chestpain==3|zchestpain==3|xchestpain==3) 
recode earlytypical .=0  
 
gen earlyexertional=1 if (chestpain==2|zchestpain==2|xchestpain==2)& earlytypical==0 
recode earlyexertional .=0  
 
gen earlyatypical=1 if (chestpain==1|zchestpain==1|xchestpain==1)& earlytypical==0 & earlyexertional==0 
recode earlyatypical .=0  
 
gen earlynopain=1 if (chestpain==0|zchestpain==0|xchestpain==0)& earlytypical==0 & earlyexertional==0 
& earlyatypical==0 
recode earlynopain .=0  
5.5.4  Risk factors 
At  baseline,  standardised  assessments  were  made  of  smoking,  hypertension 
(blood pressure higher than or equal to 130/85 mmHg or on antihypertensive 
medication), total cholesterol, body mass index (BMI), self reported diagnosis of 
diabetes, and family history (in parents or siblings) of onset of coronary heart 
disease  before  age  55  years.  Metabolic  syndrome  was  defined  by  the  2001 
National  Cholesterol  Education  Program  Adult  Treatment  Panel-III  criteria  at 
phase 3 by the presence of three or more of: central obesity, elevated fasting 
blood  triglycerides,  reduced  blood  HDL  cholesterol,  elevated  blood  pressure, 
elevated  fasting  glucose.148  This  definition  gave  less  emphasis  to  glucose 
intolerance and acknowledged the importance of central obesity - it included the 
presence  of  enlarged  waist  circumference  in  the  set  of  diagnostic  criteria  for 
metabolic  syndrome.  It  is  a  widely-used  definition,  though  may  become 
superseded  by  the  more  recently  announced  (2005)  International  Diabetes 
Federation definition.j Validation of this measure is increasingly reported in the 
literature.149 
                                                        
j This insists on the presence of waist circumference. This new definition also recommends using 
ethnic-specific waist circumference cut-offs, and proposes a lower threshold for fasting blood 
glucose. 100 
 
Impaired glucose tolerance was defined as a fasting plasma glucose <7 mmol/l 
and postloadk glucose≥ 7.8 mmol/l (140 mg/dl) and <11.1 mmol/l. Civil service 
employment grade was used as a measure of socioeconomic position. On the 
basis of salary and work role, the civil service defines a hierarchy of employment 
grades, in three levels: unified grades 1-7 (high), executive officers (medium), 
and clerical and support staff (low). 
5.5.5  Follow-up 
The outcome in prognostic analyses was a combined measure of coronary death 
and non-fatal myocardial infarction by phase 7, the latest study phase for which 
events data are available. 99% of participants were flagged for mortality at the 
National  Health  Service  Central  Registry.  Coronary  death  was  defined  by  the 
International Classification of Diseases-Ninth Revision (ICD-9) code 410–414.150 
Based on all available data (from questionnaire, study ECGs, hospital acute ECGs 
and  cardiac  enzymes),  non-fatal  myocardial  infarction  was  defined  following 
MONICA  criteria.l  Classification  of  non-fatal  myocardial  infarction  was  carried 
out  blind  to  other  study  data  independently  by  two  trained  coders,  with 
adjudication by a third in the (rare) event of disagreement. 
5.5.6  Statistical analysis 
Cumulative incidence was estimated with 95% confidence intervals of those who 
complained of typical, exertional and non-exertional chest pain through the six 
phases of the study following phase 1. Those who had complained for chest pain 
at  one  phase  were  then  not  counted  in  following  phases.  For  baseline 
characteristics,  continuous  variables  were  presented  as  means  with  standard 
deviation  and  proportions  as  percentages.  These  baseline  clinical  and  socio-
demographic data were tabulated by ethnic group across types of chest pain, and 
tested  for  age-adjusted  linear  trend  across  those  types,  in  South  Asian 
                                                        
k levels 2 hours after a 75-g oral glucose tolerance test 
l The MONICA (Multinational MONItoring of trends and determinants in CArdiovascular disease) 
Project was established in the early 1980s in many centres around the world to monitor trends in 
cardiovascular diseases, and to relate these to risk factor changes in the population over a ten 
year period. 101 
 
participants  and  in  White  participants,  using  the  χ2  test  for  linear  trend  for 
proportions and the analysis of variance for trend for continuous variables.  
The relative risk of future coronary death and non-fatal myocardial infarction 
was  examined  among  those  with  typical,  exertional  and  non-exertional  chest 
pain on at least one of the first three phases compared to those with no chest 
pain  at  any  of  these  three  early  stages.  Using  the  Cox’s  proportional  hazards 
model,  adjusted  rates  and  95%  confidence  intervals  were  calculated  for 
outcomes and adjusted for age, sex, hypertension, blood cholesterol, ex/current 
smoker,  BMI,  diabetes,  living  alone,  family  history  and  grade  at  work.  The 
relative  risk  of  future  coronary  death  and  non-fatal  myocardial  infarction  of 
South Asian versus White participants was calculated within each type of chest 
pain. 
All  analyses  were  performed  using  STATA  (version  10;  StataCorp,  College 
Station, TX, USA). 
5.6  Results 
Irrespective of the type of chest pain, South Asian participants tended to be 
older, less likely to have smoked, more likely to be hypertensive and diabetic, 
more  likely  to  live  with  a  partner,  have  a  higher  prevalence  of  metabolic 
syndrome and be in lower grades of work than White participants (Table 17). 
Across  the  types  of  chest  pain,  there  was  an  increasing  prevalence  of 
hypertension  and  higher  cholesterol  levels  and  trends  towards  more 
metabolic  syndrome  and  higher  body  mass  index  with more  typical  chest 
pain. 102 
 
  Ethnic group  Whole cohort     No chest pain  Non-exertional 
chest pain 
Exertional chest 
pain 
Typical angina   P for trend across 
chest pain types 
N  South Asian 
White 
580 
9195 
  312 
5444 
134 
2619 
73 
587 
58 
534 
 
Age  in years 
(mean, (SD)) 
South Asian 
White 
45.65 (5.72) 
44.31 (6.08) 
  45.26(5.99) 
44.36(6.10) 
45.71(5.33) 
43.77(5.94) 
46.14(5.71) 
44.70(6.19) 
47.14(4.99) 
45.90(6.11) 
0.115 
<0.001 
Men 
 
South Asian 
White 
357 (61.55) 
6309 (68.61) 
  183 (41.35) 
3591 (65.96) 
100 (74.63) 
2019 (77.09) 
45 (61.64) 
387 (65.93) 
27 (46.55) 
308 (57.68) 
0.482 
0.726 
Ex/current smoker  South Asian 
White 
190 (33.04) 
4767 (52.28) 
  96 (31.17) 
2700 (50.05) 
50 (37.59) 
1425 (54.77) 
28 (38.36) 
334 (57.29) 
16 (27.59) 
300 (56.93) 
0.758 
<0.001 
Hypertensive 
 
South Asian 
White 
70 (12.07) 
714 (7.77) 
  32 (10.26) 
410 (7.53) 
11 (8.21) 
168 (6.41) 
10 (13.70) 
52 (8.86) 
16 (27.59) 
83 (15.54) 
0.002 
<0.001 
Cholesterol (mean (SD) in mmol/l) 
 
South Asian 
White 
5.96 (1.24) 
5.97 (1.16) 
  5.90(1.21) 
5.94(1.18) 
5.94(1.23) 
5.94(1.12) 
5.95(1.16) 
6.09(1.19) 
6.39(1.48) 
6.19 (1.17) 
0.052 
<0.001 
Hyperglycaemic 
  Diabetic 
 
  Impaired glucose tolerance 
 
 
South Asian 
White 
South Asian 
White 
 
22 (3.84) 
61 (0.67) 
46 (7.93) 
561 (6.10) 
   
9(2.93) 
38(0.70) 
25(8.01) 
327(6.01) 
 
6(4.55) 
14(0.54) 
9(6.72) 
157(5.99) 
 
4(5.48) 
3(0.52) 
7(9.59) 
37(6.30) 
 
2(3.45) 
6(1.13) 
5(8.62) 
40(7.49) 
 
0.464 
0.737 
0.784 
0.270 
Metabolic syndrome 
 
South Asian 
White 
66 (15.94) 
754 (10.58) 
  34(15.89) 
391(9.51) 
15(14.71) 
214(10.11) 
6(11.76) 
76(16.20) 
11(23.40) 
73(16.98) 
0.516 
<0.001 
BMI 
(mean (SD)) 
South Asian 
White 
24.44 (3.32) 
24.55 (3.45) 
  24.26(3.42) 
24.42(3.39) 
24.64(3.14) 
24.46(3.23) 
24.49(2.93) 
25.16(3.99) 
24.84(3.71) 
25.65 (4.01) 
0.537 
<0.001 
Living with partner 
 
South Asian 
White 
487 (84.26) 
6766 (73.85) 
  256(82.58) 
3995(73.61) 
118 (88.06) 
1987(76.22) 
61(83.56) 
403(69.01) 
50(86.21) 
375(70.36) 
0.424 
0.146 
Family history  
 
South Asian 
White 
227 (39.14) 
3599 (39.14) 
  115(36.86) 
2060(37.84) 
52(38.81) 
1029(39.29) 
32(43.84) 
247(42.08) 
27(46.55) 
259(48.50) 
0.106 
<0.001 
Job grade -low  South Asian 
White 
290 (50.00) 
1733 (18.85) 
  158(50.64) 
1095(20.11) 
55(41.04) 
377(14.39) 
43(58.90) 
124(21.12) 
32(55.17) 
128(23.97) 
0.514 
0.703 
The categories of chest pain total 9184 White and 577 South Asian participants who had data on chest pain at phase 1. The whole cohort comprises the 9195 White participants at phase 1 and the 580 South Asian 
participants. Data are n (%) unless otherwise specified. Test for trend is age-adjusted. 
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5.6.1  Incidence of different forms of chest pain by ethnic group 
At  baseline,  South  Asian  participants  had  a  higher  prevalence  of  typical 
angina compared to White participants (4.8% vs 2.8%, χ2= 5.50, p=0.019) 
and exertional chest pain (7.8% vs 4.1%, χ2= 14.97, p<0.001) but not non-
exertional chest pain (22.2% vs 25.2%, χ2=  2.97, p=0.085), as  depicted in 
Figure  5.  By  phase  7,  South  Asian  participants  had  higher  cumulative 
frequencies  of  typical  angina  (17.0%  vs  11.3%,  χ2=16.93,  p<0.001)  and 
exertional chest pain (15.4% vs 8.5%, χ2= 31.06, p<0.001) compared to White 
participants but less non-exertional chest pain (24.6% vs 31.3%, χ2=11.76, 
p=0.001).  
 
(Cumulative % with 95% CI bars) 
Figure 5 Whitehall-II – Cumulative incidence of different types of chest pain by ethnic group 
over seven study phases 104 
 
5.6.2  Prognosis of chest pain  
During the mean follow-up of 15.1 years, 367 incident cases of total coronary 
events (49 in South Asian participants) occurred among the total cohort of 
participants who had been free from any coronary event at baseline. In the 
whole  cohort,  the  South  Asian  participants  was  more  likely  than  White 
participants  to  sustain  the  endpoint  of  coronary  death  and  non-fatal 
myocardial  infarction  (HR  in  South  Asian  participants  compared  to  White 
participants  2.22  (95%  CI  1.59-3.09)  adjusted  for  age,  sex,  hypertension, 
blood  cholesterol,  ex/current  smoker,  overweight,  diabetes,  living  alone, 
family history and grade at work). 
5.6.2.1 Prognosis within ethnic groups of those with pain compared to those with no 
chest pain 
In  both  South  Asian  and  White  participants,  those  with  baseline  typical 
angina and exertional chest pain had a worse prognosis for the long-term 
coronary outcome compared to those with no baseline chest pain (in South 
Asian  participants  with  typical  angina  (adjusted  HR  4.67  (95%  CI  2.12-
10.30),Table  18).  However,  both  South  Asian  and  White  participants  who 
complained  of  baseline  non-exertional  chest  pain  did  not  have  a  worse 
prognosis  compared  to  those  who  complained  of  no  chest  pain  (in  South 
Asian participants adjusted HR 1.34 (95% CI 0.56-3.22), Table 18).  
5.6.2.2 Prognosis within types of pain for South Asian compared to White populations 
Within those with typical angina at baseline, South Asian participants had a 
worse long-term prognosis than White participants (HR 2.56 (95% CI 1.36-
4.84),Table  18).  The  South  Asian  participants  also  had  a  worse  long-term 
prognosis  than  the  White  participants  within  the  whole  cohort  (HR  2.22 
(95% CI 1.59-3.09)) and in those with non-exertional chest pain, and there 
was a similar suggestion in those with exertional chest pain. There were no 
ethnic differences in long-term prognosis in the bigger group of participants 
that had no chest pain at baseline. 105 
 
 
Study population    Ethnic group  N  Number of events by 
phase 7 
Rate/1000 person 
years 
(95%CI) 
HRs within ethnic groups compared to those 
with no chest pain 
HRs within types of pain for South Asian 
compared to White participants 
(95%CI) 
          Age and sex-adjusted  Adjusted*   Age and sex-adjusted  Adjusted* 
Whole cohort   White   9195  318  2.26 (2.03,2.53)  n/a  n/a  1  1 
  South Asian  580  49  6.09 (4.60,8.06)  n/a  n/a  2.46 (1.82,3.32)  2.22 (1.59,3.09) 
                 
                 
No chest pain  White   5444  138  1.67 (1.42,1.96)  1  1  1  1 
  South Asian  312  15  3.44 (2.08,5.71)  1  1  1.92 (1.13,3.28)  1.58 (0.87,2.86) 
                 
Non-exertional chest pain  White   2619  80  1.95 (1.57,2.43)  1.13 (0.86,1.49)  1.16 (0.88,1.53)  1  1 
  South Asian  134  9  4.68 (2.44,9.00)  1.24 (0.54,2.84)  1.34 (0.56,3.22)  2.10 (1.05,4.20)  2.17 (1.04,4.53) 
                 
Exertional chest pain  White  587  41  4.56 (3.36,6.19)  2.71 (1.91,3.84)  2.34 (1.64,3.32)  1  1 
  South Asian  73  8  8.21 (4.11,16.4)  2.37 (1.01,5.60)  2.52 (1.02,6.18)  1.70 (0.79,3.65)  1.74 (0.75,4.03) 
                 
Typical angina  White  534  59     7.49 (5.80,9.66)  4.32 (3.18,5.87)  3.56 (2.59,4.88)  1  1 
  South Asian  58  17  21.9 (13.6,35.3)  6.93 (3.40,14.10)  4.67 (2.12,10.30)  2.94 (1.71,5.06)  2.56 (1.36,4.84) 
*adjusted for age, sex, hypertension, blood cholesterol, ex/current smoker, overweight, diabetes, living alone, family history and grade at work; n/a – not applicable 
The study population of the whole cohort represents those at phase 1.  
The study populations of the types of chest pain represent those who complained of these pains at phases 1, 2 or 3. The types are mutually exclusive, as those with exertional chest pain excluded those who 
had complained of typical angina at one of the phases 1, 2 or 3, and baseline non-exertional chest pain excluded those who had complained of typical angina or exertional chest pain at one of the phases 1, 2 or 
3. 
 
Table 18 Whitehall-II - Prognosis for coronary death and non-fatal myocardial infarction, comparing types of chest pain to those with no chest pain, and 
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5.6.3  Mortality of whole cohort  
Overall  incident  coronary  and  cardiovascular  mortality  was  higher  in  South 
Asian participants than among White participants, but all-cause mortality was 
not higher in South Asian participants than among White participants (Table 19). 
Overall  incident  coronary  events  (coronary  death  and  non-fatal  myocardial 
infarction)  was  higher  in  South  Asian  participants  than  among  White 
participants. 
Outcome  Ethnic 
group 
Subjects   Number of 
events 
(To Sep 04) 
Rate/1000 
person 
years 
Age-adjusted 
hazard ratio 
(95%CI) 
P value 
White   9189  525 (5.7%)  3.33  1  All – cause 
mortality   South Asian  577  41 (7.1%)  4.16  1.13 (0.82-1.55) 
0.456 
White   9184  140 (1.5%)  0.89  1  Cardiovascular 
death  South Asian  577  23 (4.0%)  2.34  2.34 (1.50-3.64) 
<0.001 
White   9184  80 (0.9%)  0.51  1  Coronary death 
South Asian  577  21 (3.6%)  2.13  3.73 (2.30-6.03) 
<0.001 
White   9164  318 (3.5%)  2.23  1  Coronary death 
and NFMI   South Asian  576  49 (8.5%)  5.86  2.62 (1.94-3.54) 
<0.001 
Table 19 Whitehall-II – Incidence of whole cohort for differing outcomes, comparing South 
Asian to White participants 
 
5.7  Discussion 
5.7.1  Objective addressed 
I found a higher cumulative incidence of typical angina and exertional chest pain 
in South Asian participants compared to White participants, in a study of almost 
10000 people with detailed characterisation of symptoms of stable angina using 
the Rose questionnaire at seven time-points over 18 year follow-up. I found that 
in both South Asian and White participants, typical angina and exertional chest 
pain at baseline were strongly associated with increased rates of coronary events 
when compared to those with no chest pain, but that those with non-exertional 
chest pain did not have a worse prognosis compared to those with no chest pain. 
Thus,  the  Rose  questionnaire  was  valid  in  predicting  prognosis  in  the  South 
Asian participants. The overall cohort revealed worse prognosis in South Asian 
participants compared to White participants and that within types of pain, all 
types of chest pain tended to predict a more adverse prognosis in South Asian 107 
 
participants. South Asian participants with no chest pain at baseline were not at 
higher long-term risk than the White participants with no chest pain at baseline.  
5.7.2  The burden of symptoms and their prognostic validity in South Asian 
populations 
The  diagnosis  of  angina  is  perceived  to  be  more  difficult  in  the  South  Asian 
population as they are often labelled as having ‘atypical’ pain when presenting 
with  ischaemia.40  Though  angina  on  Rose  questionnaire  predicts  mortality  in 
European populations,151 its consistency in South Asian populations has been 
questioned in a cross-sectional study39 and no studies have examined its ability 
to predict long-term coronary events in patients of South Asian origin. I now 
show here that cumulative incidence of typical angina as ascertained by Rose 
questionnaire is higher in South Asian compared to White participants, and that 
this angina has an adverse prognosis in both White and South Asian participants 
compared to those with no chest pain. Non-exertional chest pain was not higher 
in baseline prevalence or in cumulative incidence in South Asian compared to 
White participants. It was not associated with coronary events in either ethnic 
group when compared to those with no chest pain. These results suggest that the 
Rose  angina  questionnaire  can,  in  both  South  Asian  and  White  populations, 
discriminate between prognostically significant chest pain and chest pain that 
does not result in adverse cardiac outcomes.  
5.7.3  The prognosis of chest pain symptoms in South Asian compared to White 
populations 
South  Asian  participants  had  a  worse  long-term  prognosis  than  White 
participants  within  the  whole  cohort  and  within  all  types  of  chest  pain,  and 
though there appeared to be no ethnic differences in long-term prognosis in the 
bigger group of participants that had no chest pain at baseline, it is conceivable 
that a lack of power may hide a worse prognosis in South Asian participants even 
in this group (HR 1.58 95% CI (0.87-2.86)). 
Thus, though South Asian participants with non-exertional pain are at relatively 
less risk than those South Asian participants with typical angina, the finding that 
South  Asian  participants  have  a  worse  long-term  prognosis  than  White 
participants  within  all  types  of  chest  pain  (exertional  chest  pain  not  being 108 
 
significant, though this may reflect lack of power) may be a reflection of their 
overall higher incidence of fatal coronary disease, and of non-fatal myocardial 
infarction. Thus the presence of non-exertional pain at baseline may be unrelated 
to these later events, as it does not constitute an incident coronary event as such. 
Using  the  definitions  of  baseline  chest  pain  in  Whitehall-II  illustrates  the 
difficulty in defining an incident event, and hence in the calculation of prognosis. 
Phase 1 represents a point in time in the life of the participants, by which time 
some of the cohort may already have had chest pain prior to being included in 
the study. To truly detect the prognosis of incident angina requires a cohort in 
which recruitment of all participants occurs at the first time they complain of 
chest pain. Whitehall-II, as a prospective cohort study of healthy individuals, was 
primarily suited to the study of cumulative incidence following recruitment.   
Richer data on how coronary risk factors were managed in primary care may 
also explain prognostic patterns. It is conceivable that South Asian participants 
with non-exertional pain were at higher risk than White populations with non-
exertional pain due to differences in risk factor profile and their management of 
them in primary care. The clinical careers of people with angina evolve over 
time,  punctuated  by  changes  in  morbidity  and  in  healthcare  response.  The 
Whitehall II study, in common with other population based studies, is not able to 
characterise the detailed history of appropriateness of each management step in 
this career.  
Finally, the use of the measures of chest pain at baseline for prognosis between 
ethnic groups may be inaccurate due to small numbers. Only 58 South Asian 
participants had typical chest pain at phases 1, 2 or 3 and this renders prognostic 
analyses comparing them with White participants with typical chest pain less 
precise.  
5.7.4  Relation with clinical presentation and diagnosis and implications for 
clinicians 
A higher incidence of angina among South Asian participants is consistent with 
their  higher  incidence  of  fatal  coronary  disease,  and  of  non-fatal  myocardial 
infarction. These results have implications on workload for primary care doctors, 109 
 
chest pain clinics and secondary care investigation resources in areas of high 
concentrations  of  South  Asian  people.  Adequate  allocation  of    appropriate 
healthcare  resources  on  a  population  level  in  such  areas  will  be  necessary, 
especially  as  the  current  rate  of  decline  of  angina  prevalence  is  much  lower 
compared to the more marked decline observed for mortality from myocardial 
infarction.152  
The prospective validity of the Rose questionnaire in South Asian populations for 
the prediction of adverse coronary events in those with typical angina compared 
to  those  with  no  chest  pain  highlights  the  importance  of  making  the  correct 
diagnosis  from  symptoms.  It  has  been  previously  shown  in  this  cohort  that 
people reporting angina symptoms, but without a diagnosis, were at increased 
risk of death and poor subsequent physical functioning than those who did not 
report  symptoms.153    I  was  unable  to  extend  this  to  my  analyses  due  to  low 
numbers of South Asian participants diagnosed with angina. Conceivably, those 
with typical angina who had been diagnosed with angina would do better than 
those with typical angina as yet undiagnosed.  
5.7.5  Limitations 
A strength of this work is that no previous cohort has reported on differences 
between  South  Asian  and  White  populations  in  repeat  measures  of  a 
standardised  assessment  of  chest  pain  symptoms  over  long-term  follow  up. 
However,  the  2003  Health  Survey  for  England  revealed  that  though  the 
prevalence of angina in Pakistani men was significantly higher than the general 
population,  this  was  not  the  case  for  Indian  and  Bangladeshi  men.58  The 
Whitehall-II study comprised mainly Indian people (74%, with 13% Sri Lankan, 
10% Pakistani, and 3% Bangladeshi) and thus may underestimate the overall 
future risk of coronary disease for ‘South Asians’ if baseline levels of coronary 
disease  are  lower  than  a  more  representative  South  Asian  population.  This 
heterogeneity within the South Asian group could not be accounted for in our 
study.  However,  the  Whitehall-II  study,  from  previously  published  reports  on 
baseline characteristics comparing its South Asian and White participants is,62 in 110 
 
its  marked  social  and  ethnic  differences  in  coronary  heart  disease,  broadly 
comparable to other studies in the South Asian population in the UK.  
5.7.6  Implications 
This  study  reports  a  higher  incidence  of  angina  in  South  Asian  participants, 
though  the  aetiology  of  this  is  not  possible  to  investigate  with  this  dataset.  
Diabetes is likely to contribute to the higher incidence of coronary disease in 
South  Asian  people  and  cumulative  prevalence  of  diabetes  in  this  study  was 
significantly higher in South Asian than White participants (10.5% v 2.7% by 
phase  7).  Using  such  a  study  design,  with  serial  measures  of  chest  pain  in  a 
cohort of diabetics would allow further investigation into the aetiology of angina.   
Improved resolution of angina as an epidemiological variable will also allow its 
increased  use  as  a  non-fatal  outcome.  More  long  term  prospective  studies  of 
chronic  symptomatic  conditions  are  needed,  as  increasingly  these  conditions 
represent  the  bulk  of  where  coronary  disease  presents,  shifting  away  from 
presenting  acutely  to  secondary  care.  A  better  understanding  of  angina, 
increasingly  the  most  common  initial  symptomatic  manifestation  of  coronary 
disease,29  will  encourage  better  coding  of  this  early  clinical  manifestation  of 
coronary disease in primary care databases.  
5.8  Conclusions 
I have demonstrated here that South Asian people have a higher incidence of 
typical angina over long-term follow-up compared to White people, but that they 
did not have a higher incidence of chest pain that was non-exertional in nature. 
Typical  angina  as  measured  by  the  Rose  angina  questionnaire  had  a  worse 
prognosis  for  coronary  death  and  non-fatal  myocardial  infarction,  but  non-
exertional  chest  pain  did  not  in  both  South  Asian  and  White  people,  when 
compared to those with no chest pain. My findings demonstrate that South Asian 
people  have  an  increased  incidence  of  prognostically-significant  angina 
compared to White people. 
5.9  Building to next chapter 
I have shown that typical angina, as measured using the Rose questionnaire, is 
common in South Asian people and that both South Asian and White populations 111 
 
with  typical  angina  have  a  higher  risk  of  adverse  coronary  outcomes  than  in 
those with no chest pain. 
The Whitehall-II cohort is an observational cohort of mainly healthy participants 
with no account possible for the interaction of the participants with healthcare 
services. The Whitehall-II study pre-dates the widespread introduction of rapid 
access  chest  pain  clinics  in  the  UK  and  was  an  observational  study  with  no 
intervention planned. My analyses showed that within all those with chest pain 
irrespective of type, South Asian people had a worse long-term prognosis than 
White people. However, whether a more equitable outcome of incident angina in 
South  Asian  and  White  populations  would  occur  if  assessed  in  a  health  care 
facility is not known. 
For  the  next  stage  of  this  thesis,  I  planned  to  investigate  the  presentation, 
management and prognosis of this early stage of coronary disease  at a rapid 
access  chest  pain  clinic.  These  clinics  are  designed  from  the  outset  to  assess 
those  with  recent-onset  chest  pain,  and  hence  provide  a  source  of  incident 
symptoms. I wanted to continue to examine the theme of typicality of pain by 
ethnic  group,  and  examine  its  prognosis  as  it  presented  to  the  clinical 
environment,  and  thus  to  examine  how  the  typicality  of  pain  between  ethnic 
groups  influence  clinical  management.  Early  and  appropriate  identification  of 
angina will result in early and appropriate clinical management, and this will in 
turn affect prognosis. 
The Rose questionnaire is a tool used mostly in epidemiological research, and 
often through self-report rather than direct interview. In the chest pain clinic, the 
patient  presents  with  symptoms  to  the  doctor.  They  are  directed  towards 
describing their chest pain using specific descriptors when questioned by the 
doctor seeing them. The doctor typically asks the patient about four components 
of  the  chest  pain  they  are  presenting  with:  character,  site,  duration  and 
precipitating factors. I now aimed to quantify this verbal history and assess how 
such  words  were  different  between  ethnic  groups  and  whether  these  words, 
used in diagnosis, had any prognostic significance. 112 
 
 
6  Prognosis of incident typical and atypical chest pain 
6.1  Summary of chapter 
 
Background South Asian people have been reported as being more likely than 
White  people  to  report  atypical  angina  yet  less  likely  to  undergo  coronary 
angiography  to  investigate  angina.  This  work  sought  to  determine  whether 
atypical  symptoms  of  angina  in  South  Asian  populations  predicted  clinically 
important outcomes and influenced receipt of appropriate clinical management. 
Methods  2189  South  Asian  participants  (980  women)  and  5605  White 
participants (2676 women) with new-onset chest pain of median age 54 (IQR 44-
64) were prospectively recruited from six rapid access chest pain clinics in the 
UK and followed up for death due to coronary disease or admission with acute 
coronary syndrome over a mean of 5.0 years. Participants were also followed up 
for receipt of coronary angiography and revascularisation. 
Results Atypical chest pain was reported by South Asian participants more than 
White  participants  (59.9%  vs  52.5%,  p<0.001).    Typical  symptoms  were 
predictive of a diagnosis of angina across ethnicity. Typical symptoms compared 
to atypical symptoms were associated with the coronary outcome in both South 
Asian and White participants (HR 1.58 (1.14-2.18), South Asian). In those with 
typical symptoms, South Asian participants were more likely to experience the 
coronary outcome (HR 1.41, 95% CI 1.04–1.91) but were less likely to receive 
angiography (HR 0.52 (95% CI 0.41-0.67; p<0.001) and revascularisation than 
White participants. 
Conclusions Typical chest pain compared to atypical chest pain was as likely to 
be associated with a worse prognosis in South Asian as in White populations. 
Systematic  and  potentially  inequitable  differences  in  management  between 
ethnic  groups  could  not  be  explained  by  differences  in  presentation  of 
symptoms. 113 
 
 
6.2  Introduction  
South  Asian  people39-41  and  other  minority  ethnic  groups42  43  with  suspected 
ischaemia  are  more  likely  to  report  atypical  features  of  chest  pain.  The 
description  of  symptoms,  articulated  by  patients  and  recorded  by  doctors, 
remains  a  cornerstone  of  diagnosing  stable  angina  pectoris,  yet  descriptions 
have been largely derived and validated against White men.34 
South  Asian  people  are  less  likely  than  White  people  to  undergo  coronary 
angiography to investigate angina.61 It has been proposed that differences in how 
patients  describe  their  symptoms  may  contribute  to  inequalities  in  medical 
care,40 63 because the diagnostic validity of symptoms plays an important role in 
deciding appropriate clinical management.47  
The  previous  chapter  showed  both  South  Asian  and  White  populations  with 
typical angina had a higher risk of adverse coronary outcomes than in those with 
no chest pain, and that South Asian people with chest pain may have a worse 
prognosis than White people. To examine the prognosis of true incident angina 
between South Asian and White populations ideally requires a cohort in which 
recruitment of all participants occurs at first onset of chest pain, and which takes 
into account the description of symptoms articulated.  
6.3  Research objective to be investigated 
This chapter sought to investigate specific research objective 2. 
To determine in those presenting with incident chest pain whether differences 
exist  in  the  description  of  symptoms  between  South  Asian  and  White 
populations,  and  the  association  of  symptom  descriptors  with  prognosis  and 
receipt of management strategies for chronic coronary disease. 
6.4  Specific research questions 
To:  
i.  Is the description of angina pain as typical or atypical associated with 
coronary outcomes in White and South Asian populations? 114 
 
ii.  Are  differences  in  how  populations  of  White  and  South  Asian  origin 
report their symptoms related to their ensuing clinical management? 
6.5  Methods 
6.5.1  Population 
11082  consecutive  participants  with  recent-onset  chest  pain  recruited  in  six 
rapid access chest pain clinics in the United Kingdom from 2 January 1996 to 31 
December 2002 constituted the study population. These ambulatory care clinics 
are run by cardiology teams and accept same day referrals from family doctors of 
those  in  whom  incident  angina  pectoris  is  suspected.    Participants  who  had 
previously been investigated or diagnosed with coronary disease, or in whom 
acute,  or  unstable  coronary  syndromes  were  suspected  were  not  eligible  for 
referral to these clinics.  Data were electronically recorded by the cardiologist 
using identical databases. Of those participants with no previous history of chest 
pain  (n=  9518),  I  excluded  re-attendances  during  the  study  period  (n=448), 
participants  without  chest  pain  (n=291),  participants  diagnosed  with  acute 
coronary syndromes on the day of visit (n=246) and participants who reported 
previously  diagnosed  coronary  heart  disease  or  revascularisation  procedure 
(n=579) so as to include incident chest pain patients only. I excluded participants 
with missing clinical and demographic data (n=501), participants for whom a 
diagnosis was either not entered (n=132) or not identified as angina or non-
cardiac chest pain (n=83, e.g. having other diagnoses such as pericarditis) and 
those who were not traced by the Office for National Statistics or the National 
Health Service-wide clearing system (n=40). 
Of the remaining 8762 participants with complete data and follow-up, I analysed 
the 7794 participants with an ethnic code of White or Asian (excluding 968 from 
other ethnic groups), which constituted the study group (Figure 6). 
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Figure 6 Chest pain clinic study - Recruitment of participants 
 
     
 
 
 
 
 
 
 
 
 
 
 
Participants seen in rapid access chest pain clinics (n=11082) 
Excluded (n = 1564)  
•  Previous coronary artery disease or revascularisation (n = 579) 
•  Diagnosed with acute coronary syndromes on the day of the visit (n = 246) 
•  Previous visit to a rapid-access chest pain clinic during the study period (n = 448) 
•  No chest pain (n = 291) 
First presentation with chest pain (n = 9518) 
Excluded (n = 756) 
•  Missing clinical or demographic data (n = 501) 
•  No diagnosis entered (n = 132) 
•  Pain not diagnosed as angina or non-cardiac chest pain (n = 83) 
•  Not tracked by the Office for National Statistics or the National Health Service-wide 
clearing system (n = 40) 
Participants with a complete dataset (n = 8762) 
Excluded (n = 968)  
•   Ethnic background other than White or South Asian 
Participants included (n = 7794; 5605 White, 2189 South Asian) 116 
 
  
6.5.2  Ethnicity 
The cardiologist ascribed ethnicity as “Asian”, “White”, “black” or “other” during 
the consultation. In a validation study within the Newham chest pain clinic, I 
found that of 34 consecutive participants (25 South Asian), 88% self-assigned 
their ethnicity using the 2001 census classification in line with the assessment of 
the cardiologist (kappa statistic 0.766).   
6.5.3  Risk factors and treatment strategy 
Data  on  smoking  status  (no,  ever/current),  history  of  hypertension,    history 
hypercholesterolemia/cholesterol  level,  history  of  diabetes  and  cardiac 
medication  (aspirin,  β-blocker,  statin,  nitrate,  nicorandil,  calcium-channel 
antagonist, ACE (angiotensin-converting enzyme) inhibitor) were recorded by 
the cardiologist and exercise electrocardiogram testing was performed if deemed 
appropriate by the cardiologist.  
6.5.4  Descriptors of chest pain  
Whilst  taking  the  history  from  the  participant,  cardiologists  recorded  a 
descriptor for each of the following four components of chest pain:  
•  character (aching, constricting, stabbing, nondescript) 
•  site (central, left-sided, right-sided, submammary, epigastric, other) 
•  duration (seconds, < 5 minutes, 5–15 minutes, 15–30 minutes, hours or 
variable)  
•  precipitating  factors  (none,  exercise,  exercise  and  rest,  stress,  eating, 
other).  
Health advocates trained to support the needs of those whose first language was 
not English were available if the participant did not attend with English-speaking 
friends/family members.  For each component, one descriptor was selected from 
a drop-down menu (Table 20). Based on the Diamond-Forrester classification,34 I 
considered typical pain to be that which the participant described as having a 117 
 
constricting quality, being located centrally or on the left-side (which may have 
included radiation of the pain to the left shoulder or arm, a typical characteristic 
in some with angin) of the chest, lasting between a few seconds and 15 minutes, 
and being provoked by exercise (table below). 
 
Table 20 Chest pain clinic study - Descriptors of four components of chest pain used by 
cardiologists and classification of their typicality 
 
I used a “symptom score” to classify the participant’s description of pain as:  
•  typical (3 or more characteristics of typical pain) or  
•  atypical (2 or fewer characteristics).  
The cardiologist also  made a personal assessment of the participant’s overall 
symptoms  as  typical  or  atypical  (“cardiologist  summary”).  At  the  end  of  the 
consultation,  using  information  from  other  sources  such  as  the  full  clinical 
    Typical  Atypical 
Central   √   
Left sided   √   
Right sided     √ 
Sub-mammary     √ 
Epigastric     √ 
Site  
Other     √ 
Nothing     √ 
Exercise   √   
Exercise and rest   √   
Stress     √ 
Eating     √ 
Precipitating factor  
Other     √ 
Aching     √ 
Constricting   √   
Stabbing     √ 
Character  
Nondescript     √ 
Seconds     √ 
<5 minutes   √   
5-15 minutes   √   
15-30 minutes     √ 
Duration of episodes  
Hours/variable     √ 118 
 
history, clinical examination and exercise electrocardiography, the cardiologist 
diagnosed  the  cause  of  the  participant’s  chest  pain  as  either  angina  or  non-
cardiac chest pain.    
STATA do-file – generation of symptom score 
 
gen typloc=1 if cplocation==1|cplocation==2 
gen typdur=1 if cpduration==3|cpduration==2 
gen typprec=1 if cpprovocation==2|cpprovocation==3 
gen typqual=1 if cpquality==3 
 
recode typloc .=0 
recode typdur .=0 
recode typprec .=0 
recode typqual .=0 
 
gen typacc=typloc+typdur+typprec+typqual 
gen typicality=1 if typacc>=3 
replace typicality=0 if typacc<3  
label variable typicality " 1 typical 0 atypical" 
 
6.5.5  Follow-up  
Using unique National Health Service numbers, the study was able to monitor 
mortality  among  participants  by  use  of  data  from  the  Office  for  National 
Statistics.  The  cohort  was  able  to  monitor  hospital  admissions,  coronary 
angiography  and  revascularisation  by  use  of  the  national  Hospital  Episode 
Statistics,  supplied  by  the  National  Health  Service  Wide  Clearing  System. 
Successful matching was achieved for 99.5% of the cohort. Causes of death and 
admission to hospital were coded according to the International Classification of 
Diseases, 10th revision (ICD-10).  
The combined primary outcome was death from coronary artery disease (ICD-10 
codes I20-I25) and hospital admission due to an acute coronary syndrome (acute 
myocardial infarction, ICD-10 codes I21-I23) or unstable angina (ICD-10 codes 
I20.0–120.9, 124.0, I24.8, I24.9) within five years. The management outcomes 
were  receipt  of  coronary  angiography  as  a  confirmatory  diagnostic  test  and 
subsequent  coronary  revascularisation  (either  percutaneous  coronary 
intervention  or  coronary  artery  bypass  surgery,  whichever  was  first)  within 
three years of a clinic visit. 119 
 
6.5.6  Statistical analysis 
When  examining  baseline  clinical  and  chest  pain  characteristics,  age  was 
presented  as  a  median  with  the  inter-quartile  range  and  compared  between 
groups using Student’s t-test, whilst proportions were compared using the χ2-
statistic. To examine the probability of receiving a diagnosis of angina according 
to exercise ECG result, cardiologist summary or symptom score, likelihood ratios 
were used with 95% confidence intervals by ethnicity to test the likelihood that a 
positive exercise ECG or typical cardiologist summary or typical symptom score 
would  be  expected  in  a  participant  given  a  diagnosis  of  angina  by  the 
cardiologist.  When calculating likelihood ratios for cardiologist summary and 
the  symptom  score,  those  participants  with  a  positive  exercise  ECG  were 
excluded (182 South Asian participant, 668 White participants) so as to remove 
the  potential  influence  a  positive  exercise  ECG  may  have  on  formulating  a 
diagnosis of angina. To examine the prognostic validity of cardiologist summary 
and symptom score on coronary outcome, adjusted Cox proportional hazards 
regression were conducted by ethnicity. A hazard ratio less than 1 represents a 
better prognosis. Adjusted Cox proportional receipt of coronary angiography and 
revascularisation  in  those  that  had  presented  with  typical  descriptors  and  in 
those  with  atypical  descriptors.  In  these  analyses,  a  hazard  ratio  less  than  1 
represents  a  lower  likelihood  of  receiving  the  procedure.  Adjustments  were 
made using age (as a continuous variable), sex, diabetes, smoking, hypertension, 
anti-anginal  medication  (β-blocker,  calcium-channel  antagonist,  oral  nitrate, 
nicorandil),  secondary  prevention  medication  (aspirin,  statin,  ACE  inhibitor), 
revascularisation (PCI or CABG) and exercise ECG result (positive or negative). 
6.6  Results 
In total, the cohort included 7794 participants: 2676 White women, 2929 White 
men, 980 South Asian women and 1209 South Asian men. From tTable 21, South 
Asian women and men were younger than their White counterparts, with lower 
levels of smoking but a higher prevalence of diabetes mellitus. 
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      Women    Men   
      S Asian (n=980)  White (n=2676)  p    South Asian (n=1209)  White (n= 2929)  p 
  Age in yrs, median(IQR)    50.6 (42-58)  57.6 (49-67)  <0.001    49.8 (41-59)  54.7 (45-65)  0.001 
Risk factors  Smoker    35 (3.6%)  683 (25.5%)  <0.001    320 (26.3%)  924 (31.6%)  0.001 
  Diabetes     209 (21.3%)  165 (6.1%)  <0.001    219 (18.1%)  207 (7.1%)  0.001 
  Hypertension    367 (37.5%)  1017 (38.0%)  0.759    365 (30.2%)  875 (29.9%)  0.840 
Medication   Secondary prevention  aspirin  232 (23.7%)  843 (31.5%)  <0.001    328 (27.1%)  1028 (35.1%)  <0.001 
    statin  61 (6.2%)  371 (13.9%)  <0.001    117 (9.7%)  445 (15.2%)  <0.001 
    ACE inhibitor  62 (6.3%)  171 (6.4%)  0.944    83 (6.9%)  213 (7.3%)  0.644 
  Anti-anginals  β Blocker  155 (15.8%)  557 (20.8%)  0.001    214 (17.7%)  701 (23.9%)  <0.001 
    Calcium antagonist  99 (10.1%)  474 (17.7%)  <0.001    102 (8.4%)  537 (18.3%)  <0.001 
    Oral nitrate  67 (6.8%)  229 (8.6%)  0.091    94 (7.8%)  300 (10.2%)  0.014 
    Nicorandil  3 (0.3%)  38 (1.4%)  0.005    9 (0.7%)  60 (2.1%)  0.003 
Central  402 (41.0%)  1592 (59.5%)      450 (37.2%)  1728 (59.0%)   
Left sided  404 (41.2%)  583 (21.8%)      560 (46.3%)  804 (27.5%)   
Right sided  40 (4.1%)  56 (2.0%)      50 (4.2%)  86 (2.9%)   
Sub-mammary  64 (6.5%)  223 (8.3%)      103 (8.5%)  149 (5.1%)   
Epigastric  69 (7.0%)  218 (8.2%)      44 (3.61%)  158 (5.4%)   
Site 
Other  1 (0.1%)  7 (0.3%)  <0.001    2 (0.2%)  4 (0.1%)  <0.001 
Nothing   603 (61.5%)  1399 (52.3%)      765 (63.3%)  1524 (52.0%)   
Exercise  173 (17.7%)  752 (28.1%)      216 (17.9%)  958 (32.7%)   
Exercise and rest  142 (14.5%)  340 (12.7%)      164 (13.6%)  288 (9.8%)   
Stress  29 (3.0%)  121 (4.5%)      27 (2.2%)  94 (3.2%)   
Eating  32 (3.3%)  60 (2.2%)      34 (2.8%)  60 (2.1%)   
Precipitating factor 
Other  1 (0.1%)  4 (0.2%)  <0.001    3 (0.3%)  5 (0.2%)  <0.001 
Aching  325 (33.2%)  1059 (39.6%)      407 (33.7%)  1110 (37.6%)   
Constricting  230 (23.5%)  762 (28.5%)      295 (24.4%)  884 (30.2%)   
Stabbing  269 (27.5%)  558 (20.9%)      303 (25.1%)  623 (21.3%)   
Character  
Nondescript  156 (15.9%)  297 (11.1%)  <0.001    204 (16.9%)  322 (11.0%)  <0.001 
Seconds  39 (4.0%)  147 (5.5%)      69 (5.7%)  236 (8.1%)   
<5 minutes  156 (15.9%)  513 (19.2%)      230 (19.1%)  627 (21.4%)   
5-15 minutes  226 (23.1%)  699 (26.0%)      269 (22.5%)  733 (25.0%)   
15-30 minutes  123 (12.6%)  259 (9.7%)      129 (10.7%)  282 (9.6%)   
Participant pain 
descriptors 
Duration of episodes 
Hours/variable  436 (44.5%)  1058 (39.5%)  0.001    512 (42.0%)  1051 (35.9%)  <0.001 
Investigations  Exercise ECG   Positive  56 (12.8%)  200 (13.2%)  0.499    126 (17.3%)  468 (24.0%)  0.001 
Typical  163 (16.6%)  647 (24.2%)      193 (16.0%)  834 (28.5%)    Cardiologist summary  
Atypical  817 (83.4%)  2044 (75.8%)  <0.001    1016 (84.0%)  2095 (71.5%)  <0.001 
Typical  386 (39.4%)  1243 (46.5%)      492 (40.7%)  1509 (51.5%)   
Symptom 
assessment 
Symptom score 
Atypical  594 (60.6%)  1433 (53.6%)  <0.001    717 (59.3%)  1420 (48.5%)  <0.001 121 
 
Table 21 Chest pain clinic study - Baseline data and chest pain characteristics, comparing 
participants of South Asian origin with those of White origin by sex  
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6.6.1  Chest pain descriptors 
South  Asian  participants  of  both  sexes  were  more  likely  to  report  atypical 
descriptors  compared  to  White  participants  (Table  21).  Their  pain  was  less 
associated with exercise, more stabbing or non-descript than constricting and 
more  likely  to  last  hours  or  variable  periods  when  compared  to  White 
participants.  Though  left-sided  pain  was  included  as  typical  in  the  symptoms 
score as it may code for the very typical sensation of chest pain radiating to the 
left arm, South Asian participants had chest pain that tended to be more left-
sided than central. As left pain was not coded separately as left chest or left arm, 
it is not possible to discern whether this left chest pain is mostly atypical or 
mostly radiated typical pain in South Asian participants, though the pattern of 
results from the other descriptors hints to the former. Overall, atypical chest pain 
was reported by more South Asian participants than White participants (59.9% 
v. 52.5%, p<0.001). South Asian participants of both sexes were more likely to 
have their symptoms described as atypical by the cardiologist, and less likely to 
be given a diagnosis of angina by the cardiologist.  There was 73.3% agreement 
(kappa statistic 0.43) between the cardiologist summary and symptom score.  
6.6.2  Symptoms and diagnosis  
Neither  sex  nor  ethnicity  modified  the  association  between  the  exercise  ECG 
result and the diagnosis of angina, with high likelihood ratios (Figure 7) across 
sex and ethnicity. Hence, typical symptoms strongly predicted a positive exercise 
ECG result. After excluding patients with a positive exercise ECG which would 
have strongly influenced a diagnosis of angina, both the cardiologist summary 
and the symptom score of typical symptoms were still predictive of a diagnosis 
of angina across sex and ethnicity. Likelihood ratios were lower for the symptom 
score compared with cardiologist summary but remained well above 1.0. 
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Figure 7 Chest pain clinic study - Likelihood that exercise ECG result, cardiologist summary 
or symptom score leads to a diagnosis of angina, by sex and ethnicity 
 
6.6.3  Symptoms and their validity in predicting prognosis 
The overall prognosis for the combined coronary outcome in the cohort was no 
worse  in  South  Asian  compared  to  White  participants  (adjusted  for  age,  sex, 
diabetes, smoking, hypertension and hypercholesterolaemia, HR 1.04 (95% CI 
0.75-1.45)). 
Typical symptoms predicted coronary outcome in South Asian participants as 
well as in White participants, using both the cardiologist summary and symptom 
score (Table 22). 123 
 
 
Chest pain assessment    Chest pain description  Risk of coronary 
death or ACS 
 
    Typical  Atypical  HR*  P** 
Cardiologist summary  South Asian   64/356  100/1833  1.97 (1.38-2.81) 
  White  223/1481  151/4124  2.41 (1.91-3.05) 
0.353 
Symptom score  South Asian   97/878  67/1311  1.58 (1.14-2.18) 
  White  261/2663  113/2942  1.62 (1.29-2.05) 
0.902 
Coronary outcome - death due to coronary heart disease or acute coronary or hospital admission with unstable angina 
*Hazard ratio for typical vs atypical (95%CI) adjusted for age, sex, diabetes, hypertension, smoking and revascularisation 
** P for difference between two hazard ratios
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Table 22 Chest pain clinic study - Typical compared to atypical chest pain as a predictor of 
coronary outcome in South Asian and in White participants 
Within both those with typical symptoms and atypical symptoms, South Asian 
participants  were  no  more  likely  to  suffer  the  coronary  outcome  than  White 
participants on unadjusted survival curves (Figure 8, unadjusted log rank test 
p=0.53 in typical category, p=0.88 for atypical).  
 
Figure 8  Chest pain clinic study - Typicality of chest pain according to symptom score 
comparing South Asian to White participants and cumulative probability of coronary 
death/ACS  
Within  those  with  typical  symptoms,  on  examining  adjusted  Cox  regression 
hazard ratios (Table 23) to take into account differences in baseline risk profile, 
South Asian participants with typical pain were as likely as White participants 
with typical pain to experience a coronary outcome for cardiologist summaries 124 
 
(HR 1.27, 95% CI 0.89–1.81) and more likely with symptom scores (HR 1.41, 
95% CI 1.04–1.91). Atypical pain had a similar prognostic value for coronary 
outcomes in South Asian participants compared to White participants. There was 
no  interaction  between  sex  and  ethnic  background  (likelihood  ratio  for 
interaction: typical pain p=0.34; atypical pain p=0.76).  
South Asian vs. White   Hazard ratio (95% CI)* 
  Coronary 
Angiography* 
Revascularisation*  Coronary death or 
ACS** 
Typical       
Cardiologist summary  0.58 (0.45-0.75)  0.52 (0.36-0.75)  1.27 (0.89-1.81) 
Symptom score  0.52 (0.41-0.67)  0.53 (0.38-0.74)  1.41 (1.04-1.91) 
Atypical       
Cardiologist summary  0.55 (0.38-0.78)  0.61 (0.35-1.05)  1.38 (0.94-2.02) 
Symptom score  0.59 (0.39-0.88)  0.49 (0.24-1.00)  1.19 (0.73-1.92) 
Coronary outcome - death due to coronary heart disease or acute coronary or hospital admission with unstable angina 
* Adjusted for age, sex, diabetes, smoking, hypertension, secondary prevention/anti-anginals and exercise ECG result 
**  Adjusted  for  age,  sex,  diabetes,  smoking,  hypertension,  secondary  prevention  medication,  revascularisation  and 
exercise ECG result 
 
Table 23 Chest pain clinic study - Type of chest pain (typical and atypical) and subsequent 
receipt of angiography, receipt of revascularisation and prognosis in South Asian compared 
to White participants 
 
6.6.4  Symptoms and their relation to clinical management 
South Asian participants with typical or atypical pain were less likely than White 
participants with typical or atypical pain respectively to receive angiography and 
revascularisation (Table 23-typical symptom score, adjusted HR for angiography 
0.52, 95% CI 0.41–0.67; adjusted HR for revascularisation 0.53, 95% CI 0.38–
0.74). The adjustments were designed to be appropriate for the management 
outcome – the use of anti-anginal medication specifically important in progress 
to  angiography  and  revascularisation.  Further  analyses  showed  that  these 
results were also independent of whether or not the cardiologist had made the 
diagnosis of angina – by including only those in whom the diagnosis of angina 
was made, South Asian participants with typical pain were still less likely than 
White  participants  with  typical  pain  to  receive  angiography  and 
revascularisation  (typical  cardiologist  summary,  adjusted  HR  for  angiography 125 
 
0.59, 95% CI 0.45–0.76; adjusted HR for revascularisation 0.49, 95% CI 0.34–
0.72). 
Revascularisation  rates  were  higher  among  patients  who  reported  typical 
symptoms than among those who reported atypical symptoms (women, adjusted 
HR  for  revascularisation  3.86,  95%  CI  2.35–6.35;  South  Asian  participants, 
adjusted HR 3.16, 95% CI 1.93–5.19).  
6.6.5  The impact of diagnosis on prognosis 
In both those diagnosed with angina and those not, the overall prognosis for 
coronary  death  in  the  cohort  was  no  worse  in  South  Asian  participants  
compared to White participants (diagnosed as angina, HR 1.20 (95% CI 0.88-
1.64)  adjusted  for  age,  sex,  diabetes,  smoking,  hypertension,  secondary 
prevention and exercise ECG result). 
6.6.5.1 The symptom score 
I defined typical pain as three or more of these characteristics and atypical pain 
two  or  fewer  (the  ‘symptom  score’)  to  make  a  binary  descriptive  variable  of 
chest pain. I did not analyse as per the three types initially described by Diamond 
and  Forrester  (non-cardiac,  atypical,  typical)  even  though  the  data  collection 
form did allow the cardiologist to assess the symptoms as non-cardiac, atypical 
and typical. Investigating these categories, ‘atypical’ behaved similarly to ‘non-
cardiac’, as those with atypical pain did not have higher hazard ratios for risk of 
coronary  outcome  compared  to  ‘non-cardiac’  (Table  24).  The  Diamond  and 
Forrester classification is rarely used by cardiologists, most preferring to assess 
typical  or  atypical  in  the  real-world  clinical  setting.  Hence,  I  used  a  binary 
symptom score. 
  Male  Female 
Cardiologist 
assessment  
symptoms 
South Asian 
(n=1219) 
White  
(n=2959) 
South Asian 
(n=986) 
White  
(n=2704) 
Non-cardiac  1  1  1  1 
Typical  3.28 (1.42-7.58)  7.04 (2.81-17.67)  8.90 (0.92-86.43)  5.04 (1.76-14.41) 
Atypical  1.19 (0.57-2.52)  1.57 (0.61-4.05)  4.85 (0.59-39.70)  1.11 (0.37-3.35) 
 
Table 24 Chest pain clinic study - Non-cardiac compared to typical and atypical chest pain as 
a predictor of coronary outcome in South Asian and White participants by sex 126 
 
In the initial exploration of the database, I tried to ascertain whether individual 
descriptors within the components of chest pain might be markers of prognosis 
(e.g. central chest pain alone). However, numbers within each descriptor type 
were too small and from a clinical point of view, most cardiologists tend to build 
a picture of typicality of symptoms from a constellation of features rather than 
one feature itself. My early analyses did however show me the validity of the 
Diamond  and  Forrester  classification  (Table  25).  When  examining  character, 
constricting descriptors had a worse prognosis than aching, stabbing and non-
descript. Similarly, descriptors that were central in location and precipitated by 
exercise had the worse prognosis within their components of chest pain.  127 
 
 
    Male  Female 
    South Asian (n=1219)  White (n=2959)  South Asian (n=986)  White (n=2704) 
Aching  0.36 (0.15-0.82)  0.55 (0.33-0.91)  -  0.71 (0.36-1.41) 
Stabbing  0.53 (0.25-1.15)  0.32 (0.16-0.66)  -  0.36 (0.13-0.95) 
Constricting  1  1  1  1 
Character 
Nondescript  0.78 (0.36-1.69)  0.48 (0.22-1.01)  -  1.02 (0.45-2.31) 
           
Central  1  1  1  1  Site 
  Left sided  0.60 (0.33-1.09)  0.55 (0.32-0.95)  0.84 (0.24-2.91)  0.37 (0.16-0.88) 
           
Nothing   1  1  1  1 
Exercise  2.85 (1.41-5.75)  3.77 (2.33-6.12)  2.85 (0.48-17.11)  8.86 (3.90-20.14) 
Precipitating factor 
Exercise and rest  1.91 (0.89-4.09)  2.90 (1.45-5.79)  5.63 (1.34-23.76)  5.63 (2.10-15.15) 
           
Seconds 
1-5 minutes 
5-15 minutes  
15-30 minutes 
Duration 
Hours/ Variable 
 
Numbers too small for analysis  
Unadjusted hazard ratios (95%CI); HR>1 indicates poorer prognosis. 
Table 25 Chest pain clinic study – Individual chest pain descriptor and risk of coronary outcome in South Asian and White participants by sex 
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6.6.5.2 Symptoms and risk factors in prediction of prognosis 
I examined further the effect of high coronary risk (having two or more of the risk 
factors:  smoking,  hypertensive,  diabetic,  or  hypercholesterolemia)  versus  low 
coronary risk on outcomes in the whole cohort. High coronary risk was a predictor 
of outcomes in the whole cohort of coronary outcome as would be expected (age 
and  sex-adjusted  HR  1.41  (1.08-1.85).  Limiting  analyses  to  South  Asian 
participants with atypical pain, high coronary risk compared to low coronary risk 
remained a predictor of outcomes (age and sex-adjusted HR 3.22 (1.22-8.55)). This 
was rendered non-significant on adjustment for receipt of secondary prevention 
therapy but not coronary revascularisation (Table 26). Thus in South Asian people 
with a profile of high coronary risk but with atypical pain, management should be 
concentrated on secondary prevention not revascularisation. The symptom score 
thus  highlights  to  the  general  practitioner  those  people  irrespective  of  ethnic 
group, in whom referral to a chest pain clinic is appropriate. 
 
  Adjusted for age 
and sex 
 
Adjusted for age, 
sex and 
revascularisation  
Adjusted for age, 
sex and secondary 
prevention  
South Asian person 
with atypical pain 
3.22 (1.22-8.55)  2.82 (1.05-7.56)  2.49 (0.91-6.85) 
Coronary outcome - death due to coronary heart disease or acute coronary or hospital admission with unstable angina 
*Hazard ratio for typical vs atypical (95%CI) adjusted for age, sex or ethnicity, diabetes, hypertension, smoking and 
revascularisation 
High coronary risk = two or more of the risk factors: smoking, hypertensive, diabetic, or hypercholesterolemia 
 
 
Table 26 Chest pain clinic study - High coronary risk compared to low coronary risk in South 
Asian participants with atypical pain as a predictor of coronary outcome, adjusted for 
management strategy  
6.7  Discussion  
6.7.1  Objective addressed 
In a study of over 7000 consecutive participants presenting to a rapid access chest 
pain  clinic  with  detailed  data  on  symptom  characterisation,  typical  chest  pain 
compared  to  atypical  chest  pain  was  as  likely  to  be  associated  with  a  worse 
prognosis in South Asian as in White participants. South Asian participants with 
prognostically  significant  angina  pectoris  did  not  present  atypically.  Systematic 
and  potentially  inequitable  differences  in  management  between  ethnic  groups 129 
 
could not be explained by differences in presentation of symptoms. The overall 
prognosis for coronary death in the cohort was no worse in South Asian compared 
to White participants. 
The central diagnostic cannon of stable angina34 for the last three decades, which 
has assessed pre-test probability of coronary disease using symptom typicality, age 
and  sex,  has  now  had  its  contemporary  validity  in  South  Asian  people 
demonstrated by this study.  
6.7.2  Symptoms in South Asian people 
I  found  that  typical  symptoms  were  predictive  of  a  diagnosis  of  angina  across 
ethnicity. Furthermore, typical symptoms were predictive of coronary outcomes in 
South  Asian  participants  when  they  were  compared  to  atypical  presentations. 
Although  South  Asian  participants  attending  the  chest  pain  clinic  did  report  a 
marked  excess  of  atypical  symptoms,  the  rate  of  subsequent  adverse  coronary 
outcomes in this group was similar in White and South Asian participants. Since 
both doctors and patients may be aware that in the general population coronary 
heart disease mortality is higher in South Asian people,10 155 my findings might be 
explained by a lower threshold for referral of South Asian people from primary 
care  to  a  chest  pain  clinic  with  any  chest  pain  symptoms,  hence  reversing  the 
possibility of selection bias favouring white patients. Indeed, a previous survey 
found some evidence that South Asian people with chest pain may be more willing 
to seek care.41  
These  results  contrasted  with  the  Whitehall-II  findings  that  revealed  a  worse 
prognosis in South Asian compared to White populations within each type of chest 
pain. Whitehall-II was a healthy population rather than clinical cohort, and thus it 
is conceivable that those South Asian participants with typical angina in the early 
stages of Whitehall-II went undiagnosed and hence unmanaged. Furthermore, a 
chest pain clinic provides a more reliable measure of incidence, as it is designed to 
capture recent-onset chest pain which Whitehall-II was not. The chest pain clinic, 
with its detailed coding of the description of symptoms by cardiologists in a clinic 
designed for capturing incident angina, shows that incident atypical chest pain in 130 
 
South  Asian  participants  does  not  have  a  worse  prognosis  than  in  White 
participants. 
Chest pain characteristics, and their perception, have been compared in different 
ethnic groups.42  43 South Asian, compared to White populations, report a higher 
likelihood  of  seeking  care.41  African-American  people  may  be  more  likely  to 
attribute their symptoms to a non-cardiac source than White people but were not 
more  likely  to  have  atypical  symptoms  in  a  prospective  study  based  in  an 
emergency  department.156  African-American  people  have  also  been  reported  to 
complain  more  of  shortness  of  breath  than  White  people  when  presenting  for 
coronary angiography.157 
6.7.3  Typicality of symptoms and other explanations for inequalities in 
management 
I found lower rates of coronary angiography and revascularisation among South 
Asian  participants  compared  with  White  participants.  This  could  not  be  fully 
explained by the presence of typical or atypical symptoms, as even South Asian 
participants  with  typical  pain  were  less  likely  to  undergo  diagnostic  and 
therapeutic invasive procedures. Studies of inequalities in invasive management of 
angina among South Asian people have lacked details about pain symptoms. It is 
also unlikely that differences in symptom severity explain this under-management 
because functional impact and tendency to seek care are higher among South Asian 
people with chest pain.41 
South Asian and White people may differ in their understanding of the risks and 
benefits of revascularisation. Written communication in English, waiting lists, and 
repeated out-patient assessments may represent barriers for South Asian people 
trying to negotiate the administrative hurdles towards revascularisation. Ethnic 
groups may also differ in willingness to undergo revascularisation, with studies 
from  the  United  States  reporting  that  Black  and  White  people  have  different 
preferences for treatment.158  
Unmeasured factors may account for the under-management observed. The degree 
of co-morbidities was not well-captured on this database and referral selection 131 
 
may depend on interactions between co-morbidities. As an example, patients with 
aortic valve stenosis causing chest pain would have been more likely to be referred 
for cardiac catheterisation but less so as renal function progressively declines due 
to perceived surgical operative risk. Further social factors such as employment, 
language barriers, and patient preferences were not available as measures in these 
data.  The  cohort  did  not  have  data  on  refusal  of  revascularisation,  nor  on  the 
efficacy of ensuing medical treatment with anti-anginal drugs alone. The factors 
comprising  angiography  decision  making  are  thus  complex,  prognostically 
important, and often immeasurable.  
6.7.4  Clinical implications of history taking 
A history of typical symptoms was based solely on pre-defined response types to 
four questions – character, site, duration and precipitating factors. Typical pain 
was  associated  with  a  diagnosis  of  angina  and  worse  prognosis  for  coronary 
outcomes in South Asian participants compared to those with a history of atypical 
symptoms. This symptom score could potentially be quickly elicited from a history 
taken by the general practitioner in order to decide upon referral to a chest pain 
clinic  in  the  place  of  more  detailed  risk  scores.  The  cardiologist  summary 
demonstrated stronger associations with a diagnosis of angina, or risk of coronary 
outcomes  on  follow-up,  than  did  the  symptom  score.  This  may  reflect  the 
incorporation of risk factor information, and clinical experience into the estimate 
of  pre-test  disease  likelihood.  Though  weaker,  the  simpler  symptom  score 
remained predictive of outcomes. This will encourage the general practitioner that 
a simple and quick history eliciting these descriptors of chest pain is an effective 
means  to  determining  the  appropriateness  for  referral  to  a  cardiologist 
irrespective of ethnicity. This work helps to guide the general practitioner that the 
management of the patient with atypical pain but multiple coronary risk factors is 
to focus on the risk factors, not the atypical pain. 
6.7.5  Limitations 
A major strength of this study is the detailed description of chest pain among a 
large  number  of  participants  with  recent  onset  symptoms,  without  previous 
investigation,  myocardial  infarction  or  revascularisation,  at  the  interface  of 132 
 
primary and secondary care.  The high proportion of South Asian participants in 
the study reflects the high concentration of South Asian people in the areas where 
the  chest  pain  clinics  were  located,  and  thus  gives  a  realistic  picture  of  likely 
disease burden and potential demand on healthcare services in areas with a high 
proportion of South Asian people in the local population. 
Several limitations should however be considered in interpreting these findings. 
First, the recorded history may have been biased by the knowledge of the exercise 
ECG  findings;  for  this  reason,  I  excluded  those  with  an  abnormal  exercise  ECG 
when assessing diagnosis of angina.  
Second, the category of South Asian encompasses different language, religions and 
cultural  groups,  amongst  whom  cardiovascular  risk  profile  differ.20  Further 
research  is  required  to  test  whether  symptom  validity  differs  between 
Bangladeshi, Indian, Pakistani or Sri Lankan people.  
Third, data were not available on the findings of subsequent coronary angiography 
if  it  took  place.  As  revascularisation  is  largely  driven  by  the  severity  of 
angiographic disease, this data may have in part explained why revascularisation 
was not undertaken in some. 
Fourth, though data entry for smoking status, history of hypertension and diabetes 
and  medication  were  100%  complete,  history  of  hypercholesterolemia  was 
unknown in 68.49% of the cohort and 78.4% did not have a cholesterol level - 
hence this variable was not entered into the multi-variate analyses by symptom 
category model. Adding hypercholesterolemia or statin therapy into the prognostic 
multi-variate analyses symptom category did not significantly alter the direction 
nor strength of the hazard ratios. 
Finally, when examining prognosis for coronary death in South Asian compared to 
White participants by chest pain symptoms category, increased power would have 
excluded a differential outcome between ethnic groups more confidently. With all 
four summary estimates for the coronary outcome to the right of 1 (Table 23), it 133 
 
may  be  that  lack  of  power  hides  worse  outcomes  for  South  Asian  participants 
irrespective of presenting symptomatology similar to that observed in Whitehall-II.  
6.7.6  Implications  
Better coding of the symptoms articulated by the patient with chest pain may aid 
in  the  diagnostic  process  for  angina.  A  potential  limitation  of  this  quantitative 
study is that the actual words used by patients, their meaning and context were 
not reported. This was addressed in an ethnographic qualitative study of 59 clinic 
consultations performed alongside this study by colleagues at the Newham site to 
understand how the chest pain classification and diagnosis were reached.159 They 
found  that  symptom  histories  represented  a  complex  negotiation  between 
cardiologist  and  patient,  with  much  ambiguity  and  re-telling.  There  was  little 
evidence that this negotiation was patterned by sex or ethnicity. Importantly, none 
of the South Asian patients in this study relied on translators; the minority who 
needed help with English were accompanied by a younger family member. This 
work relied on the pre-specified coding in the database; it is likely that doctors 
may  record  in  free  text  further  relevant  details  of  symptoms  pertinent  to  the 
diagnosis of angina. Electronic processing of this natural language might aid the 
identification  of  patients  with  angina,160  though  this  would  be  dependent  on 
adequate documentation of the history by the doctor. 
6.8  Conclusions 
South Asian people with typical chest pain were found to be at increased risk of 
adverse  coronary  outcomes  compared  with  those  who  presented  with  atypical 
pain. South Asian people with prognostically important angina pectoris did not 
present  atypically,  and  differences  in  symptom  description  did  not  account  for 
their lower rates of coronary angiography and revascularisation compared with 
White people. Thus, symptoms of chest pain are valid diagnostic and potentially 
important  prognostic  tools  across  ethnic  backgrounds.  Further  study  should 
examine why South Asian people with the same prognosis as White people receive 
poorer care. 134 
 
6.9  Building to next chapter 
I have shown that typical angina in South Asian populations, when ascertained by 
the words articulated by a patient to a specialist doctor, was valid in predicting a 
poorer prognosis than chest pain that is less typical of angina. By building a simple 
measurement  tool  from  the  clinical  history,  I  used  facets  from  normal  clinical 
practice to show that history-taking is as valid in South Asian people as it is in 
White people, and that atypical chest pain, commoner in South Asian people, has a 
better prognosis than typical angina.  
Overall prognosis in South Asian compared to White populations was not worse in 
this cohort. This contrasts with the findings of Whitehall-II, which demonstrated a 
worse prognosis in South Asian people compared to White people in all types of 
chest pain. Hence, the results of analysing this cohort, at the first stage of contact 
with the health services along the natural history of coronary disease, demonstrate 
that early clinical assessment may be able to delay the natural course of coronary 
disease. However, there are no randomised trials comparing this rapid access chest 
pain clinic model for the assessment of undifferentiated chest pain to older models 
of healthcare such as the out-patient cardiology service to definitively prove this.  
However,  under-treatment  still  prevailed  in  this  cohort.  The  next  stage  of  this 
thesis  sought  to  study  patients  with  chronic  chest  pain  in  need  of  specialist 
secondary care management. I wanted to continue to investigate prognosis, but 
examine both non-fatal and fatal outcomes. Specifically, I wanted to move onto 
symptomatic prognosis. If prognosis for fatal events in incident angina is relatively 
equitable  between  ethnic  groups  presenting  to  a  chest  pain  clinic,  I  sought  to 
investigate whether similar equity existed in how chronic angina improved with 
management strategies instigated in secondary care. Such symptomatic, non-fatal 
outcomes are important to the quality of life of the patient with chronic symptoms 
as well as to providing an overall picture of prognosis of coronary disease in South 
Asian compared to White populations. I will thus – in addition to prognosis for 
serious  coronary  clinical  events  such  as  myocardial  infarction  and  death,  now 
examine symptomatic prognosis.  135 
 
 
7  Symptomatic outcomes following coronary angiography in 
patients with chronic stable angina  
7.1  Summary of chapter 
 
Background In patients with angina, the overall prognosis for coronary death is 
no worse in South Asian compared to White populations. However, it is not known 
whether there are disparities in symptomatic outcomes between South Asian and 
White populations from clinical management strategies in those with angina.  
Methods Six-year prospective cohort study to determine whether improvement of 
angina  symptoms  differs  between  South  Asian  and  White  patients  following 
revascularisation or medical management. 
Results  43.9%  of  South  Asian  patients  reported  improvement  in  angina  at  six 
years compared with 60.3% of White patients (age-adjusted odds ratio 0.56, 95% 
CI 0.41-0.76,  OR adjusted for diabetes, hypertension, smoking, number of diseased 
vessels, left ventricular function and social class 0.59, 95% CI 0.41-0.85). Similar 
proportions of White and South Asian patients underwent percutaneous coronary 
intervention (PCI) (19.6% vs 19.9%) and coronary artery bypass surgery (CABG) 
(32.8% vs 30.1%). South Asian patients were less likely to report improved angina 
after PCI (OR 0.19, 95% CI 0.06-0.56) or CABG (OR 0.36, 95% CI 0.17-0.74). There 
was less evidence of ethnic differences in angina improvement when treatment 
was medical (OR 0.87, 95% CI 0.48-1.57).  
Conclusions South Asian patients had poorer symptomatic prognosis following 
coronary angiography, being less likely to experience long-term improvements in 
angina than White patients after receipt of revascularisation. That prognosis for 
fatal  events  is  no  worse  in  South  Asian  populations  but  that  prognosis  for 
morbidity outcomes may be worse than in White populations adds to the overall 
picture of prognosis for coronary disease between these ethnic groups. 136 
 
7.2  Introduction  
Angina is the most common initial manifestation of coronary heart disease,29 a 
significant burden in primary care31 and has considerable economic implications.32 
The Health Survey for England on minority health reported that the prevalence of 
angina pectoris may be higher in South Asian people.161  In these patients with 
exertional angina, prognosis for outcomes such as myocardial infarction and death 
is not improved by coronary revascularisation.  
The previous chapter showed that, in patients with incident angina, the overall 
prognosis for coronary death was no worse in South Asian compared to White 
populations.  It  also  found  lower  rates  of  revascularisation  among  South  Asian 
patients compared with White patients. If revascularisation appears most suited 
for rapid symptom control rather than in improving prognosis for fatal outcomes, 
to fully examine prognosis of coronary disease in South Asian patients compared 
with White patients requires the study of symptomatic outcomes for those with 
angina.  
Ethnic  disparities  in  clinical  outcomes  following  revascularisation  have  been 
reported in African-Americans.71 There is little evidence on morbidity outcomes in 
South Asian patients compared with White patients following presentation with 
angina, such as change in symptoms following treatment, and whether differing 
strategies  of  clinical  management  equally  improve  symptom  burden  by  ethnic 
groups.   
7.3  Research objective to be investigated 
This chapter sought to investigate specific research objective 3. 
To  determine  impact  on  symptomatic  prognostic  outcomes  (change  in  angina 
severity)  in  South  Asians  and  White  populations  from  different  management 
strategies for chronic angina.  
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7.4  Specific research questions 
i.  Does  the  improvement  of  angina  differ  between  South  Asian  and  White 
patients six years following coronary angiography? 
ii.  Do  differing  treatment  modalities  affect  improvement  of  angina 
differentially by ethnic group? 
iii.  Do South Asian and White patients appropriate for revascularisation report 
improved angina at six years? 
7.5  Methods 
7.5.1  Population  
4121  consecutive  patients  were  eligible  for  inclusion  in  the  ACRE 
(Appropriateness  of  Coronary  Revascularisation)  study  if  they  underwent 
coronary angiography at the Barts and London Hospitals Trust, London between 
15 April 1996 and 14 April 1997. There were no exclusion criteria and written 
informed patient consent was obtained.  
7.5.2  Ethnicity 
Self-assigned  ethnicity  was  based  on  the  1991 census  classification  by 
questionnaire on the day of index coronary angiography and identified 424 South 
Asian patients. For patients with missing data, given and family names were cross 
matched on a database of 15 000 names used to identify South Asian patients in 
routine data from east London.141 This database identified a further 78 South Asian 
patients. This system was considered valid because the name database is highly 
specific  (99%);  the  name  assigned  and  self-assigned  methods  identified  similar 
proportions of South Asian people (15.6% and 12.8%, respectively) and confining 
the analyses to those with self assigned ethnicity did not affect the results. 
7.5.3  Assessment of angina status at baseline and follow-up 
7.5.3.1 Canadian Cardiovascular Society classification angina 
On  the  day  of  index  coronary  angiography,  patients  completed  a  questionnaire 
about  their  general  health,  coronary  heart  disease  risk  factors  and  angina 138 
 
symptoms (data available for 3301/4020, 82% response rate) using the Canadian 
Cardiovascular Society classification.  
Canadian Cardiovascular Society Functional Classification of Angina 
Class  Activity Evoking Angina        Limits to Physical Activity 
I  Prolonged exertion        None 
II  Walking > 2 blocks or > 1 flight of stairs    Slight 
III  Walking < 2 blocks or < 1 flight of stairs    Marked 
IV  Minimal or at rest        Severe 
2833 of the 4020 (70%) had data on both CCS angina and ethnicity.  
At follow-up, all patients who were alive and had consented to follow-up were sent 
a questionnaire asking about their angina (mean date 1st October 2002, response 
rate 78%). CCS for angina class was available at both baseline and follow-up in 
1508 White patients and 196 South Asian patients (Figure 9). The patients’ general 
practitioners were also sent a questionnaire at time of follow-up asking whether 
the  patient  had  a  current  diagnosis  of  angina  in  order  to  cross-check  patient 
questionnaire responses for angina. 139 
 
 
 
Figure 9 ACRE - Recruitment of patients with chest pain data  
at baseline and follow-up 
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At  follow-up  (Table  27),  presence  of  angina  on  CCS  classification  (I-IV)  was 
associated with general practitioner diagnosis of angina in both White (χ2=105, 
p<0.001)  and  South  Asian  patients  (χ2=4.0,  p=0.045).  CCS  was  also  strongly 
associated  with  nitrate  prescription  (χ2=114  in  White  patients,  15.3  in  South 
Asian patients, p<0.001 in both ethnic groups). 
Ethnicity  CCS class 
(angina) 
N  Nitrate 
prescription 
P  N  GP diagnosis 
of angina 
p 
White  0      (no)  592  162(27.36)  <0.001  590  70(11.86)  <0.001 
  I-IV  (yes)  727  412(56.67)    720  264(36.67)   
               
South Asian  0      (no)  44  6 (13.64)  <0.001  43  9 (20.93)  0.045 
  I-IV  (yes)  98  47 (47.96)    97  37 (38.14)   
(%)   
Table 27 ACRE - Presence of angina or not by CCS in White and South Asian patients at 
follow-up cross-tabulated to data on nitrate prescription GP diagnosis of angina on general 
practitioner questionnaire at follow-up 
It has also previously been reported in this cohort that CCS class was linearly 
associated  with  angiographic  findings,  revascularisation  rates,  mortality  and 
nonfatal myocardial infarction.57 In age-adjusted analyses, a higher CCS class was 
associated  with  an  increased  number  of  diseased  vessels  and  worse  left 
ventricular  function.  After  adjusting  for  age,  sex,  smoking,  history  of 
hypertension, diabetes, number of diseased vessels, left ventricular function, use 
of aspirin, beta-blockers or statins, and revascularisation status (for death and 
nonfatal myocardial infarction), a higher CCS class was linearly associated with 
higher  coronary  angioplasty  (P<0.001)  and  bypass  graft  (P=0.03)  rates,  and 
higher all-cause mortality and nonfatal myocardial infarction (P<0.001; CCS IV 
versus I: hazard ratio 2.44, 95% CI 1.46 to 4.09).  
7.5.3.2 Rose angina questionnaire 
Cardiac symptoms using questions derived from the Rose angina questionnaire 
were also sought. However, the completion rate was significantly lower than for 
CCS  in  both  ethnic  groups  (60%  in  South  Asian  patients,  69.8%  in  White 
patients). 141 
 
7.5.4  Baseline clinical details 
On  the  day  of  coronary  angiography,  eligible  patients  were  identified  by 
examination of ward admission and catheter laboratory logbooks.   Data were 
extracted on clinical presentation, present medications, past history of diabetes, 
smoking  and  hypertension,  family  history  of  coronary  disease  (heart  attack, 
angina or sudden cardiac death in parent/sibling aged under 60), occupation (to 
assign  social  class  according  to  the  Registrar  General’s  classificationm)  and 
education from case notes by trained nurses using standardised recording forms. 
The number of diseased vessels at angiography was calculated from the severity 
of disease in each of 27 coronary artery segments (as defined by the Coronary 
Artery  Surgery  Study162).  Left  ventricular  function  was  assessed  by 
ventriculography.  
7.5.5  Appropriateness ratings 
A nine member expert panel (four cardiologists, three cardiothoracic surgeons, a 
general  doctor,  and  a  primary  care  doctor)  was  convened  to  rate  the 
appropriateness of PCI and CABG. Using a technique developed by  the RAND 
corporation  in  the  USA,59  the  expert  panel  rated  2178  mutually  exclusive 
indications for coronary angiography. A specific indication was defined by logical 
combinations of clinical presentation, test results, and current treatment. Median 
scores ranged from  1-9, with 1-3 being inappropriate, 4-6 uncertain, and 7-9 
appropriate. Angiography was "inappropriate" when risks exceeded benefits and 
                                                        
m An official scheme of class analysis used in British surveys and censuses, though increasingly 
being supplanted by newer classifications. It grouped occupations into five socio-economic 
classes with the implication that occupation was a meaningful indicator of social welfare. 
 
I Professional occupations—e.g. doctors and lawyers. 
II Managerial and lower professional occupations—e.g. managers and teachers. 
IIIN Non-manual skilled occupations—e.g. office workers. 
IIIM Manual skilled occupations—e.g. bricklayers, coalminers. 
IV Semi-skilled occupations—e.g. postal workers. 
V Unskilled occupations—e.g. porters, dustmen. 
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"uncertain" when benefits and risks approximated equality or when the expert 
panel was divided in its judgement.  
7.5.6  Angiographic findings 
These were obtained from the free text angiogram report held in the case notes 
and coded blind to the clinical details by a trained coder. The number of diseased 
vessels was calculated from the severity of disease as defined by the Coronary 
Artery Surgery Study.162 163  
7.5.7  Follow up for mortality and hospitalisation 
At baseline, 99% of patients were flagged for mortality by the Office for National 
Statistics and were followed up until 14 October 2003. Patients were flagged 
with  the  National  Health  Service-Wide  Clearing  Service  for  all-cause  hospital 
inpatient admissions since the date of their index coronary angiogram until 1st 
October  2002,  matched  on  NHS  number,  or  date  of  birth,  postcode  and  sex. 
Details on hospital admission such as revascularisation procedures and non-fatal 
myocardial  infarction  (ICD-10  code  121)  were  collected  from  case  notes  and 
from the Patient Administration Systems from the 13 referring hospitals.  
7.5.8  Statistical analysis 
To  measure  course  of  angina,  follow-up  angina  score  was  subtracted  from 
baseline angina score (both 0 to +4). Then, the change in angina was coded as  
0  if angina class had not changed or worsened from baseline to follow-up   
(-4 to 0), and  
1  (+1 to +4) if angina had improved.  
STATA do-file – generation of angina change  
 
gen diff_angina=pccs-ccscoded 
gen change_angina=diff_angina 
recode change_angina -4/0=0 1/4=1 
label var change_angina "change in angina status" 
label define change_angina 0 "worse/none" 1 "improved" 
 
where  
pccs= CCS angina at baseline 
ccscoded=CCS angina at follow-up 
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All  covariates  that  were  significantly  associated  with  change  in  angina  in  the 
univariate  analysis  were  included  in  the  main  analysis.  Logistic  regression 
analysis  was  conducted  to  examine  the  relationship  between  ethnicity  and 
change in angina class. The likelihood ratio test was used to select covariates for 
the final model (at a threshold of p<0.1). Findings are presented as odds ratios 
with 95% confidence intervals. Survival analysis was performed to examine the 
association  of  change  in  angina  class  and  death.  Kaplan  Meier  curves  were 
plotted as a measure of absolute risk and Cox proportional hazards regression 
conducted  for  relative  risk  differences.  Confounders  included  in  the  Cox 
regression  were  hypertension,  smoking,  number  of  diseased  vessels,  left 
ventricular function and social class.  
7.6  Results 
7.6.1  Baseline correlates of angina 
In order to validate the measure of angina across both ethnic groups, I examined 
angina class versus baseline variables. South Asian patients with worse angina 
(higher angina class) were more likely to smoke, have lower mean systolic blood 
pressure, be in a lower social class, have a higher body mass index, have a history 
of heart failure, and have a higher doctor-defined angina class (Table 28). White 
patients with worse angina revealed similar trends, and were in addition more 
likely  to  have  diabetes,  a  history  of  myocardial  infarction  and  be  on  calcium 
antagonists, nitrates or ACE inhibitors. There was no evidence of any significant 
differences between the trends in White patients and the trends in South Asian 
patients (p for interaction column). 144 
 
Table 28 ACRE - Baseline characteristics in each angina class, in South Asian and White patients  
                   Ethnic group  South Asian  White    
CCS class   I 
(N=10) 
III 
(N=71) 
III 
(N=128) 
IV 
(N=125) 
P for trend  I 
(N=166) 
III 
(N=446) 
III 
(N=685) 
IV 
(N=905) 
P for trend  P for 
interaction 
      Age (mean, years)  56.2  54.0  55.9  56.5  0.150  58.4  60.3  61.5  61.8  <0.001  0.998 
      Men  7 (70)  52 (73)  106 (83)  93 (74)  0.905  139 (84)  324 (73)  518 (76)  590 (65)  <0.001  0.089 
      Ever smoked   2 (22)  29 (42)  60 (48)  65 (56)  0.014  113 (69)  306 (70)  488 (73)  674 (77)  0.001  0.217 
      Hypertensive  3 (30)  26 (37)  50 (39)  54 (43)  0.317  49 (30)  145 (33)  200 (29)  287 (32)  0.837  0.323 
      Systolic blood pressure (mmHg)  141.2  135.7  133.2  130.6  0.051  134.5  136.3  134.3  132.5  0.009  0.308 
       Total cholesterol (mean,mmol/l)  5.69  5.80  5.53  5.61  0.458  5.48  5.67  5.65  5.63  0.501  0.303 
       Diabetes  3 (30)  18 (25)  42 (33)  45 (36)  0.280  12 (7)  35 (8)  71 (10)  102 (11)  0.033  0.880 
       Body Mass Index (mean, kg/m2)  25.3  25.8  25.6  26.7  0.092  27.6  27.1  27.2  28.1  0.002  0.536 
       Family history coronary disease  3 (33)  28 (42)  38 (34)  38 (35)  0.584  82 (52)  182 (43)  285 (45)  436 (51)  0.052  0.260 
       Lower social class  3 (43)  42 (61)  79 (68)  87 (73)  0.047  91 (56)  235 (54)  377 (57)  519 (59)  0.089  0.121 
       Left school <16  3 (43)  33 (58)  61 (62)  41 (44)  0.186  28 (18)  66 (16)  91 (14)  94 (11)  0.013  0.751 
Medication 
       Aspirin   8 (80)  53 (75)  94 (73)  95 (76)  0.898  136 (82)  334 (75)  511 (75)  691 (76)  0.726  0.784 
       ACE inhibitor  1 (10)  18 (25)  33 (26)  28 (22)  0.839  27 (16)  90 (20)  138 (20)  210 (23)  0.040  0.451 
       Statin  0  11 (15)  21 (16)  18 (14)  0.733  35 (21)  107 (24)  151 (22)  193 (21)  0.751  0.605 
       Beta-blocker  5 (50)  37 (52)  56 (44)  56 (45)  0.539  82 (49)  229 (51)  331 (48)  374 (41)  0.002  0.773 
       Calcium antagonist  5 (50)  32 (45)  60 (47)  73 (58)  0.153  76 (46)  212 (48)  316 (46)  540 (60)  <0.001  0.907 
       Nitrate   5 (50)  34 (48)  76 (59)  70 (56)  0.505  78 (47)  282 (63)  431 (63)  657 (73)  <0.001  0.221 
Clinical presentation 
       Previous myocardial infarction  5 (50)  29 (41)  51 (40)  55 (44)  0.897  62 (37)  163 (37)  295 (43)  399 (44)  0.006  0.518 
       Higher doctor-defined CCS (III-IV)  2 (22)  20 (30)  56 (47)  68 (63)  <0.001  23 (15)  110 (26)  245 (41)  501 (60)  <0.001  0.739 
       Previous percutaneous coronary 
intervention 
1 (10)  3 (4)  9 (7)  13 (10)  0.230  15 (9)  27 (6)  45 (7)  117 (13)  <0.001  0.909 
       Previous CABG  1 (10)  1 (1)  8 (6)  20 (16)  0.003  12 (7)  29 (7)  67 (10)  148 (16)  <0.001  0.125 
Angiographic findings 
    Zero/mild/moderate diseased vessels  3 (30)  22 (31)  35 (27)  32 (26)  35 (21)  110 (25)  144 (21)  224 (25)  0.301 
      1 diseased vessel  4 (40)  18 (26)  30 (23)  27 (22)  51 (31)  118 (27)  207 (30)  229 (25)   
      2 diseased vessels  2 (20)  19 (27)  27 (21)  18 (15)  32 (19)  87 (20)  142 (21)  181 (20)   
      3 diseased vessels/LMS  1 (10)  11 (16)  36 (28)  45 (37) 
0.943 
48 (29)  128 (29)  187 (28)  265 (29)   
0.716 
      Impaired left ventricle   1 (13)  6 (10)  30 (28)  29 (31)  0.136  24 (19)  80 (22)  125 (22)  168 (23)    0.366 
P value for trend is age-standardised. Values for categorical variables are numbers of patients with percentages of total number with data for that variable (all cells were more than 75% complete for data); 
continuous variables are as stated. P value for interaction examines whether trends across CCS by ethnic group are different, a high p value implying no significant difference and thus suggesting equivalent trends in 
both ethnic groups, hence taking into account smaller numbers in the South Asian group. Table does not include patients CCS=0 (n=32 for South Asian patients, 265 for White patients). 145 
 
 
7.6.2  Mortality and relationship with angina status  
Worse angina at baseline was associated with higher rates of all-cause mortality 
in both South Asian (log-rank test p= 0.009) and White patients (log-rank test 
p<0.001) on survival analysis (Figure 10).  
 
Figure 10 ACRE - Mild compared to severe baseline angina and risk of future all-cause 
mortality, in White and South Asian patients 
7.6.3  Change in angina status between ethnic groups  
The mean baseline CCS class was 2.83 (SD 1.18) in South Asian and 2.73 (SD 
1.30) in White patients (two sample t test = -1.40, p= 0.162). At six-year follow-
up, means were 2.13 (SD 1.62) and 1.44 (SD 1.56) respectively (two sample t test 
= -6.45, p<0.001,Figure 11). 146 
 
 
Figure 11 ACRE - Mean Canadian Cardiovascular Score of angina at baseline and 6-year 
follow-up, in White and South Asian patients 
Consistent with this, South Asian patients were more likely to have a diagnosis of 
angina on the six-year follow-up general practitioner questionnaire than White 
patients (71/216 (32.9%) vs. 403/1691 (23.8%), age-adjusted OR 1.52, 95% CI 
1.11-2.07).  
Fewer  South  Asian  patients  (43.9%  (86/196))  reported  an  improvement  in 
angina  at  six  years  compared  to  White  patients  (60.3%  (910/1508)),  age-
adjusted  OR  0.56,  95%  CI  0.41-0.76).  Adjusting  for  diabetes,  hypertension, 
smoking, number of diseased vessels, left ventricular function and social class 
did not attenuate this finding (Figure 12).  
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Figure 12 ACRE - Odds of improvement of angina in South Asians compared with White 
patients within whole study patient and by management strategy post-angiography  
(Medical management strategy –use of oral medication alone (such as anti-anginal medication) 
 
7.6.4  Angina status and relation to revascularisation 
Similar  proportions  of  each  ethnic  group  underwent  percutaneous  coronary 
intervention  (South  Asian  19.9%  (100/502),  White  19.6%  (583/2974))  and 
CABG  (South  Asian  30.1%  (151/502),  White  32.8%  (974/2974))  following 
angiography. Stratifying on management post-angiography, South Asian patients 
were less likely to report improved angina after PCI (OR 0.19, 95% CI 0.06-0.56) 
and  CABG  (OR  0.36,  95%  CI  0.17-0.7,Figure  12).  However,  there  was  less 
evidence for ethnic differences in angina improvement if treated medically by 
medication alone.  
7.6.5  Angina status, appropriateness for revascularisation and relation to 
revascularisation 
Confining  analyses  to  those  patients  judged  appropriate  for  revascularisation, 
South  Asian  patients  still  reported  less  improvement  in  angina  at  six  years 
compared to White patients (fully-adjusted OR 0.42, 95% CI 0.23-0.76). 
The  ACRE  study  has  previously  reported  that  the  overall  rate  of 
revascularisation  is  lower  among  South  Asian  than  White  patients.61  In  this 148 
 
paper, there was no difference between South Asian and White patients in the 
proportions that were rated by the panel as appropriate for revascularisation 
(72%  v  68%)  but  among  patients  deemed  appropriate  for  angioplasty,  South 
Asian patients were less likely to receive it than White patients. 
7.6.6  Risk of myocardial infarction and death 
There  was  no  statistically  significant  difference  in  the  rates  of  non-fatal 
myocardial infarction between South Asian and White patients (Table 29). South 
Asian  patients  had  a  statistically  significantly  lower  rate  of  all-cause  and 
coronary  death.  However,  when  adjusting  for  age,  these  differences  were 
rendered non-significant.  
 
  Ethnic group  Number of 
events 
Rate/1000 person 
years (95%CI) 
Hazard ratio 
(95%CI) 
P  
White  275  13.90 (12.35-15.64)  1  Myocardial infarction 
South Asian  41  12.25 (9.02-16.64)  0.88 (0.63-1.22) 
0.447 
White   1  adjusted for age 
South Asian 
 
0.87 (0.62-1.21) 
0.400 
White   587  31.42 (28.98-34.06)  1  All-cause mortality  
South Asian  64  19.56 (15.30-24.98)  0.62 (0.48-0.81) 
<0.001 
White   1  adjusted for age 
South Asian 
 
0.91 (0.70-1.18) 
0.460 
White patients  263  17.24 (15.28-19.45)  1  Coronary mortality 
South Asians  31  11.34 (7.98-16.13)  0.66 (0.46-0.96) 
0.031 
White   1  adjusted for age 
South Asian 
 
0.93 (0.64-1.36) 
0.720 
Table 29 ACRE - Numbers of outcomes (myocardial infarction and death (all 
cause/coronary)), rates and hazard ratios (crude/adjusted for age) in South Asian 
compared with White patients 
7.7  Discussion 
7.7.1  Objective addressed 
This is the first study to report on long-term differences between South Asian 
and White patients in symptomatic outcomes of coronary disease. My findings 
reveal  that  South  Asians  patients  were  less  likely  to  experience  long-term 
improvement in angina following coronary revascularisation when compared to 
White patients, despite similar rates of infarction and death. 149 
 
In those with angina, revascularisation appears most suited for rapid symptom 
control rather than in improving prognosis for fatal outcomes. Thus this work 
used a symptomatic outcome, and found relief of angina to be worse in South 
Asian  compared  to  White  patients.  Such  symptomatic  outcomes  add  to  the 
overall picture of prognosis of coronary disease in South Asian compared with 
White populations, as relief of angina determines return to work and perceived 
health status.  48 By ignoring ‘symptomatic prognosis’, an incomplete picture of 
prognosis  is  painted,  which  appears  equitable  between  ethnic  groups  when 
examining case fatality alone. 
7.7.2  Why does angina improve less in South Asian patients after 
revascularisation? 
I tested whether South Asian patients undergoing revascularisation were less 
appropriate  candidates  for  the  procedure.  Using  pre-defined  and  validated 
definition  of  appropriateness,  I  still  found  a  lesser  improvement  in  angina 
amongst South Asian compared with White patients. 
South Asian populations may have smaller coronary arteries compared to White 
populations,164 though this may be explained by body size.72 Revascularisation of 
smaller  coronary  arteries  has  been  associated  with  less  favourable  clinical 
outcomes165  and  I  found  that  the  rate  of  repeat  percutaneous  coronary 
interventions in South Asian patients was higher than among White patients (OR 
1.70, 95% CI 1.01-2.86). Diabetes may also alter the perception of cardiac pain if 
associated  with  neuropathy.166  However,  after  adjusting  for  the  higher 
prevalence of diabetes and lower body mass index in South Asian patients in 
ACRE  compared  to  White  patients,  this  did  not  attenuate  the  observed 
differences  in  angina  improvement  between  the  ethnic  groups.  Adjustments 
were also made for other coronary risk factors, though an association between 
these risk factors and symptom persistence has not found in previous studies.147 
I also adjusted for the number of diseased coronary vessels, as persistence of 
angina may be a marker of disease severity such as increased atherosclerotic 
burden.38  150 
 
Overall, the reasons for the lesser improvement in angina in South Asian patients 
compared to White patients could not be fully elucidated by this study. 
7.7.3  Limitations 
I acknowledge the inherent difficulty in measuring angina in any ethnic group, 
especially  via  a  questionnaire  written  in  English.  However,  several  lines  of 
evidence suggest that the ethnic differences in symptoms I report are likely to be 
robust.  Firstly, South  Asian  patients  had  a  higher  prevalence  of  primary  care 
doctor-diagnosed angina at six years; secondly, increasing angina as measured 
by  CCS  at  baseline  was  associated  with  worsening  patterns  in  other  baseline 
clinical  measures  and  higher  rates  of  prospective  all-cause  mortality;  thirdly, 
there were no important differences in non-response bias between ethnic groups 
in  those  responding  and  not  responding  to  the  questionnaire  and  finally, 
analyses with angina diagnosis obtained from the Rose questionnaire yielded 
similar  results,  with  South  Asian  patients  reporting  a  trend  towards  less 
improvement in angina compared with White patients (age-adjusted OR 0.68, 
95%  CI  0.41-1.11).  The  importance  of  symptomatic  outcomes  should  be 
underlined. Angina patients with similar functional limitation vary considerably 
in  tolerance  of  their  symptoms,  which  in  turn  influences  the  management 
instigated by their doctor.33 The presence of chest pain in primary care patients 
is  associated  with  poorer  functional  status,  especially  in  role  functioning.167 
Patient-defined measures thus need to be developed to take into account the fact 
that patients and clinicians differ in regard to the distress caused by symptoms. 
168  
The ACRE study could not discriminate the differing peoples within the South 
Asian term and evidence exists of differences in coronary risk factors between 
these  peoples.20  Though  ACRE  did  have  details  on  individual  South  Asian 
nationality,  numbers  were  too  small  with  which  to  carry  out  comparative 
analyses.  There is however less evidence on differences in symptoms of angina 
between these peoples.  
Conceivably, if one ethnic group had higher coronary mortality than the other, 
then angina follow-up data may have been biased by the lack of data from those 151 
 
who  had  died,  who  may  have  had  lesser  improvement  in  angina  had  they 
survived. A greater proportion of White patients had died by six years compared 
to South Asian patients. However, by excluding all those that had died, I found 
that in those that survived to six years there was still a lesser improvement in 
angina in South Asian patients than White patients (OR 0.49, 95% CI 0.31-0.78, 
adjusting for diabetes, hypertension, smoking, number of diseased vessels, left 
ventricular  function  and  social  class).  The  relative  numbers  who  had  died 
compared to those that survived remained low in both ethnic groups and would 
thus  not  have  significantly  biased  the  overall  finding  of  less  improvement  of 
angina in South Asian patients compared to White patients at follow-up.  
As  a  prospectively  recruited  clinical  cohort,  all  patients  who  consecutively 
attended  for  angiography  over  the  recruitment  phase  were  included  –  this 
eliminates selection bias in following up those selected for angiography, though 
it cannot taken into account possible selection bias in the selection process for 
angiography.  South  Asian  people  with  angina  pectoris  had  lower  rates  of 
coronary  angiography  compared  with  White  people  in  the  Chest  Pain  Clinic 
study, a study of incident angina.  However, chronic angina is more likely to sway 
the  cardiologist  in  favour  of  coronary  angiography.  The  time  from  initial 
symptoms to ultimately receiving coronary angiography may be longer in South 
Asian people, especially in light of their increased number of interactions with 
healthcare  professionals  prior  to  receiving  coronary  angiography  than  White 
people,61  but  when  faced  with  chronic,  persistent    symptoms  they  may  not 
under-investigated in the long-term. Unmeasured factors may account for the 
under-management  observed  in  the  Chest  Pain  Clinic  study,  such  as  co-
morbidity,  patient  preferences  and  the  efficacy  of  ensuing  medical  treatment 
with anti-anginal drugs alone which may have rendered coronary angiography 
unnecessary. 
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7.7.4  Implications 
Few  studies  examine  morbidity,  symptomatic  outcomes  following 
revascularisation and our study revealed no differences in long-term mortality 
between  these  two  ethnic  groups  following  angiography.  Coronary 
revascularisation for angina, either by PCI or CABG, is performed primarily for 
relief of symptoms yet in this study did not improve angina among South Asian 
patients  as  much  as  it  did  for  White  patients.  Hence,  studying  symptomatic 
outcomes by ethnicity may be of more importance than case fatality alone in the 
study of the prognosis of chronic stable angina. 
It  would  have  been  of  interest  to  ascertain  whether  in  ACRE,  typicality  of 
symptoms was prognostically related to better symptomatic outcomes, had the 
data  been  available.  However,  in  the  Chest  Pain  Clinic  study  of  the  previous 
chapter,  South  Asian  participants  were  under-treated  by  revascularisation 
compared to White participants irrespective of typicality of symptoms. This was 
despite  descriptors  of  chest  pain  being  used  equally  across  ethnic  group  in 
making a diagnosis of angina and being equally predictive of coronary events. 
Thus, atypical presentation of chest pain at initial presentation may not have 
accounted  for  the  longer-term  poorer  symptomatic  outcomes  in  South  Asian 
patients in ACRE. 
7.8  Conclusions 
I found that South Asian patients were less likely to have improved angina than 
White patients six years after undergoing coronary revascularisation, even after 
having taken into account appropriateness for revascularisation and differences 
in clinical characteristics. The use of a symptomatic outcome adds to the overall 
picture of prognosis of coronary disease in South Asian compared with White 
populations,  as  whilst  prognosis  for  fatal  events  is  no  worse  in  South  Asian 
patients  with  chronic  stable  angina,  prognosis  for  morbidity,  symptomatic 
outcomes may be.  153 
 
 
7.9  Building to next chapter 
I have shown that, in patients undergoing coronary angiography, South Asian 
patients  had  no  worse  a  prognosis  for  ‘hard’  outcomes  such  as  myocardial 
infarction  and  death  compared  to  white  patients,  but  that  symptomatic 
prognosis was worse in ACRE. This was not accounted for by under-treatment, 
which still prevailed in this cohort as it did in the Chest Pain Clinic study.  
The next stage of this thesis sought to study patients with acute chest pain as an 
emergency  presenting  to  secondary  care.  I  wanted  to  continue  to  examine 
prognosis at this more serious manifestation of coronary disease, and examine 
whether mortality differed between ethnic groups. The heterogeneous nature of 
acute coronary syndromes would be considered as prognosis will depend on the 
severity of disease at presentation. There are no contemporary studies that have 
examined  prognosis  between  ethnic  groups  using  the  newer  definitions  of 
myocardial infarction incorporating troponin level. Furthermore, prevalence of 
diabetes, socio-environmental factors and management strategy, which differed 
between White and South Asian participants in the previous two cohorts of this 
thesis,  may  further  influence  prognosis  differentially  between  ethnic  groups. 
Diabetes in South Asians may have increased potency in causing ensuing disease, 
and since these acutely unwell patients are most likely to derive the greatest 
benefit  from  intensive  therapy,  under-treatment  here  will  significantly  affect 
future risk of death.   
Thus I sought to investigate whether ethnic differences existed in prognosis of 
acute chest pain, and to consider the effect of not only biological differences but 
also  severity  of  disease  at  presentation  and  socio-environmental  and  clinical 
management measures.  154 
 
 
8  The prognosis of acute coronary syndromes  
8.1  Summary of chapter 
 
Background Understanding the prognosis of acute coronary syndromes (ACS) in 
South  Asian  compared  to  White  populations  necessitates  adequate 
differentiation  of  ACS  type  and  assessment  of  degree  of  disease  severity  at 
presentation, and consideration of factors such as diabetes, social environment 
and clinical management that may confound prognostic analyses by ethnicity.  
Methods  3037  South  Asian  and  68843  White  patients  admitted  with  acute 
coronary syndrome in 2004 in England and Wales were followed up for all-cause 
death at one year. Prognostic analyses were further stratified by risk factors, 
clinical management strategies and socio-demographic characteristics. 
Results South Asian patients were younger than White patients, and were more 
likely to be men, less likely to smoke, but were more likely to be hypertensive or 
diabetic. South Asian patients were not more likely to be under-treated. One-year 
risk-factor adjusted survival in South Asian patients was marginally better than 
White patients at one year (HR (95% CI) 0.83 (0.71-0.97)). Stratifying on risk 
factors, clinical management strategies and socio-environmental characteristics 
did not appear to confer a worse prognosis in South Asian compared to White 
patients.  
Conclusions  Survival  following  acute  coronary  syndromes  was  no  worse  in 
South Asian compared to White patients. Diabetes, was not associated with a 
higher relative risk in South Asian compared to White patients, nor were any 
other  risk  factors,  clinical  management  strategies  and  socio-environmental 
characteristics. 
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8.2  Introduction  
Studies examining prognosis of myocardial infarction between South Asians and 
White populations are conflicting. Some report a better prognosis,123 others an 
equitable prognosis126 and others a worse prognosis96 in South Asian compared 
to White populations. To understand the prognosis of acute coronary syndromes 
in full, its different phenotypes need to be taken into account as they will differ in 
degree of disease severity and will hence affect any explanation the prognosis of 
acute coronary disease may have for the higher coronary mortality rate in South 
Asian compared to White populations. 
Prognosis of acute coronary syndromes is also affected by a range of factors that 
range  from  biological  risk  factors  through  socio-environmental  factors  to 
differences in clinical management. Certain risk factors such as diabetes mellitus 
may be more potent in causing an adverse prognosis in South Asian compared to 
in White populations.93 Furthermore, some,61 but not all57 62 169 studies, suggest 
that  underuse  of  effective  medical  treatments  is  more  common  among  South 
Asian people and that underuse may be associated with the deprived areas South 
Asian people live in.29  
8.3  Research objective to be investigated 
This chapter sought to investigate specific research objective 4. 
To compare fatal prognostic outcomes of acute coronary syndromes in South 
Asian and White populations and assess factors underlying prognosis. 
8.4  Specific research questions 
i.  Do  South  Asian  patients  suffer  an  increased  case  fatality  compared  to 
White patients when presenting with acute coronary syndromes? 
ii.  Do  the  new  definitions  of  myocardial  infarction  using  troponin  in 
prognostic analyses affect outcomes differentially by ethnic group?  
iii.  What is the impact of differences of risk factors, clinical management and 
socio-environmental characteristics at baseline in South Asian compared 
to White patients on ensuing prognosis? 156 
 
8.5  Methods  
The  Myocardial  Infarction  National  Audit  Project  (MINAP)  is  a  registry  of  all 
patients with an acute coronary syndrome who have been admitted to all 230 
hospitals in England and Wales.134  A standardised data collection form is used 
by all hospitals. MINAP uses a highly secure electronic data entry transmission 
and analysis system developed by the Central Cardiac Audit Database group to 
collect  and  analyse  records  of  patients  with  all  types  of  acute  coronary 
syndrome.170 The study monitors mortality among patients by linkage with the 
Office of National Statistics using the National Health Service number unique to 
each patient. 
MINAP data for all patients with first admission with ACS during the year 2004 in 
England and Wales was used. Of 91684 patients, there were 68843 who were 
coded  White  and  3037  Asian.  The  definitions  of  admission  variables  were  as 
follows: 
•  Smoking: ex- and current smokers 
•  Diabetes: known and newly-diagnosed cases 
•  Hyperlipidaemia: previously treated hypercholesterolaemia 
•  Medication:  whether  or  not  the  patient  was  already  taking  an  aspirin, 
statin, beta-blocker or ACE inhibitor 
Further data were available on  
•  peak troponin level  
•  area  deprivation  (Index  of  Multiple  Deprivation  (IMD)  2000  score,  see 
appendix 13.7.1) 
•  the distance the patient lived from the hospital 
•  whether  admitting  hospital  had  Membership  of  Association  of  UK 
University Hospitals 
•  receipt of in-patient coronary angiography. 157 
 
8.6  Statistical analysis 
Admission  characteristics  were  examined  by  ethnic  groups  in  risk  factors, 
clinical  management  and  socio-environmental  characteristics.  χ2  tests  were 
conducted to compare proportions, two-sample t tests for continuous variables. 
Admission characteristics were then examined between ethnic groups using the 
ACS types. 
For prognostic analyses, Cox proportional hazards regression was performed to 
assess risk of all-cause death at one year. Adjustments for age (as a continuous 
variable), sex, hypertension, hyperlipidaemia, smoking and diabetes were made. 
These analyses were repeated for each ACS type. Analyses in the whole cohort 
were then stratified by admission factors (age above/below 65, sex, presence or 
absence  of  individual  coronary  risk  factors,  disease  severity,  clinical 
management  factors  and  social  environment)  and  formally  examined  as  to 
whether a statistical difference existed between hazard ratios of each strata with 
the Bland-Altman two-tailed test of interaction.154  
The  choice  of  cut-off  level  for  a  significant  level  of  troponin  varies  between 
previously published trials, though as a cut-off level between 0.1 and 0.2 µg/L 
has been proposed to identify patients at higher risk in most trials,77 171-173 0.1 
was used. For deprivation, quartiles were used, and examined highest quartile 
against  lowest  quartile.  For  distance  from  hospital,  analyses  were  examined 
around the median of 7.6km. 
8.7  Results 
8.7.1  Admission characteristics of whole cohort 
South Asian patients were younger than White patients, and were more likely to 
be  men  (Table  30).  They  were  less  likely  to  smoke,  but  more  likely  to  be 
hypertensive or diabetic. South Asian patients were more likely to live in more 
deprived  areas,  but  lived  closer  to  hospitals  and  were  more  likely  to  use  a 
teaching hospital. South Asian patients did not have higher troponins than White 
patients. South Asian patients were on more medications on arrival to hospital – 
the proportion having only one or less of aspirin, statin, beta-blocker or ACE 
inhibitor was lower than in White patients. They were also more likely to have a 158 
 
coronary angiogram performed as an in-patient. Regarding the ACS types, similar 
proportions of South Asian and White patients were observed for STEMI, though 
there were increased numbers of troponin-negative ACSs in South Asian patients 
and fewer NSTEMIs. 
 
% - percentages represent the proportion of those with this entry for this field out of total number available for the field 
Drugs - aspirin, statin, beta-blocker or ACE inhibitor 
 
Table 30 MINAP - Admission data in South Asian and White patients, in 2004 
 
8.7.2  Admission characteristics of types of acute coronary syndromes 
Admission characteristics were examined by ACS type in South Asian and White 
patients  (Table  31).  Within  all  three  types,  South  Asian  compared  to  White 
patients were younger, more likely to be men, smoked less, were more likely to 
be hypertensive and diabetic, were more likely to live in more deprived areas but 
Ethnic group    South Asian  White    
         
Risk factors        p 
Age  Mean, SD  61.56 (13.6)  69.47   (13.2)  <0.001 
  Over 65  1118  (37.4%)  41595  (60.3%)  <0.001 
Sex  Men  2261  (74.3%)  43746  (63.3%)  <0.001 
Smoking  Yes  1152  (47.7%)  39308  (71.7%)  <0.001 
Hypertension  Yes  1493  (52.9%)  29051  (45.2%)  <0.001 
Hyperlipidaemia  Yes  1098  (41.5%)  17868  (29.2%)   <0.001 
Diabetes  Yes  1219  (43.8%)  11417  (18.0%)  <0.001 
         
Disease severity         
Troponin ≥0.1  Yes  1271  (52.3%)  32267  (56.9%)  <0.001 
         
Social environment         
Deprivation score quartile  Most deprived  328    (48.4%)  3341    (24.1%)  <0.001 
Distance from hospital  Far (≥7.6km)  97      (14.1%)  7583   (51.2%)  <0.001 
Teaching hospital  No  2010 (66.2%)  55890 (81.2%)  <0.001 
         
Clinical management         
Treatment  0-1  drugs 
(fewer) 
617   (20.3%)  17739 (25.8%)  <0.001 
In-patient angiogram done  No  1095 (44.6%)  29076 (59.9%)  <0.001 
         
Final diagnosis         
  STEMI    870   (33.5%)  18684 (32.2%) 
  NSTEMI/Trop +ve    1318 (50.8%)  34711 (59.8%) 
  Trop -ve    408   (15.7%)  4654   (8.0%) 
<0.001 159 
 
closer  to  hospitals  and  were  not  more  likely  to  be  under-treated.  This  was 
consistent with the admission findings for the whole cohort (Table 30). 
Examining across the three types, STEMIs had higher troponins than NSTEMIs, in 
turn  higher  than  troponin-negative  ACSs,  and  there  was  more  in-patient 
coronary angiography of patients with STEMI and NSTEMI than in those with 
troponin-negative ACS. STEMI and NSTEMI patients were on more medication on 
arrival than troponin-negative ACS patients. 
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()-percentages representing the proportion of those with this entry for this field out of total number available for the field 
-no data available    Drugs - aspirin, statin, beta-blocker or ACE inhibitor 
Table 31 MINAP - Admission characteristics in each type of acute coronary syndrome in South Asian compared to White patients 
           ACS Type                           STEMI    NSTEMI/Troponin +ve  Troponin  -ve 
           Ethnic group    South Asian  White  South Asian  White  South Asian  White 
N    870  18684  1318  34711  408  4654 
Risk factors               
Age  Mean, SD  60.08 (12.7)  66.30 (13.0)  64.26 (12.7)  72.41 (12.9)  60.26 (12.1)  66.72 (12.5) 
  Over 65  318 (37.2)  10138 (54.8)  681 (52.3)  25178 (75.3)  163 (41.5)  2658 (57.6) 
Sex  Men  668 (77.2)  12983 (69.7)  979 (74.5)  21039 (60.8)  290 (71.6)  2901 (62.7) 
Smoking  Yes   365 (50.9)  11805 (75.9)  478 (46.1)  19099 (70.3)  148 (47.7)  2751 (71.5) 
Hypertension  Yes   344 (43.3)  6884 (40.0)  685 (55.9)  15581 (47.7)  257 (64.4)  2378 (53.4) 
Hyperlipidaemia  Yes   229 (31.0)  4175 (25.6)  460 (40.0)  8788 (28.0)  239 (64.8)  2066 (48.1) 
Diabetes  Yes   309 (37.7)  2320 (13.5)  575 (47.3)  6761 (20.9)  168 (48.0)  784 (17.7) 
               
Disease severity               
Troponin ≥0.1  Yes  511 (92.6)  13036 (94.1)  722 (60.4)  18091 (56.7)  1 (0.28)  30 (0.76) 
               
Social 
environment 
             
Deprivation  score 
quartile  
Most deprived   286 (81.3)  2925 (48.9)  42 (80.8)  416 (46.4)  -  - 
Distance  from 
hospital 
Far (≥7.6km)  84 (14.0)  6535 (50.9)  11 (12.9)  965 (52.2)  -  - 
Teaching hospital  No   604 (69.4)  14792 (79.2)  975 (74.0)  28868 (83.2)  211 (51.7)  3788 (81.4) 
               
Clinical 
management 
             
Treatment  0-1 drugs (fewer)  149 (17.1)  3370 (18.0)  227 (17.2)  7848 (22.6)  371 (90.9)  3,815 (82.0) 
In-patient 
angiogram done 
No   233 (34.5)  7179 (53.2)  395 (37.0)  13916 ( 57.0)  221 (58.6)  2031 (60.1) 161 
 
 
8.7.3  Prognosis in whole cohort 
Of 68843 White patients, 12823 had died at one year (rate/1000 person years 
(95%CI) - 0.64 (0.63-0.65)). Of 3037 South Asian patients, 286 had died at one 
year (rate/CI 0.33 (0.29-0.37)).  
The hazard ratios (and 95% CIs) on cox regression analysis comparing South 
Asian with White patients were:            
Crude  0.53 (0.47-0.59) 
Age-adjusted  0.92 (0.82-1.04) 
Adjusted for sex, hypertension, 
hyperlipidaemia, smoking, diabetes 
0.83 (0.71-0.97) 
 
Thus, crude survival in South Asian patients was markedly better than White 
patients at one year, and only marginally better after adjustment for age and of 
risk factors (HR 0.83 (95% CI 0.71-0.97)). Further adjustment for factors such as 
troponin level and treatment did not alter this result (HR 0.84 (95% CI 0.71-
1.00)). Adjustment for age and deprivation score revealed that survival in South 
Asian patients was similar to White patients (HR 0.97 (95% CI 0.73-1.28)). 
8.7.4  Prognosis by acute coronary syndrome type 
Prognosis was examined by ACS type comparing South Asian with White patients 
(Figure 13). Though there was a trend towards better survival in South Asian 
patients on crude analyses in all three ACS types as for the whole cohort, on 
multi-variate  adjustment,  survival  was  similar  in  South  Asian  compared  with 
White patients for each ACS type. 
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Figure 13  MINAP - Risk in South Asian compared to White patients within each type of acute 
coronary syndrome of all-cause mortality at one year  
South Asian patients were noted to have more troponin-negative ACS admissions 
than White patients. I thus examined prognosis for STEMI/NSTEMI combined, 
excluding troponin-negative ACS admissions, and found that survival remained 
no worse in South Asian patients compared with White patients (HR 0.87 (95% 
CI  0.74-1.01),  adjusted  for  age,  sex,  hypertension,  hyperlipidaemia,  smoking, 
diabetes).  
8.7.5  Prognosis among diabetics 
The  potency  of  diabetes  for  causing  coronary  disease  was  examined  by 
investigating the risk of one year death in patients with diabetes compared to 
patients without diabetes within each ethnic group for the whole cohort. 
The hazard ratios on cox regression analysis in patients with diabetes compared 
to patients without diabetes, in South Asian and in White patients are depicted in 
Table  32.  Diabetes  in  South  Asian  patients  was  associated  with  a  poorer 
prognosis than in those South Asian patients who were not diabetic (adjusted HR 
1.60  (95%  CI  1.18-2.17)).  A  similarly  poor  prognosis  was  observed  in  White 
patients with diabetes compared to White patients without diabetes (adjusted 163 
 
HR 1.50(95%  CI 1.42-1.57)). Hence, diabetes was as potent in causing future 
adverse outcomes in South Asian and White patients. 
        HR (95%CI) 
Ethnic 
group 
Diabetes  Number  of 
events/Number 
Rate/1000  person 
years (95%CI) 
Crude  Adjusted** 
South 
Asian 
Yes 
 
No 
155/1213 (12.8%) 
 
101/1554 (6.5%) 
0.44 (0.38-0.52) 
 
0.22 (0.18-0.27) 
 
1.97  
(1.53-2.53)* 
 
 
1.60  
(1.18-2.17)** 
 
White   Yes  
 
No 
2874/11293 (25%) 
 
8894/51549(17.3%) 
0.91 (0.88-0.94) 
 
0.58 (0.57-0.60) 
 
1.52  
(1.45-1.58)* 
 
 
1.50  
(1.42-1.57)** 
 
**Adjusted for age, sex, hypertension, hyperlipidaemia, smoking  
Drugs - aspirin, statin, beta-blocker or ACE inhibitor 
 
Table 32 MINAP - Risk in patients with diabetes compared to patients without diabetes of all-
cause mortality at one year, in South Asian and White patients  
 
8.7.6  Stratifying prognosis by admission characteristics  
Table 33 reveals age-adjusted stratified analyses for risk of death at one year 
comparing South Asian and White patients. 
8.7.6.1 Diabetes and other risk factors:  
When  examining  survival  within  diabetic  status,  South  Asian  patients  had  a 
better survival compared to White patients irrespective of diabetic status (HR in 
patients with diabetes 0.75 (95% CI 0.63-0.88)). 
Further adjusting the analyses within diabetics for sex, smoking, hypertension 
and hyperlipidaemia did not change the better survival observed in South Asian 
compared to White patients (HR 0.77(95% CI 0.63-0.94), table below). When 
additionally adjusting for receipt of aspirin, statin, beta-blocker or ACE inhibitor, 
South  Asian  and  White  patients  had  a  similar  survival.  82%  of  South  Asian 
patients with diabetes were on two or more of these medications compared to 
76% of White patients with diabetes (χ2 20.41, p<0.001). 
 
 164 
 
    Age-adjusted  *Model 1  **Model 2 
Diabetes  Yes  0.75 (0.63-0.88)  0.77(0.63-0.94)  0.81 (0.67-1.00) 
  No  0.78 (0.64-0.95)  0.82(0.65-1.04)  0.83 (0.65-1.05) 
*Model 1 - adjusted for age, sex, hypertension, hyperlipidaemia, smoking 
**Model 2 - adjusted for treatment with aspirin, statin, beta-blocker or ACE inhibitor 
Table 33 MINAP - Risk in South Asian compared to White patients, stratified by diabetes, of 
all-cause mortality at one year  
When  examining  survival  within  sex,  analyses  revealed  similar  prognoses 
between ethnic groups in men and women. Prognosis was also the same in South 
Asian  compared  to  White  patients  with  diabetes  in  those  with  and  without 
hypertension.  South  Asian  patients  that  smoked  or  had  high  cholesterol  also 
appeared to have a similar prognosis to their White counterparts with these risk 
factors.   
8.7.6.2 Disease severity  
Stratified analyses by troponin ≥0.1 suggested a better prognosis in South Asian 
compared to White patients with troponin <0.1 (HR 0.75 (95% CI 0.60-0.94), 
p=0.049 for two-tailed test for interaction with those with high troponin). 
8.7.6.3 Social environment 
Stratifying  by  distance  from  patient  home  to  hospital  and  teaching  status  of 
hospital revealed similar prognoses between ethnic groups. South Asian patients 
in  less  deprived  areas  had  a  worse  prognosis  than  White  patients  in  less 
deprived  areas  (HR  2.34  (95%  CI  1.21-4.56);  p=0.025  for  two-tailed  test  for 
interaction with more deprived areas).  
8.7.6.4 Clinical management  
Stratified  analyses  by  coronary  angiography  and  pharmacological  treatment 
revealed similar prognoses between ethnic groups. There was a worse prognosis 
in South Asian patients compared to White patients amongst those selected for 
in-patient angiography (HR 1.32 (95% CI 1.04-1.66)). 
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    HR (95%CI)  P for interaction 
Risk factors       
Age  Over 65  0.66 (0.58-0.75)  0.132 
  Under 65  0.83 (0.63-1.08)   
Sex  Men  0.91 (0.78-1.05)  0.865 
  Women  0.93 (0.76-1.14)   
Smoking  Yes  0.78 (0.62-0.99)  0.057 
  No  1.04 (0.87-1.25)   
Hypertension  Yes  0.95 (0.81-1.11)  0.303 
  No  0.83 (0.68-1.02)   
Hyperlipidaemia  Yes  0.98 (0.79-1.20)  0.581 
  No  0.91 (0.77-1.06)   
Diabetes  Yes  0.75 (0.63-0.88)  0.766 
  No  0.78 (0.64-0.95)   
Disease severity       
Yes  0.99 (0.84,1.16)  0.049  Troponin ≥0.1 
No  0.75 (0.60,0.94)   
Social environment       
Most deprived   0.72 (0.47,1.11)   0.025  Deprivation score 
(quartiles)  Least deprived   2.34 (1.21,4.56)    
Far (≥7.6km)  0.61 (0.23,1.63)  0.243  Distance from hospital 
Near(<7.6km)  1.12 (0.84,1.49)   
Teaching hospital  No  0.88 (0.76,1.01)  0.151 
  Yes  1.06 (0.86,1.31)   
Clinical management       
Treatment  0-1 drugs  1.03 (0.86,1.23)   
  2-4 drugs  0.93 (0.80,1.09)  0.215 
No  0.85 (0.72,1.01)    In-patient angiogram done 
Yes  1.32 (1.04,1.66)  0.003 
Table 34 MINAP - Risk in South Asian compared to White patients, stratified by risk factors, 
markers of disease severity, social environment and clinical management, of age-adjusted 
all-cause mortality at one year  
 
8.8  Discussion 
South Asian and White patients differed when presenting with acute coronary 
syndromes. The former were younger, more likely to be men, more likely to be 
diabetic and were more likely to live in more deprived areas. However, South 
Asian patients did not present with higher troponin levels than White patients, 
lived  closer  to  hospitals,  which  themselves  were  more  likely  to  be  teaching 
hospitals and were not more likely to be under-treated. Survival in South Asian 
patients was no worse than in White patients after adjustment of confounding 
factors  and  if  anything  may  be  marginally  better.  The  increased  coronary 
mortality of the South Asian population from census data is thus not due to a 166 
 
worse  case  fatality  in  them  compared  to  the  White  population  following 
presentation with acute coronary syndromes.  
8.8.1  Admission characteristics and prognosis by acute coronary syndrome type 
Within  all  three  ACS  types  (STEMI,  NSTEMI,  troponin-negative),  South  Asian 
patients compared to White patients had similar baseline characteristics (such as 
being younger and more likely to be diabetic), consistent with the admission 
findings  for  the  whole  ACS  cohort.  Both  South  Asian  and  White  STEMI  and 
NSTEMI patients were on more medication  on arrival than troponin-negative 
ACS, suggesting that they were already perceived to be at-risk patients. South 
Asian patients with troponin-negative ACSs were on less medication on arrival 
than white patients with troponin-negative ACS, and this may reflect they were 
appropriately  perceived  to  be  low-risk  patients  (perhaps  with  atypical 
symptoms). Survival was similar in South Asian patients compared with White 
patients for each ACS type. 
There  were  increased  numbers  of  troponin-negative  ACSs  in  South  Asian 
patients  and  fewer  NSTEMIs.  However,  even  when  excluding  those  with 
troponin-negative  ACS  admissions  (who  may  not  have  genuine  coronary 
disease), the prognosis in South Asian patients compared to White patients was 
no worse. 
8.8.2  Diabetes 
The prevalence of diabetes was markedly higher in South Asian compared to 
White patients and diabetes in South Asian and White patients was associated 
with a worse survival than those who did not have diabetes. 
Though  these  findings  are  what  would  be  expected,  the  findings  of  the 
exploratory stratified analyses differ from some of the literature in South Asian 
patients with diabetes. Firstly, South Asian patients with diabetes in MINAP had 
a better survival than White patients with diabetes. The better survival in South 
Asian  patients  with  diabetes  compared  with  White  patients  with  diabetes 
contrasts  with  the  higher  incidence  of  coronary  complications  of  diabetes 
amongst  the  South  Asian  population  compared  to  White  populations  as 
presented in this thesis’s systematic review of incident coronary disease (Section 167 
 
3.6.1.2.2,  the  UK  Prospective  Diabetes  Study  32124    and  Southall  Diabetes 
Survey125 studies), Hence, diabetes in the South Asian population may indeed 
lead to a higher incidence of coronary events but prognosis from those coronary 
events once they have become a patient is no worse than in White patients with 
diabetes presenting with coronary disease. 
Secondly, MINAP did not find worse medical care in South Asian patients than in 
White patients, as cross-tabulation analyses of diabetes status and medication 
revealed  better  treatment  in  South  Asian  patients  with  diabetes.  This  better 
treatment may account for the better survival observed in South Asian patients 
with diabetes compared to White patients with diabetes following presentation 
with  an  acute  coronary  syndrome.  Adjusting  for  medication  usage  rendered 
survival similar in South Asian patients compared to White patients in stratified 
analyses of diabetes status. Previous studies in primary care have shown that the 
proportion of South Asian patients with good diabetes control is lower than the 
general  population  as  is  the  proportion  receiving  insulin.174  This  may  partly 
explain the higher incidence of coronary disease in South Asian patients with 
diabetes, but the results in MINAP infer that if providing good care in secondary 
prevention results in improved survival, the incidence of coronary complications 
in South Asian patients with diabetes could in a similar way be reduced by good 
quality care in primary care. A review of the literature on ethnic differences in 
the  prevalence  of  complications  and  mortality  among  patients  with  diabetes  
suggested that any differences could be due to differences in quality of diabetes 
care.175 
8.8.3  Other risk factors 
South Asians patients were younger than White patients, and adjusting for age 
for the whole cohort rendered the markedly better crude survival in South Asian 
patients closer to unity. Stratifying on age did not reveal a better prognosis in 
South Asian patients compared to White patients in either age group. However, it 
is  likely  that  the  younger  age  of  presentation  explains  a  large  part  of  why 
survival in South Asian patients compared to White patients was no worse in the 
whole cohort. 168 
 
8.8.4  Disease severity 
Baseline differences in the severity of disease may also be a factor in differing 
prognoses, and within those with a lower troponin, South Asian patients had a 
better  prognosis  compared  to  White  patients.  However,  as  noted  above,  the 
prognosis  in  South  Asian  compared  to  White  patients  for  those  with  either 
STEMI or NSTEMI was no worse in South Asian patients compared with White 
patients. Adjustment of prognostic analyses within the whole cohort for troponin 
level did not change this, and suggests that the marginal survival advantage in 
South  Asian  patients  in  the  whole  cohort  is  not  explained  by  lesser  disease 
severity at presentation.  
8.8.5  Social environment  
Analyses  stratified  by  deprivation  suggested  that  South  Asian  patients  had  a 
worse prognosis than White patients in less deprived areas. Though survival in 
South Asian patients was marginally better than White patients at one year in the 
whole  cohort,  after  adjusting  for  age  and  deprivation  score,  95%  confidence 
intervals were equally spaced around unity (0.73-1.28). I investigate and discuss 
this further in the next chapter, as much of this finding may be explained by 
residual confounding.  
8.8.6  Clinical management  
With regard to clinical management, South Asian patients had a worse prognosis 
compared to White patients with in-patient angiography (HR 1.32 (95% CI 1.04-
1.66)). This result does not however take into account factors that may have 
driven  clinicians  to  performing  angiography  as  a  result  of  adverse  clinical 
features  on  presentation  (sicker  patients  needing  more  urgent  invasive 
investigation) and these data do not consider whether or not revascularisation 
was  undertaken  after  angiography.  It  would  be  the  actual  process  of 
revascularisation rather than the process of angiography itself that would have 
determined prognosis.  
8.8.7  Limitations  
The large numbers within MINAP provided considerable statistical power but 
this  is  potentially  attenuated  by  the  quality  of  those  numbers.    Analyses  of 
MINAP  in  chapter  4  stood  up  to  scrutiny  in  terms  of  data  quality  in  spite  of 169 
 
missing data. The marginally better survival in South Asian patients in the whole 
cohort was a surprise, though a more conservative conclusion that the South 
Asian patient certainly does not have a worse prognosis than the White patient 
should be made in light of the incompleteness of data.   
Some factors which are likely to play a role in determining prognosis (such as 
degree of angiographic coronary disease) were unavailable in MINAP and hence 
this limited the scope of the stratified prognostic analyses. Other variables not 
available  include  readmission  to  hospital  and  also  clinical  management  as  an 
out-patient  following  discharge.  Angiography  and  revascularisation  may  have 
been performed at a later date as an out-patient. Such limitations could in the 
future be addressed by linkage of MINAP to NHS data sources such as Hospital 
Episode Statistics. Such linkages will themselves depend on the availability and 
quality of identifiers of variables such as ethnicity.  
Length  of  follow-up  was  only  one  year  within  MINAP,  and  thus  makes 
conclusions on long-term prognosis impossible. However, with time, longer-term 
follow-up in MINAP could be sought. 
8.8.8  Implications 
It  may  be  that  the  younger  age  of  South  Asian  patients  with  acute  coronary 
syndromes explains the similar prognosis, and certainly from adjusting for age, 
the markedly better prognosis seen on crude prognostic analyses disappeared. 
Though these results are encouraging and perhaps demonstrates a wide uptake 
of  appropriate,  evidence-based  treatment  across  demographic  groups  in  a 
disease  well-serviced  by  evidenced-based  therapy,  the  results  should  not 
prevent  further  analyses  of  prognostic  outcomes  by  ethnic  groups  following 
presentation with acute coronary syndrome.  
 
Firstly, prognosis for non-fatal symptomatic outcomes may not be equitable by 
ethnicity - this thesis has already observed this for symptomatic outcomes from 
revascularisation for chronic angina. Secondly, the younger average age of South 
Asian patients, which may reflect the age distribution of the local population, 
combined with equitable survival to that of older White patients, will markedly 170 
 
increase the number of cases of coronary heart disease among the South Asian 
population.  Finally,  the  future  burden  of  heart  failure  will  thus  increase 
disproportionately  in  the  South  Asian  population  if  survival  continues  to 
improve.  These  results  thus  have  clear  implications  for  the  allocation  of 
healthcare resources in this population of acute coronary syndrome patients. 
8.9  Conclusions 
Survival  following  acute  coronary  syndromes  was  no  worse  in  South  Asian 
patients than White patients. Diabetes, although more common in South Asian 
patients, was not associated with a higher relative risk of death in South Asian 
patients compared to White patients, nor were any other risk factors, clinical 
management strategies and socio-environmental characteristics. 171 
 
 
9  The contribution of incidence and prognosis to overall 
coronary death rates in South Asian and White populations 
9.1  Summary of chapter 
 
Background  The  systematic  review  of  this  thesis  reported  that  South  Asian 
populations  have  a  higher  incidence  of  fatal  coronary  disease  but  could  not 
answer  whether  prognosis  is  worse  in  South  Asian  compared  to  White 
populations. The results of this thesis thus far have shown a higher incidence of 
fatal  and  non-fatal  coronary  disease  in  South  Asian  compared  to  White 
populations but that prognosis for serious clinical events is no worse in South 
Asian populations.  
Methods The four new prospective studies of this thesis, one aetiologic (South 
Asian  N=580  initially  healthy),  and  three  prognostic  (N=2189  with  suspected 
stable angina, N= 502 undergoing coronary angiography and N=3037 with acute 
coronary syndromes) were examined for mortality outcomes. Previous studies 
on  incidence  and  prognosis  included  on  my  systematic  review  were  meta-
analysed with these four studies using a random effects model respectively. 
Results   In analysing seven studies, South Asian populations showed an overall 
higher risk of incident coronary events than White populations (fatal and non-
fatal HR 1.47 (1.29–1.66)). Ten prognostic studies examining risk of death from 
coronary disease showed overall survival was better in South Asian than White 
populations (HR 0.80 (0.71-0.88)). This effect was not explained by risk factors, 
disease severity at presentation, clinical management nor social environment.  
Conclusions Incidence of non-fatal and fatal coronary disease is higher in South 
Asian  than  White  populations,  but  prognosis  for  risk  of  death  is  better  once 
coronary  disease  is  manifest.    The  dissociation  between  the  aetiologic  and 
prognostic findings suggests that public health initiatives to reduce disparities in 
mortality should focus on primary prevention. 172 
 
 
9.2  Introduction 
There is a higher cross-sectional coronary mortality in South Asian compared to 
White populations in the UK. Understanding the contribution of incidence and 
prognosis  to  this  may  allow  interventions  to  prevent  disease  onset  or  its 
progression to be better targeted. From the systematic literature review, most 
studies reported that South Asian populations have a higher incidence of fatal 
coronary  disease  compared  to  White  populations,  though  data  on  non-fatal 
events  were  few.  When  considering  prognosis,  of  the  studies  retrieved,  the 
results could not answer whether prognosis was worse in South Asian compared 
to White populations. 
In its investigation into the higher cross-sectional coronary mortality in South 
Asian compared to White populations in the UK, this thesis has so far contributed 
in the following ways: 
-  There  is  a  higher  incidence  of  prognostically-significant  angina  in  South 
Asian compared to White populations. South Asian populations also have a 
higher incidence of non-fatal myocardial infarction or coronary death than 
White populations (Chapter 5). 
-  Prognosis in terms of fatal events is no higher in South Asian compared to 
White populations either with angina (Chapters 6, 7) or after acute coronary 
syndromes (Chapter 8).  
I now sought to examine my studies in the context of these previous studies. A 
higher case fatality (i.e. worse prognosis) in South Asian people might have been 
expected for two main reasons.  First, South Asian populations have a higher 
prevalence  of  insulin  resistance  and  diabetes  mellitus  than  White  European 
populations,176  and  the  presence  of  diabetes  among  people  with  coronary 
disease is associated with higher survival.177 Certain risk factors such as diabetes 
mellitus may result in poorer outcomes in South Asians with diabetes than in 
White people with diabetes.93 Second, some,61 but not all57 62 169 studies, suggest 173 
 
that  underuse  of  medical  treatments,  more  common  among  South  Asian 
populations, is associated with the deprived areas they live in.29  
9.3  Research objective to be investigated 
This chapter sought to investigate specific research objective 5. 
To assess the contribution of incidence and prognosis to the higher coronary 
death  rates  in  South  Asian  compared  to  White  populations  through  meta-
analysis of the four cohorts and previously reported studies. 
9.4  Specific research questions  
i.  What are the relative effects of South Asian ethnicity compared to White 
ethnicity  in  healthy  populations  (aetiologic  effects)  and  in  populations 
with already-manifest coronary disease (prognostic effects) from meta-
analysing  the  four  cohort  studies  of  this  thesis  with  those  previously 
reported in the literature ? 
ii.  What is the influence of biological risk factors, clinical management and 
socio-environmental characteristics on prognosis within the prognostic 
studies of this thesis? 
9.5   Methods 
For  the  meta-analysis,  studies  obtained  by  systematic  review  that  examined 
incidence of fatal outcomes in South Asian compared to White populations were 
combined  with  the  fatal  outcomes  found  in  Whitehall-II  (aetiologic,  healthy 
population cohort). This was repeated for studies examining non-fatal combined 
with fatal outcomes. For prognosis, studies obtained by systematic review that 
examined fatal outcomes in South Asian compared to White populations were 
combined with the fatal outcomes found in the Chest Pain Clinic Study, ACRE 
(coronary angiogram cohort) and MINAP (acute coronary syndrome cohort).    
Stratified analyses on prognosis by biological risk factors, clinical management 
and socio-environmental characteristics were then conducted within the studies 
of this thesis. The style already utilised in the previous chapter was used, and 
extended across all three prognostic cohorts. As an example, to examine whether 
the severity of coronary disease at presentation influenced prognosis by ethnic 174 
 
group,  measures  appropriate  to  the  stage  of  disease  at  which  the  cohort 
recruited were used. Exercise electrocardiography and typicality of angina were 
used  in  the  chest  pain  clinic  cohort,  severity  of  angina  (by  Canadian 
Cardiovascular Society score), angiographic disease and left ventricular function 
were used in the coronary angiogram cohort and troponin level was used in the 
acute coronary syndrome cohort.  
All three studies had data on biological risk factors and medication. The three 
prognostic  studies  also  included  data  on  deprivation,  though  by  different 
measures.  The  chest  pain  cohort  used  the  Townsend  score,  the  coronary 
angiogram (ACRE) cohort Carstairs, and the acute coronary syndrome (MINAP) 
cohort had data on Index of Multiple Deprivation 2000 (IMD) score (appendix 
13.7). The acute coronary syndrome cohort also had data on the distance the 
patient lived from the hospital and receipt of in-patient coronary angiography. 
9.6   Statistical analysis  
In  calculating  incidence,  a  combined  non-fatal  outcome  (non-fatal  myocardial 
infarction and admission with angina) in Whitehall-II was used, as well as risk of 
coronary  death.  For  prognostic  analyses  within  Whitehall-II,  risk  of  coronary 
death in those with typical angina at baseline was assessed.  Risk of coronary 
death in the Chest Pain Clinic Study and ACRE were assessed and all-cause death 
in  MINAP  was  assessed  as  cause-specific  death  was  unavailable.  Cox 
proportional  hazards  regression  were  performed,  adjusted  for  age  (as  a 
continuous variable), sex, hypertension, blood cholesterol, smoking and diabetes 
in all cohorts. These analyses were then stratified in the prognostic studies by 
baseline  factors  (age  above/below  65,  sex,  presence  or  absence  of  individual 
coronary risk factors, disease severity, clinical management factors and social 
environment)  and  formally  examined  as  to  whether  a  statistical  difference 
existed between hazard ratios of each strata with the Bland-Altman two-tailed 
test of interaction. 
Using  the  systematic  review,  relative  risks,  adjusted  where  available,  were 
extracted from each study.  In studies in which summary relative risk estimates 
were not given, crude data in the paper were examined to estimate unadjusted 175 
 
odds ratios and confidence intervals. The authors of studies were approached to 
confirm relevant numerical data where necessary (Thanks to Sarah Wild and 
Colin Fischbacher). 
Results of individual studies found on systematic review were combined with the 
studies  of  this  thesis  using  the  metan  command178  in  Stata10  and  calculated 
pooled  odds  ratios,  weights,  and  95%  confidence  intervals  using  a  random 
effects model. Heterogeneity was examined using the I2 statistic.154 
9.7   Results 
9.7.1  The studies of this thesis 
All  hazard  ratios  are  adjusted  for  age,  sex,  hypertension,  blood  cholesterol, 
ex/current smoker, diabetes. 
•  Whitehall-II:  
o  Incidence for coronary death was higher in South Asian compared 
to White participants (adjusted HR 3.83 (95% CI 2.32-6.30)). 
o  Incidence  for  non-fatal  events  (non-fatal  myocardial  infarction, 
angina) was higher in South Asian compared to White participants 
(adjusted HR 1.64 (95% CI 1.33–2.02)).  
o  Prognosis  for  coronary  death  in  those  with  typical  angina  at 
baseline  was  similar  in  South  Asian  compared  to  White 
participants (adjusted 2.07 (95% CI 0.61-6.97)). 
•  Chest Pain Clinic study 
o  Prognosis for coronary death was similar in South Asian compared 
to White participants (adjusted HR 0.82 (95% CI 0.29-2.33)). 
•  ACRE 
o  Prognosis for coronary death was similar in South Asian compared 
to White participants (adjusted HR 0.80 (95% CI 0.47-1.36)). 
•  MINAP 
o  Prognosis for all-cause death was marginally better in South Asian 
compared to White participants (adjusted HR 0.83 (95% CI 0.71-
0.97)). 176 
 
9.7.2  Meta-analysis of incidence studies  
9.7.2.1 Fatal events 
The upper panel of figure 14 below focuses on coronary death rates amongst 
South Asian compared to that of White majority populations. Balarajan’s data 
based on the 1981 census reveals a higher mortality in South Asian men and 
women compared to the whole population of England and Wales,8 as does Wild’s 
study based on 1991 census.10 Whitehall-II and Forouhi et al122 represent the 
only  prospective  studies  of  healthy  individuals  for  risk  of  coronary  death  in 
healthy individuals comparing South Asian and White populations, both showing 
a higher incident mortality in South Asian compared to White populations. 
On  meta-analysis,  these  studies  reveal  higher  incident  coronary  mortality  in 
South Asian compared to White populations (HR 1.43 (95% CI 1.39–1.46)). 
9.7.2.2 Fatal and non-fatal events 
The lower panel of figure 14 below focuses on non-fatal incidence coronary rates 
amongst  South  Asians  compared  to  that  of  White  majority  populations.  Both 
Fischbacher  et  al’s123  study  and  the  UK  Prospective  Diabetes  Study  32124  
examine  incidence  of  non-fatal  myocardial  infarction  combined  with  fatal 
myocardial infarction. Whitehall-II and Mather et al125 are able to study non-fatal 
events alone. 
Irrespective of whether or not non-fatal events are combined with fatal ones, all 
studies bar UKPDS32 reveal a higher incidence of coronary events in South Asian 
compared to White populations, confirmed on meta-analysis (HR 1.47 (95% CI 
1.29–1.66)).  177 
 
 
The upper panel shows studies examining fatal events; the bottom panel analyses from studies examining non-fatal events 
Figure 14 Meta-analysis of incidence studies of coronary disease in South Asian compared to White populations 178 
 
9.7.3  Meta-analysis of prognostic studies 
9.7.3.1 Previously published studies 
The upper panel of figure 15 below focuses on the previously published studies 
retrieved  on  systematic  literature  review.  On  observation  of  the  confidence 
intervals around the point estimates, prognosis for death seemed to not be worse 
in South Asian compared with White populations.   
9.7.3.2 Studies from this thesis 
The point estimates from the prognostic studies of this thesis (Chest Pain Clinic, 
ACRE and MINAP) suggested a trend towards a better prognosis in South Asian 
compared with White populations, especially with the more recent and larger 
studies.  Prognosis  in  those  with  typical  angina  in  Whitehall-II,  a  cohort  not 
presenting to healthcare services, was similar in South Asian compared to White 
populations.  
On meta-analysis of previously published studies with studies from this thesis, a 
better  prognosis  for  death  following  presentation  with  coronary  disease  was 
observed for South Asian compared to White populations (HR 0.80 (0.71-0.88)). 179 
 
 
 
 
 
The upper panel shows previously published studies; the bottom panel analyses from new studies from this thesis  
Figure 15 Meta-analysis of prognostic studies of coronary disease in South Asian compared to White populations 180 
 
9.7.4  Ethnic comparisons of prognosis within strata of prognostic factors 
Whether South Asian participants of this thesis’ studies had a worse prognosis 
than White participants in any of strata of prognostic factors is assessed in Table 
35.  181 
 
Table 35 Risk in South Asian compared to White participants, stratified by risk factors, markers of disease severity, social environment and clinical 
management, of age-adjusted all-cause mortality at one year in three prognostic cohorts 
Study   Chest Pain Clinic  Coronary angiogram (ACRE)  Acute coronary syndrome (MINAP) 
Page 1/2    South Asian  White   p  HR (95%CI)  South 
Asian 
White   p  HR (95%CI)  South Asian  White   p  HR (95%CI) 
Whole study  Unadjusted 
Age-adjusted 
*Adjusted 
2189  5605    0.63 (0.39-1.02) 
1.08 (0.66-1.76) 
0.82 (0.29-2.33) 
502  2974    0.66 (0.46-0.96) 
0.93 (0.64-1.36) 
0.80 (0.47-1.36) 
3057  69638    0.53 (0.47-0.59) 
0.92 (0.82-1.04) 
0.83 (0.71-0.97) 
Risk factors 
Age  Over 65  270(12.3)  1602 (28.6)  <0.001  0.74 (0.33-1.64)  89 (17.7)  1159 (39.0)  <0.001  1.22 (0.69-2.15)  1118 (37.4)  41595 (60.3)  <0.001  0.66 (0.58-0.75) 
  Under 65        0.99 (0.53-1.84)        1.08 (0.65-1.78)        0.83 (0.63-1.08) 
                           
Sex  Men  1209 (55.2)  2929 (52.3)  0.018  1.09 (0.61-1.92)  391 (77.9)  2112 (71.0)  0.002  0.78 (0.51-1.19)  2261 (74.3)  43746 (63.3)  <0.001  0.91 (0.78-1.05) 
  Women        0.93 (0.45-1.91)        1.95 (0.80-4.74)        0.93 (0.76-1.14) 
                           
Smoking  Yes  355 (16.2%)  1607 (28.7)  <0.001  1.66 (0.71-3.92)  178 (47.2)  1937 (73.5%)  <0.001  0.88 (0.51-1.56)  1152 (47.7)  39,308 (71.7)  <0.001  0.78 (0.62-0.99) 
  No        1.05 (0.57-1.91)        1.37 (0.69-2.73)        1.04 (0.87-1.25) 
                           
Hypertension  Yes  732 (33.4 )  1892 (33.8)  0.791  1.16 (0.59-2.29)  191 (38.1)  889 (29.9)  <0.001  1.04 (0.58-1.87)  1493 (52.9)  29051 (45.2)  <0.001  0.95 (0.81-1.11) 
  No        0.93 (0.45-1.91)        0.85 (0.51-1.40)        0.83 (0.68-1.02) 
                           
Hyperlipidaemia  Yes  366 (62.8)  1256 (64.5)  0.436  1.22 (0.39-3.79)  165 (44.4)  1012 (45.5)  0.691  0.64 (0.28-1.47)  1098 (41.5)  17868 (29.2)   <0.001  0.98 (0.79-1.20) 
  No        0.70 (0.80-6.39)        1.69 (1.01-2.84)        0.91 (0.77-1.06) 
                           
Diabetic  Yes  428 (19.5)  372 (6.6)  <0.001  0.84 (0.34-2.06)  156 (31.1)  288 (9.7)  <0.001  0.90 (0.51-1.58)  1219 (43.8)  11417 (18.0)  <0.001  0.75 (0.63-0.88) 
  No        0.95 (0.52-1.75)        0.64 (0.36-1.13)        0.78 (0.64-0.95) 
Disease severity 
Angina symptoms  ^ More  356 (16.3)  1481 (26.4)  <0.001  0.96 (0.44-2.07)  201 (54.3)  1076 (50.9)  0.217  1.65 (1.00-2.74)  -  -  -  - 
  ^^Less         1.26 (0.66-2.41)        1.07 (0.55-2.09)  -  -  -  - 
                           
Exercise ECG   Positive  182 (15.6)  668 (19.3)  0.017  1.33 (0.55-3.19)  -  -  -  -  -  -  -  - 
  Negative        0.64 (0.18-2.31)  -  -  -  -  -  -  -  - 
                           
Coronary disease  >= 2 arteries  -  -  -  -  235 (47.2)  1339 (45.4)  0.452  0.97 (0.63-1.49)  -  -  -  - 
  Normal-1 
artery 
-  -  -  -        0.61 (0.26-1.42)  -  -  -  - 
Yes  -  -  -  -  98 (23.6)  563 (23.3)  0.897  0.77 (0.43-1.38)  -  -  -  -  Impaired left 
ventricular function  No  -  -  -  -        0.88 (0.45-1.71)  -  -  -  - 182 
 
                           
Yes  -  -  -  -  -  -  -  -  1271 
(52.3) 
32267 (56.9)    0.99 (0.84-1.16)  Troponin >=0.1 
No  -  -  -  -  -  -  -  -        0.75 (0.60-0.94) 
Social environment 
Most 
deprived 
242(49.9)  520 (18.6)  <0.001  0.93 (0.54-1.60)   650 (37.1)  787 (15.7)  <0.001  0.78 (0.31-1.95)  328 (48.4)  3341(24.1)  <0.001  0.72 (0.47-1.11)   Deprivation score 
(lowest quartile vs 
highest)  Least 
deprived 
      0.35 (0.05-2.53)         -(no events)        2.34 (1.21-4.56)  
                           
Far (≥7.6km)  -  -  -  -  -  -  -  -  95 (13.9)  7500 (51.1)  <0.001  0.61 (0.23-1.63)  Distance from 
hospital  Near(<7.6km)  -  -  -  -  -  -  -  -        1.12 (0.84-1.49) 
Clinical 
management 
                         
Secondary 
prevention drugs 
0-1  drugs 
(fewer) 
1,785(81.5)  4,278(76.3)  <0.001  1.23 (0.48-3.18)  221 (44.0)  1288 (43.1)  0.765  0.86 (0.43-1.72)  617 (20.3)  17739(25.8)  <0.001  1.03 (0.86-1.23) 
  2-4 drugs        0.97 (0.44-2.15)        1.04 (0.64-1.70)        0.93 (0.80-1.09) 
                           
Teaching Hospital  No  -  -  -  -  -  -  -  -  2010(66.2)  55890(81.2)    0.88 (0.76-1.01) 
  Yes  -  -  -  -  -  -  -  -      <0.001  1.06 (0.86-1.31) 
                           
No  -  -  -  -  -  -  -  -  1095 (44.6)  29076 (59.9)    0.85 (0.72-1.01)  In-patient 
angiogram done  Yes  -  -  -  -  -  -  -  -      <0.001  1.32 (1.04-1.66) 
                           
No  -  -  -  -  355 (70.7)  19 64 (66.1)  0.040  0.99 (0.65-1.51)  -  -  -  -  Revascularisation 
done   Yes  -  -  -  -        0.79 (0.34-1.84)  -  -  -  - 
Page 2/2    South Asian  White   p  HR (95%CI)  South 
Asian 
White   p  HR (95%CI)  South Asian  White   p  HR (95%CI) 
Study    Chest Pain Clinic  Coronary angiogram (ACRE)  Acute coronary syndrome (MINAP) 
* adjusted for age, sex, hypertension, blood cholesterol, ex/current smoker, diabetes; Stratified HRs are age-adjusted 
Figures are numbers (%).Percentages represent the proportion of those with this entry for this field out of total number available for the field 
HR (95%CI) – Cox proportional hazards regression ratio (95% confidence interval). comparing South Asian and White participants for coronary death (all-cause in acute coronary syndrome cohort). A hazard ratio less 
than 1    represents a better prognosis in South Asians.  
^ - typical symptoms in chest pain clinic, CCS 3-4 in coronary angiogram ^^ - atypical symptoms in chest pan clinic, CCS 1-2 in coronary angiogram.  
Secondary prevention drugs - aspirin, statins, beta-blockers and ACE inhibitor183 
 
 
9.7.4.1 Diabetes 
Diabetes  was  significantly  more  prevalent  in  South  Asian  compared  to  White 
participants in all three of our prognostic studies. When stratifying survival by 
diabetic status in each of our studies, survival was not worse in South Asian 
participants with diabetes compared to White participants with diabetes, and 
South Asian participants in the acute coronary syndrome cohort had a better 
survival compared to White participants irrespective of diabetic status.  
Further  adjusting  the  stratified  analyses  in  diabetics  for  sex,  smoking, 
hypertension and hyperlipidaemia, South Asian participants still demonstrated 
no worse a prognosis compared to White participants in the chest pain clinic and 
coronary angiogram cohorts, whilst South Asian participants with diabetes had a 
better  survival  in  the  acute  coronary  syndrome  than  White  participants  with 
diabetes (Table 36). When additionally adjusting for receipt of aspirin, statin, 
beta-blocker  or  ACE  inhibitor,  South  Asian  and  White  participants still  had  a 
similar survival in all cohorts irrespective of diabetic status.  
 
      Age-adjusted  *Model 1  **Model 2 
Diabetic  Yes  0.84 (0.34-2.06)  0.87 (0.35-2.17)  0.88 (0.35-2.22)  Chest Pain 
Clinic    No  0.95 (0.52-1.75)  0.88 (0.48-1.61)  0.90 (0.49-1.64) 
Diabetic  Yes  0.90 (0.51-1.58)  0.75 (0.34-1.68)  0.80 (0.35-1.85)  ACRE 
  No  0.64 (0.36-1.13)  0.77 (0.37-1.59)  0.74 (0.36-1.53) 
Diabetic  Yes  0.75 (0.63-0.88)  0.77 (0.63-0.94)  0.81 (0.67-1.00)  MINAP 
  No  0.78 (0.64-0.95)  0.82 (0.65-1.04)  0.83 (0.65-1.05) 
*Model 1 - adjusted for age, sex, hypertension, hyperlipidaemia, smoking 
**Model 2 - adjusted for treatment with aspirin, statin, beta-blocker or ACE inhibitor 
Table 36 Risk in South Asian compared to White participants, stratified by diabetes, of all-
cause mortality at one year in the three prognostic cohorts 
 
9.7.4.2 Other risk factors 
South  Asian  participants  were  more  likely  to  be  men,  yet  sex  did  not  confer 
different prognoses between the ethnic groups. South Asian participants were 
more likely to have been diagnosed hypertensive in the coronary angiogram and 184 
 
acute coronary syndrome cohorts but prognosis was the same in South Asian 
compared to White participants in those with and without hypertension. South 
Asian  participants  that  smoked  or  had  high  cholesterol  appeared  to  have  a 
similar prognosis to their White counterparts with these risk factors.   
9.7.4.3 Disease severity 
South Asian participants did not present with more severe disease than White 
participants as evidenced by fewer positive exercise electrocardiograms in the 
chest pain clinic cohort, an equivalent degree of coronary disease at angiography 
in  ACRE  and  a  lower  prevalence  of  a  troponin  above  0.1  in  MINAP.    Similar 
analyses  by  severity  of  disease  and  receipt  of  treatment  revealed  similar 
prognoses between ethnic groups.  
9.7.4.4 Social environment  
South Asian participants were more likely to live in deprived areas in all three 
prospective  studies,  but  were  closer  to  the  hospital  and  more  likely  to  use  a 
teaching hospital in the acute coronary syndrome cohort. The previous chapter 
has already shown that South Asian participants in less deprived areas had a 
worse prognosis compared to White participants in those areas for the acute 
coronary syndrome cohort (p=0.025 for two-tailed test for interaction with those 
in  the  more  deprived  areas).  This  was  not  observed  in  the  chest  pain  clinic 
cohort (Bland-Altman two-tailed test of interaction154 test p=0.544).  Data on 
deprivation with respect to outcome in the coronary angiogram cohort were too 
scarce, preventing similar prognostic analyses. 
Although caution is required in interpreting such subgroup analyses, I carried 
out further exploratory analyses. I compared the baseline features of those in the 
most deprived quintile of MINAP with the least deprived quintile in each ethnic 
group (Table 37). In more deprived areas, patients were younger, smoking and 
diabetes were more prevalent and patients were closer to hospitals. These were 
more likely to be teaching hospitals, and patients in more deprived areas were 
more likely to get more secondary prevention drugs. There were no consistent 
differences  in  hypertension  and  high  cholesterol  between  less  and  more 
deprived  areas.  These  patterns  were  apparent  in  both  ethnic  groups,  and 185 
 
consistent with previously reported patterns in deprived areas.179 Examining the 
overall  mortality  of  the  cohort,  those  in  more  deprived  areas  had  a  worse 
prognosis than those in less deprived areas (age-adjusted HR 1.35, 95% CI 1.12-
1.52). Hence, the measure of deprivation appeared valid. 186 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 37 MINAP - Admission characteristics comparing those in the most deprived quintile with the least deprived quintile, in South Asian and White 
participants
            Ethnic group    South Asian      White      
    Most deprived  Least  deprived  p  Most deprived  Least  deprived  p 
Risk factors 
Age  Over 65  133 (40.55)  195 (59.5)  0.061  1,655 (50.0)  2,043 (57.7)  <0.001 
Sex  Men  254 (78.2)  65 (85.5)  0.151  2,222 (68.9)  2,533 (71.7)  <0.001 
Smoking  Yes  146 (53.3)  23 (37.7)  0.028  2,374 (82.32)  2,003 (69.4)  <0.001 
Hypertension  Yes  121 (41.6)  24 (34.3)  0.264  1,192 (38.9)  1,318 (39.9)  0.408 
Hyperlipidaemia   Yes  75 (27.2)  19 (29.7)  0.685  752 (25.6)  770 (75.3)  0.744 
Diabetic  Yes  121 (39.7)  21 (28.8)  0.084  431 (14.0)  375 (11.5)  0.002 
Social environment 
Distance from hospital  Far (≥7.6km)  21 (6.4)  26 (34.2)  <0.001  949 (28.4)  2,312 (65.3)  <0.001 
Clinical management 
Secondary prevention 
drugs 
0-1 drugs 
(fewer) 
41 (12.5)  21 (27.6)  0.001  524 (15.7)  648 (18.3)  0.004 
Teaching Hospital  No  222 (67.7)  57 (75.0)  0.214  2,600 (77.8)  2,883 (81.4)  <0.001 
In-patient angiogram 
done 
No  102 (38.2)  22 (36.7)  0.825  1,370 (56.4)  1,314 (51.1)  <0.001 187 
 
    Age-adjusted   *Model 1  **Model 2  ***Model 3 
Most deprived  0.72 (0.47-1.11)   0.85 (0.52-1.39)  0.89 (0.54-1.46)  0.96 (0.56-1.66)  Deprivation 
score quartile 
 
Least deprived  2.34 (1.21-4.56)   1.72 (0.76-3.93)  1.64 (0.72-3.74)  2.18 (0.86-5.51) 
HRs (95% CI) comparing South Asian vs White participants 
*Model 1 - adjusted for age, smoking, diabetes, hypertension, hyperlipidaemia  
**Model 2 - adjusted for age, smoking, diabetes, hypertension, hyperlipidaemia, secondary prevention medication 
***Model 3 - adjusted for age, smoking, diabetes, hypertension, hyperlipidaemia, secondary prevention medication, use of 
angiography, distance to hospital and type of hospital 
 
Table 38 MINAP - Effect of deprivation on all-cause mortality at one-year comparing South 
Asian and White participants 
Adjustment  for  risk  factors,  secondary  prevention  medication,  use  of 
angiography, distance to hospital and type of hospital did not significantly alter 
the point estimates of worse prognosis seen in South Asian participants in less 
deprived areas compared to White participants in those areas, though confidence 
intervals were wider (Table 38). 
9.7.4.5 Clinical management  
South  Asian  participants  were  more  likely  to  undergo  in-patient  coronary 
angiography  than  White  participants  following  acute  coronary  syndromes, 
though  received  revascularisation  less  in  the  chest  pain  cohort.  South  Asian 
participants  were  on  fewer  secondary  prevention  drugs  at  chest  pain  clinics, 
equivalent  treatment  at  angiography,  and  more  treatment  following  acute 
coronary  syndromes.  Stratified  analyses  by  these  clinical  management  types 
revealed similar prognoses between ethnic groups, though in the acute coronary 
syndrome  cohort,  South  Asian  participants  who  underwent  in-patient 
angiography  had  a  worse  prognosis  compared  to  White  participants  who 
underwent the procedure (HR 1.32 (1.04-1.66)). 
9.8   Discussion 
9.8.1  Objective addressed 
By  meta-analysing  the  results  of  the  four  studies  of  this  thesis  with  eleven 
previously published studies, I demonstrated a higher incidence of both fatal and 
non-fatal coronary disease in South Asian compared to White populations but a 
better prognosis for death following presentation with coronary disease in South 
Asian compared to White populations. Thus, the higher cross-sectional coronary 188 
 
mortality in South Asian compared to White populations10 is more likely to be 
explained  by  the  higher  incidence  of  fatal  and  non-fatal  coronary  disease  in 
South  Asian  populations  than  a  higher  case  fatality  compared  to  White 
populations. 
9.8.2  Incidence 
I have added new incidence data from Whitehall-II and shown a higher incidence 
of both fatal and non-fatal coronary disease in South Asian compared to White 
populations. There are few healthy population studies on the incidence of non-
fatal events in South Asian compared to White populations, and none on angina. 
Whitehall-II  demonstrates  for  the  first  time  the  higher  incidence  of  non-fatal 
events in South Asian compared to White populations. 
9.8.3  Prognosis and factors affecting it 
The  higher  incidence  of  coronary  disease  in  South  Asian  compared  to  White 
populations was in contrast to the lack of adverse prognostic consequences, as 
prognosis for death was in fact better in South Asian populations.  
9.8.3.1 Risk factors 
Biologically,  South  Asian  and  White  populations  differ  when  presenting  with 
coronary disease. They tend to be younger, and more likely to be diabetic across 
the spectrum of clinical presentations of coronary disease. Age however did not, 
both on adjusted and stratified analyses, explain the better prognosis in South 
Asian  compared  to  White  populations.  Stratifying  on  diabetes  revealed  that 
diabetes  was  not  more  likely  to  result  in  adverse  outcomes  in  South  Asian 
populations, a surprise considering that glycaemic control is reportedly poorer 
among South Asian people174 and that a higher risk of diabetes complications are 
seen in this minority ethnic group compared to White people with diabetes.93 175  
9.8.3.2 Disease severity 
Differences in the severity of disease at presentation might contribute to ethnic 
differences in prognosis but no evidence of this was found across  a range of 
markers of disease severity such as degree of angiographic coronary disease and 
troponin  level.    A  lower  case  fatality  after  hospitalisation  for  acute  coronary 
syndromes might occur if South Asian populations had a higher incidence than 189 
 
White patients of death from myocardial infarction before reaching hospital. The 
work by Fischbaker et al123 however suggests this is not the case, as 21 of the 
126 first episodes of myocardial infarction recorded were sudden deaths in the 
community among South Asian populations (16.7%) in comparison to 9672 out 
of 30978 (31.2%) for non South Asian populations.  
9.8.3.3 Clinical management  
In patients with coronary disease, access to clinical management strategies will 
be a factor in determining prognosis. A priori, one might have expected South 
Asian  patients  to  be  under-managed  for  coronary  disease  and  for  this  to  be 
associated with a worse prognosis. The lack of evidence on underuse of both 
secondary prevention management and specialist investigation and treatment 
among South Asian patients in the prognostic studies of this thesis contrasts with 
previous literature reporting that South Asian patients are under-managed for 
coronary  disease29    This  may  reflect  that  care  in  minority  ethnic  groups  is 
improving, especially in the context of their predominantly inner-city locations 
near major centres of cardiac care. South Asian patients may also have quicker 
access  to  emergency  treatment  because  of  the  proximity  of  their  inner-city 
residences to hospitals, though distance to hospital in our analyses again could 
not  account  for  the  prognostic  difference,  nor  did  stratifying  on  use  of 
angiography. The TIMI phase II trial showed comparable 1-year mortality rates 
in  the  White,  Black,  and  Hispanic  patients,180  demonstrating  the  efficacy  of 
appropriate, evidence-based treatment across demographic groups in a clinical 
trial setting.   
I examined further whether the relative size of the South Asian ethnic group in a 
neighbourhood  influenced  the  care  hospitals  provide,  by  excluding  hospitals 
which  reported  <5%  South  Asian  patients  in  the  acute  coronary  syndrome 
cohort. I hypothesised that hospitals in areas of high South Asian populations 
may be more accustomed to treating this minority ethnic group in the same way 
that  hospitals  treating  fewer  cardiovascular  cases  are  less  likely  to  apply 
evidence-based processes of appropriate care.181 However, this did not alter the 
results.  190 
 
9.8.3.4 Social environment 
Analyses stratified by deprivation suggested that South Asian populations had a 
worse prognosis than White populations in less deprived areas in MINAP, with a 
similar suggestion from the point estimates in the chest pain clinic cohort. The 
results  from  these  exploratory  analyses  may  be  explained  by  unmeasured 
confounders which could not be adjusted for. For instance, South Asian people in 
less deprived areas may be more socially isolated from family and communities 
compared  to  those  in  inner  cities  where  the  relative  size  of  the  South  Asian 
ethnic  group  within  the  neighbourhood  is  higher.  The  measurement  of 
deprivation may not take into account the increased social advantages to South 
Asian people of living in tight-knit, ethnic-dense inner city areas and the impact 
of  local  healthcare  services  specifically  designed  to  serve  those  communities. 
However,  associations  between  social  network  size  and  cardiovascular  risk 
factors  such  as  waist  circumference,  blood  pressure  and  lipids  have  been 
previously examined in White and South Asian populations and no relationship 
found.182  
There are however published studies that have suggested increased deprivation 
is  not  always  linked  to  worse  ill-health.  It  has  been  previously  reported  that 
more  deprived  South  Asian  patients  with  heart  failure  have  better  all-cause 
mortality outcomes than less deprived White patients.183 South Asian patients 
with heart failure were taking both ACE inhibitor and β blockers more commonly 
at presentation in this study and the results may therefore suggest the possibility 
of  disease  modification  by  pharmacological  treatments  known  to  improve 
outcome in heart failure. Again, this study conducted stratified analyses similar 
to those in MINAP – their findings were not biased by better survival of South 
Asian patients with preserved left ventricular function, more common in South 
Asian patients. Rather, survival was better for South Asian patients than White 
populations  with  moderate  left  ventricular  systolic  dysfunction  on 
echocardiography. Thus, in this study as in MINAP, differing disease severity at 
presentation could not explain differences in prognosis between South Asian and 
White populations.  191 
 
Whilst it is increasingly recognised that the social deprivation of areas influences 
the  aetiology  and  prognosis  of  coronary  disease,105  large  contemporary 
prognostic studies with detailed and comparable data on deprivation are lacking. 
For  hospitals  serving  socially  deprived  communities  it  is  important  to 
understand the interaction of social deprivation with ethnicity.  This is crucial in 
interpreting hospital league tables of outcomes (for which a dataset like MINAP 
is a crucial tool) and in meeting key policy objectives to improve the health of the 
worst-off in society.  
Ethnic  minority  populations  tend  to  be  concentrated  in  areas  of  social 
deprivation as I have found in my cohorts, but as Figure 16 illustrates this is not 
a simple, or inevitable relationship. In London, boroughs like Camden (the 7th 
most deprived borough in London with Bangladeshis constituting 61% of the 
South  Asian  population)  and  Tower  Hamlets  (the  most  deprived  borough  in 
London, with Bangladeshis constituting 91% of South Asian population), are far 
more deprived than Harrow, one of the least deprived boroughs in London yet 
containing a high proportion of South Asian people.  Furthermore, Indians make 
up 74% of the large South Asian population in Harrow. Hence, Indians appear 
superficially to be more affluent than Bangladeshis. Thus, if Indians live in less 
deprived areas than Bangladeshis, investigating the overall relationship between 
the South Asian group and deprivation will require differences between South 
Asian  peoples  to  be  taken  into  account.  It  may  also  be  the  case  that  if  more 
Indians live in rich areas than in poor areas, then the increased risk of mortality 
for the South  Asian group living in the least deprived areas could  reflect the 
increased mortality risk of the Indian population living in rich areas compared to 
the (rich) White majority – in contrast, for the most deprived areas, it is plausible 
that  Bangladeshis  have  a  better  all  cause  mortality  compared  to  poor  White 
people living in those deprived areas. Thus, the influence of social environment 
requires appreciation of the heterogeneity of the South Asian population, and 
this requires richer data.  
In this thesis, the surprising data of the influence of deprivation on outcomes by 
ethnic groups needs further work to fully confirm these findings, and to take into 192 
 
account  the  effect  of  unmeasured,  residual  confounders  within  these 
populations.    More  advanced  analyses  using  multi-level  level  (hierarchical) 
regression  models  to  investigate  the  extent  to  which  individual  and  area 
deprivation and ethnicity may interact in their effects on prognosis of coronary 
disease would thus be a next step. 
 
Figure 16 Proportion of population classified as Indian, Pakistani or Bangladeshi at the 
2001 Census and Indices of Multiple Deprivation Score 2004, by selected London boroughs 
 
9.8.3.5 Symptomatic prognosis  
Though  prognosis  for  death  (case  fatality)  appears  better  in  South  Asian 
compared to White populations from this meta-analysis, symptomatic prognosis 
and improvement in quality of life may differ by ethnicity. Analyses within ACRE 
in chapter 7 showed that South Asian patients were less likely to have improved 
angina  than  White  patients  six  years  after  undergoing  coronary 
revascularisation. The use of a symptomatic outcome adds to the overall picture 
of prognosis of coronary disease, as whilst prognosis for fatal events is no worse 
in  South  Asian  compared  with  White  populations,  prognosis  for  non-fatal 193 
 
symptomatic may not be equitable by ethnicity. The earlier age of presentation 
and the high rates of diabetes in South Asian populations will continue to cause 
increased morbidity following presentation with coronary disease.   
9.8.4  Limitations  
Interpretation  of  the  summary  estimates  requires  caution.  This  meta-analysis 
has important limitations: 
•  The  studies  were  heterogeneous  in  their  choice  of  populations  and 
methods,  and  access  to  the  raw  individual  participant  data  from 
previously published studies was not available to allow a more accurate 
meta-analysis  to  be  conducted.  The  I2  was  particularly  high  for  the 
incidence studies at 47.6% (An I2 higher than 50% is deemed to be large 
enough  to  question  whether  combining  studies  is  valid),  and  thus this 
should be considered when applying the findings in other settings.  
•  The studies by Wild and Balarajan included in the incidence analysis were 
mortality  studies  and  thus  strictly  not  true  incidence  (first  coronary 
event) studies – however, death can be regarded as an incident event and 
these studies were age-adjusted. The data presented by these two large 
studies thus adds to the overall picture of incidence. 
•  The vast majority of participants studied for prognosis were those with 
myocardial  infarction  rather  than  angina,  of  which  a  large  proportion 
were from MINAP. However, in both the chest pain clinic and coronary 
angiogram cohorts, there was no indication that prognosis was any worse 
in  South  Asian  than  in  White  participants.    Combining  patients  with 
myocardial  infarction  and  angina  arguably  contributes  to  increased 
heterogeneity – however, the focus of attention was on the examination of 
case fatality following presentation with coronary disease between ethnic 
groups,  and  hence  the  interest  lies  in  comparison  of  longitudinal 
outcomes  irrespective  of  the  actual  clinical  phenotype  at  presentation. 
Thus,  combining  patients  with  differing  clinical  phenotypes  remains  of 194 
 
value  to  the  overall  picture  of  prognosis  of  coronary  disease  between 
ethnic groups.  
•  Some studies had follow-up data on all-cause death, and others data on 
coronary death.  
o  However, a high proportion of early deaths following an ACS are 
likely  to  be  cardiac  in  cause  -  from  the  PRAIS  UK  registry 
(Prospective Registry of Acute Ischaemic Syndromes in the UK), 
the proportion of cardiovascular deaths was 92% in the first six 
months.184 
•  Many of the studies on systematic review did not adjust for confounding 
factors such as diabetes. Having access to individual participant data from 
previously published studies could have in part reduced this limitation, 
though this  would have depended on whether data on factors such as 
diabetes were collected. 
9.8.5  Implications 
9.8.5.1 Public Health 
The dissociation between the aetiologic and prognostic findings suggests that 
public health efforts to reduce ethnic disparities in mortality need to improve on 
primary prevention, as provision of healthcare to those with manifest coronary 
disease  appears  to  be equitable  between  South  Asian  and  White  patients.  By 
providing appropriate care to all, inequity of outcomes for manifest coronary 
disease may not result.   
9.8.5.2 Clinical  
It is conceivable however that the symptomatic prognosis and improvement in 
quality of life may differ by ethnicity beyond the study of case fatality. Whilst it is 
reassuring that prognosis in terms of case fatality seems no worse in South Asian 
patients,  continuing  monitoring  of  prognosis  is  necessary  in  the  light  of  the 
higher  incidence  of  coronary  disease,  the  earlier  age  of  presentation  and 
continuing high rates of diabetes in South Asian populations.  195 
 
9.8.5.3 Research 
The analyses stratified by deprivation suggesting that South Asian patients had a 
worse  prognosis  than  White  patients  in  less  deprived  areas  in  MINAP  was 
counter  to  what  would  have  been  expected,  and  thus  to  ensure  the  correct 
answer to this question is arrived at, richer individual and service data inputted 
into such clinical registries and studies is required.  
9.9   Conclusion 
In contrast to the higher incidence of coronary disease in South Asian compared 
to White populations, once coronary disease is manifest, their prognosis in terms 
of  future  risk  of  death  may  be  better.  Public  health  efforts  to  reduce  ethnic 
disparities in mortality need a heightened focus on primary prevention whilst 
ensuring that equitable management of manifest coronary disease continues to 
result in equitable prognosis between ethnic groups.  196 
 
 
10 Discussion 
 
10.1  Overall findings  
The index finding underlying this thesis is the higher coronary mortality in South 
Asian compared to White populations in the UK. The aim of the thesis was to 
investigate  the  relative  contributions  of  incidence  and  prognosis  of  coronary 
disease to these higher mortality rates observed in South  Asian compared to 
White  populations.  Overall,  this  thesis  found  that  these  increased  coronary 
mortality rates in South Asian populations are due to their higher incidence of 
fatal and non-fatal coronary disease, as the prognosis in South Asian populations 
of manifest coronary disease is not worse than in White populations. 
As coronary disease is an aggregation of differing phenotypes such as angina and 
myocardial  infarction,  the  thesis  sought  to  separate  these  phenotypes  and 
examine their incidence and prognosis. It then sought to further disaggregate 
angina by nature of symptoms, which varies by ethnic group, and myocardial 
infarction  by  severity,  using  biomarker-based  diagnoses.  As  prognosis  can  be 
measured by both coronary events (such as death/myocardial infarction) but 
also future quality of life, the receipt and impact on improving angina symptoms 
of management strategies for chronic coronary disease was examined between 
South Asian and White populations. This is of importance as receipt and efficacy 
of management strategies for chronic coronary disease may differ between South 
Asian and White populations. 
My specific objectives were as follows, and answered thus: 
(i)  To  determine  the  incidence  and  prognosis  of  angina  in  healthy 
South Asian and White populations  
There was a higher cumulative incidence of typical angina and exertional chest 
pain  in  South  Asian  compared  to  White  populations  using  a  detailed 
characterisation of symptoms of stable angina using the Rose questionnaire at 197 
 
seven time-points over 18 year follow-up. There was not a higher incidence of 
non-exertional chest pain in South Asian compared to White populations. In both 
South Asian and White populations, typical angina and exertional chest pain at 
baseline were associated with increased rates of future coronary events when 
compared to those with no chest pain, but those with non-exertional chest pain 
did not have a worse prognosis compared to those with no chest pain. South 
Asian  populations  had  a  worse  long-term  prognosis  than  White  populations 
within all types of chest pain though South Asian populations with no chest pain 
at  baseline  were  not  at  more  long-term  risk  than  White  populations  with  no 
chest pain at baseline. 
(ii)  To determine in those presenting with incident chest pain whether 
differences exist in the description of symptoms between South Asian and 
White  populations,  and  the  impact  symptom  descriptors  have  on 
prognosis  and  receipt  of  management  strategies  for  chronic  coronary 
disease 
Although  atypical  chest  pain  was  more  common  in  South  Asian  than  White 
populations within a chest pain clinic, typical angina compared to atypical chest 
pain was as likely to be associated with a worse prognosis in South Asian as in 
White  populations.  Although  South  Asian  populations  attending  chest  pain 
clinics did report a marked excess of atypical symptoms, the rate of subsequent 
adverse coronary outcomes in this group was similar in White and South Asian 
populations.  However  South  Asian  populations  were  less  likely  to  receive 
coronary  angiography  and  revascularisation  than  White  populations  in  both 
those with typical angina and atypical chest pain. 
(iii)  To  determine  impact  on  symptomatic  prognostic  outcomes 
(change in angina severity) in South Asian and White populations from 
management strategies for chronic angina  
South Asian populations were less likely to experience long-term improvement 
in  angina  following  coronary  revascularisation  when  compared  to  White 
populations,  despite  a  similar  prognosis  for  adverse  clinical  events  such  as 198 
 
myocardial  infarction  and  death,  even  after  having  taken  into  account 
appropriateness for revascularisation and differences in clinical characteristics. 
(iv)  To  compare  fatal  prognostic  outcomes  of  acute  coronary 
syndromes  in  South  Asian  and  White  populations  and  assess  factors 
underlying prognosis  
Survival in South Asian populations was no worse than White populations at one 
year,  even  after  adjustment  of  confounding  factors.  Factors  such  as  diabetes, 
more prevalent in South Asian populations, nor any other risk factors, clinical 
management  strategies  and  socio-economic  characteristics  did  not  appear  to 
confer a worse prognosis in South Asian compared to White populations. 
(v)  To assess the contribution of incidence and prognosis to the higher 
coronary  death  rates  in  South  Asian  compared  to  White  populations 
through meta-analysis of new and previously reported studies  
By  meta-analysing  the  results  of  my  own  studies  with  eleven  previously 
published studies found on systematic review, the results reveal that incidence 
of coronary disease was higher in South Asian compared to White populations 
yet prognosis was better in South Asian populations. Thus, the higher coronary 
mortality in South Asian compared to White populations is likely to be explained 
by the higher incidence of coronary disease in South Asian populations rather 
than worse survival from coronary disease. 
10.2  Implications 
10.2.1  Aetiology and primary prevention within primary care 
The  relatively  small  number  of  South  Asian  civil  servants  in  the  Whitehall-II 
cohort, with their relatively low prevalence of diabetes, did not allow aetiologic 
questions to be reliably addressed (why the higher incidence?). Clearly, a priority 
of future research is to unravel why South Asian populations have more diabetes 
than White populations.  
The  Whitehall-II  cohort  revealed  a  higher  incidence  of  angina  in South  Asian 
compared to White people. The measurement of this angina through the Rose 199 
 
questionnaire allowed the discrimination of prognostically-important chest pain 
from non-exertional chest pain that was associated with a lower rate of adverse 
events.  Therefore,  the  use  of  the  Rose  questionnaire  to  assess  the  early 
presentation of chest pain was found to have prognostic validity in South Asian 
as  well  as  in  White  populations,  and  may  allow  its  use  in  early  detection  of 
angina to target clinical management to prevent progression to more adverse 
outcomes. 
10.2.2  Secondary prevention within hospital care 
By managing true angina well (such as in a chest pain clinic), equitable outcomes 
may  result  irrespective  of  the  ethnic  group.  Whitehall-II  revealed  a  worse 
prognosis in South Asian compared to White people in those with typical angina. 
This contrasted with the finding from the Chest Pain Clinic study which showed 
that typical angina did not predict a worse outcome in South Asian compared to 
White  people.  Whitehall-II  was  a  purely  observational  cohort,  and  thus  it  is 
conceivable that those South Asian people with typical angina went undiagnosed 
and hence unmanaged (unlike in the chest pain clinic cohort, whose participants 
were within a healthcare setting).  
South Asian populations may continue to suffer increased morbidity following 
presentation  with  acute  coronary  disease  on  account  of  their  higher  rates  of 
diabetes  and  this  disease’s  ensuing  complications.  The  coronary  angiogram 
cohort  showed  that  though  the  prognosis  in  those  with  angina  in  terms  of 
subsequent events such as myocardial infarction and death was not worse in 
South  Asian  compared  to  White  populations,  South  Asian  patients  were  less 
likely  to  experience  long-term  improvement  in  angina  following  coronary 
revascularisation  when  compared  to  White  patients.  As  the  relief  of  angina 
determines return to work and perceived health status,48 research on functional 
outcomes  is  of  importance.  As  coronary  mortality  rates  fall,  morbidity  in  the 
form of angina becomes a more common clinical problem. 
10.2.3  Further research 
Few studies have collected data on chest pain symptom descriptors by ethnic 
groups,  and  none  have  examined  their  prospective  validity.  The  increased 200 
 
prevalence  of  atypical  pain  in  South  Asian  people  may  be  a  reason  why  the 
improvement  in  angina  in  South  Asian  patients  following  revascularisation  is 
poorer than in White patients. If ACRE had had information on typicality of pain, 
this would have aided interpretation of the analyses. 
Using registry data to answer epidemiological questions has considerable cost-
saving  potential.  That survival  in  South  Asian  patients  following  presentation 
with acute coronary syndromes was better than White patients at one year, even 
after  adjustment  of  confounding  factors  may  be  a  vindication  of  care  in 
previously under-managed minority ethnic groups. This will encourage doctors 
and public health professionals than inequalities can be successfully addressed.  
However,  to  be  able  to  use  routinely-collected  clinical  data  in  research  will 
require careful data quality checking and the usage of inbuilt entry/range checks.  
10.2.4  Public health 
The  combination  of  higher  incidence  and  similar  prognosis  in  South  Asian 
compared to White populations of coronary disease, coupled with the general 
aging  of  the  whole  UK  population,  will  lead  to  an  increase  in  the  size  of  the 
prevalent  pool  of  South  Asian  people  with  coronary  disease.  Thus,  though 
coronary  mortality  rates  may  continue  to  drop,  the  total  burden  of  coronary 
heart  disease  in  South  Asian  populations  is  likely  to  increase.  Hence, 
disaggregation  of  cross-sectional  coronary  mortality  rates  into  incidence  and 
prognosis, and by differing clinical presentations such as angina and myocardial 
infarction, is essential for the complete understanding of the epidemiology of 
coronary disease in different ethnic groups.  
This  thesis  demonstrates  that  the  health  of  South  Asian  populations  in  some 
respects - such as with regard to one-year case fatality after presentation with an 
acute  coronary  syndrome  -  is  not  worse  than  the  majority  White population. 
Such results should serve to stimulate further research into discovering more 
about  the  aspects  of  service  provision  that  are  responsible  for  these 
improvements in ethnic disparities. Not collecting any ethnicity data at all (the 
case  in  countries  such  as  France)  would  mean  that  quantification  of  ethnic 201 
 
disparities  and  hence  instigation  of  measures  to  alleviate  them  and  hence 
measurement of their improvement would not be possible at all. 
10.3  Limitations 
10.3.1  Definition and validation of ethnicity  
Ethnic  inequalities  in  public  health  continue  to  be  highlighted  and  hence 
analyses of any data concerning ethnic groups remain of vital importance though 
need due caution and careful validation. As the main exposure of interest to this 
thesis was ethnicity, the comparability of measures of ethnicity within the four 
cohorts  was  of  importance.  However,  the  four  cohorts  defined  ethnicity  in 
differing ways. Ethnicity in Whitehall-II was defined according to the Office for 
National Statistics 1991 census types. In the Chest Pain Clinic Cohort, the doctor 
ascribed ethnicity as “Asian”, “White”, “Black” or “other” during the consultation. 
In the coronary angiogram cohort, self-assigned ethnicity, based on the national 
1991 census classification, was obtained by questionnaire on the day of index 
coronary  angiography.  In  the  acute  coronary  syndrome  cohort,  the  patient's 
ethnic group was classified by the coder into the groups Caucasian, Asian, Black, 
Oriental and other. 
Though the four studies used differing methodology to define ethnicity, analyses 
on the ethnicity variable of each cohort confirmed validity of the measures in 
each cohort. Thus, though due care should be taken in the usage of the ethnicity 
variable in epidemiology, this work shows the importance of collecting data on 
ethnicity.  A  future  gold  standard  for  measuring  ethnicity  would  use  a  self-
assessed  measure  and  include  information  on  country  of  birth,  religion  and 
nationality  of  the  participant  and  their  parents  to  take  into  account  the 
heterogeneity within the South Asian population as well as the differences that 
exist between a first-generation migrant and their progeny. 
10.3.2  Heterogeneity of South Asians and whites 
Cardiovascular risk within South Asian peoples is heterogeneous. For instance, 
Bangladeshis are shorter, are less obese and have a lower mean blood pressure 
than  other  South  Asian  peoples  yet  their  risk  of  developing  cardiovascular 
disease and diabetes is the highest of all the South Asian ethnic groups.17  116 202 
 
Beyond biological differences, differences in the individual reasons for migration 
(e.g., economic, educational, political)  and  differences  in baseline  literacy  and 
skills will result in further heterogeneity. Demobbed soldiers will be different 
from ship's cooks who will be different from doctors or others from professional 
and mercantile backgrounds. This will also influence the future socio-economic 
and  educational/professional  status  of  their  children.  There  is  increasing 
evidence that those of the lowest socio-economic status, those of Pakistani and 
Bangladeshi origin, have the highest rates of coronary disease.20 185  
The  majority  of  published  literature  in  ethnicity  and  health  has  aggregated 
migrants from the different geographical, religious and linguistic backgrounds 
from the sub-continent as South Asian. Studies are increasingly disaggregating 
this  ethnic  group  into  the  different  nationalities,  cultures  and  religions 
represented within it. Although in ACRE and Whitehall-II there were data on the 
breakdown of the studies’ South Asian populations into Indians, Bangladeshis, 
Pakistani and Sri Lankan, there were too few numbers for analysis. 
Equally,  as  discussed  in  section  1.3.2,  these  analyses  only  apply  to  White 
populations  based  mostly  in  England  and  Wales.  The  comparisons  cannot  be 
applied to Scotland and Ireland, to migrants from those countries to England and 
Wales, and to White migrants from Southern and Eastern Europe. 
10.3.3  Definition and validation of chest pain and angina  
Angina  is  a  clinical  constellation  of  symptoms  rendering  quantitative 
measurement difficult. Acute coronary syndromes can be measured in terms of 
biomarkers such as troponin - stable angina does not have a comparable blood 
test to measure it. Thus, it is difficult to compare cases of angina enrolled in one 
study with those in another, and indeed I have used three different measures of 
angina in the three cohorts. The advantage to the use of differing definitions of 
angina is in allowing differing questions to be asked. For instance, using the four-
level CCS score in ACRE allowed severity calculation of a change in angina, while 
the Rose questionnaire has only two levels of severity. However, using the Chest 
Pain Clinic study’s symptom score within ACRE to determine whether the pain 
was  typical  or  atypical  would  have  aided  in  determining  why  angina  was 203 
 
improving less in some compared to others. The ACRE study assumed all CCS 
angina was in fact typical angina which may not have been the case. The Chest 
Pain  Clinic  study  might  have  been  enhanced  if  data  were  available  on  the 
findings of subsequent coronary angiography if it took place, though from ACRE, 
there was little correlation between number of diseased coronary vessels and 
CCS score. This is not unreasonable, as one single severely stenosed coronary 
artery is likely to be highly symptomatic.  
Though different case definitions for angina were used in Whitehall-II, Chest Pain 
Clinic Study and ACRE, there was some consistency in the results. For example, 
typical pain had a poorer outcome than atypical, be it pain defined by the Rose 
questionnaire or by the symptom score formulated from chest pain descriptors 
in the Chest Pain Clinic Study. However, within the atypical type of chest pain, 
they may still be patients with coronary disease who go on to develop adverse 
coronary outcomes. This is applicable to both ethnic groups, though considering 
those with a confirmed myocardial infarction, chest pain is still more likely to be 
atypical  in  nature  in  South  Asian  compared  to  White  patients.40  45  46  Typical 
symptoms thus represent a filter for patients with suspected angina for further 
investigation, and that which can be improved by coronary disease management 
strategies.  
Poor communication due to language difficulties have long been offered as an 
important factor relating to the health outcomes and experiences of health care 
for  members  of  the  South  Asian  community.186  However,  throughout  the 
analyses of this thesis, the measures of chest pain used had equal cross-sectional 
and  prognostic  validity  in  South  Asian  and  in  White  populations.  The 
ethnographic  qualitative  study  of  59  clinic  consultations  performed  by 
colleagues  at  Newham  University  Hospital  also  showed  how  the  chest  pain 
classification and diagnosis were reached,159 and there was little evidence that 
this negotiation was patterned by ethnicity. None of the South Asian patients in 
this study relied on translators.  It may be that the major differences between 
South  Asian  patients  who  are  not  fluent  in  English  and  White  will  be  longer 204 
 
consultations than White patients187 and increased dissatisfaction with medical 
care188 rather than an adverse prognosis. 
10.3.4  Data quality and validity  
The cohorts for study in this thesis, selected on account of the coverage they 
provide across the different stages of the natural history of coronary disease, 
used very different methodologies. I sought to examine the quality and validity of 
this data throughout this thesis. In chapter 4, I assessed recruitment of baseline 
data through to data on follow-up and found that data, though variable in its 
completeness between the studies chosen for this thesis, was of good quality.  
Validity  of  specific  variables  essential  to  prognostic  analyses  was  assessed  in 
cross-sectional  and  prospective  analyses  within  all  four  cohorts.  When 
examining  angina  for  example,  in  Whitehall-II  there  was  an  increasing 
prevalence of hypertension and higher cholesterol levels with more typical chest 
pain and trends towards more metabolic syndrome and higher body mass index. 
In the Chest Pain Clinic study, typical symptoms strongly predicted a positive 
exercise ECG result, and both the cardiologist summary and the symptom score 
of  typical  symptoms  were  predictive  of  a  diagnosis  of  angina  across  sex  and 
ethnicity.  In  ACRE,  the  CCS  variable,  calculated  from  a  patient  questionnaire, 
correlated with South Asian patients having a higher prevalence of primary care 
doctor-diagnosed angina at follow-up. Increasing angina as measured by CCS at 
baseline  was  associated  with  worsening  patterns  in  other  baseline  clinical 
measures and higher rates of prospective all-cause mortality.  
Hence,  though  data  across  the  four  cohorts  varied  in  definitions  and 
completeness,  a  range  of  checks  on  data  quality  and  validity  ensured  any 
conclusions made from the results of the analyses were not biased.  
10.4 Future work 
10.4.1  Improving the measure of angina  
Until  standardised  case  definitions  for  angina  are  agreed,  prevalence  and 
prognostic assessments will remain variable and contradictory. Case definitions 205 
 
of angina rely on the presence of one of more findings in three domains. These 
domains are represented in the figure below.  
 
 
A – Anatomy 
F – Function 
S – Symptoms 
 
 
Figure 17 Differing angina phenotypes: anatomy, symptoms and function domains 
 
o  Anatomy  of  coronary  arteries’  lesions  may  be  data  from  coronary 
angiography (both invasive and computerised tomography). 
o  Function  in  terms  of ischaemia  may  be  data  from  exercise  ECG,  stress 
echocardiography, myocardial perfusion imaging and magnetic resonance 
imaging. 
o  Symptoms  may  be  data  from  the  Rose  angina  questionnaire,  symptom 
descriptors, CCS classification and nitrate use.   
Finding an instrument to measure angina will require the definition of the angina 
phenotype in the first instance in terms of symptoms, anatomy and functional 
findings. An atheromatous plaque causing coronary vessel narrowing visualised 
on angiography and ischaemic changes on exercise ECG may not in itself cause 
ischaemic symptoms for example and thus span the A and F cells. Syndrome X, 
with  its  anginal  symptoms  and  positive  exercise  test  but  normal  coronary 
anatomy would span the F and S cells.  
Differing phenotypes of angina may be built up using a composite of measures 
and the use of these will be dictated by the questions asked of the proposed 
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research. It is possible that multiple phenotypes underlying angina will result. 
Different combinations here will give different syndromes, and there may ethnic 
differences in any of the seven cells of the Venn diagram above. 
10.4.2  Improving the quality of the data and statistical methodology  
Throughout  this  thesis,  I  assessed  both  data  quality  and  validity  though 
techniques  available  to  me.  To  further  improve  the  data,  more  advanced 
statistical methodology could be employed. 
10.4.2.1  Propensity scores 
Propensity scores can be used to reduce bias in observational studies. The lack of 
randomisation  in  such  studies  can  complicate  prognostic  analyses  as  these 
comparisons may be biased due to prognostically important baseline differences 
among patients, often as a result of unobserved treatment selection biases. This 
would bias for example the comparison of patients with typical and atypical pain 
within  the  chest  pain  clinic.  Within  ACRE,  an  observational  study  of  invasive 
procedures,  such  studies  are  more  prone  to  bias  because  patients  who  are 
candidates for the procedure often differ in immeasurable ways from patients 
who are not. Doctors may also be more risk averse in selecting those needing 
further invasive investigation, performing interventions on lower-risk patients 
despite  greater  clinical  benefit  to  higher-risk  patients  (such  as  reduced 
prescription  of  statins  in  elderly  patients  with  a  higher  future  probability  of 
death).189 190 The propensity score for an individual is defined as the probability 
of  being  treated  conditionally  on  (or  only  on  the  basis  of)  the  individual’s 
covariate  values  and  was  originally  proposed  as  a  method  for  producing  a 
balance of many covariates between two groups.191 192 
However, propensity-based matching have the same limitations as multivariable 
risk  adjustment  model  methods  if  unmeasured  variables  that  may  determine 
allocation to one exposed group compared to another are not measured. They 
also cannot overcome initial selection bias.193 
10.4.2.2  Multiple Imputation of Baseline Data 
Imputation  is  a  procedure  used  for  entering  a  value  for  a  specific  data  item 
where the response is missing or unusable. It uses the principle that missing data 207 
 
can  range  from  being  missing  completely  at  random  (where  no  other 
information in the database can predict reasons for data missingness) to being 
not missing at random, where a systematic pattern of missingness is found (e.g., 
one of the centres of a multi-centre study may not have a sphygmomanometer 
and  thus  no  recordings  of  blood  pressure  were  taken  at  that  centre).  The 
technique relies on the capacity of the database to predict associations between 
exposure and missingness, and requires that every variable used in the statistical 
model takes account of imputation, not just those that predict missingness.  
The  technique  has  been  used  and  described  in  large observational studies  in 
cardiovascular disease. The success of this technique depends on the wealth of 
covariate data available within the dataset. The Cardiovascular Health Study, a 
population-based  study  designed  to  identify  risk  factors  for  cardiovascular 
disease in individuals aged 65 or more  years in the US, has reported on this 
technique.194 It is a relevant example to this thesis as there existed two separate 
cohorts  within  this  study  (which  were  enrolled  in  different  years)  with 
differences  in  the  data  collected,  in  particular  differing  substantially  in  their 
numbers of African American participants. The richness and slight redundancy of 
the  Cardiovascular  Health  Study  data  set  allowed  the  researchers  to  impute 
groups  of  similar  and  highly  correlated  variables  together  –  they  gave  the 
example of heart rate, measured at four different times. Multiple Imputation has 
also  been  used  in  Whitehall-II  to  assess  the  association  between  persistent 
economic difficulties and serious coronary events.195 
10.4.3  Linkage of databases  
10.4.3.1  Linking secondary care data with primary care data 
The  three  prognostic  cohorts  examined  within  this  thesis  have  all  recruited 
participants in the secondary care setting, at different points along the natural 
history of coronary disease. However, no information was available in any of the 
cohorts  before  and  after  (aside  from  outcomes)  on  other  healthcare  data. 
Linkage  with  data  from  primary  care  sources  such  as  the  General  Practice 208 
 
Research Databasen (GPRD) may augment secondary care data sets and provide 
more information on the patient journey along the natural history of coronary 
disease - such as information on earlier events (e.g. onset of hypertension) - that 
will provide more explanatory data for investigating the aetiology of events such 
as angina and myocardial infarction. The GPRD is a computerised database of 
anonymised longitudinal medical records from primary care that can be linked 
with other healthcare data. Currently data are available on around 13 million 
patients from around 488 primary care practices throughout the UK. By linking 
MINAP data to the GPRD, such a resource would be able to identify the extent 
and prognostic impact of missed opportunities for preventive care earlier in the 
patient journey.  
The  influence  of  primary  care  on  variation  in  prognosis  is  also  of  vital 
importance.  Within  MINAP,  no  data  were  available  on  healthcare  between 
admission and follow-up for vital status at one year. Prognostic analyses thus 
cannot take into account the care received in primary care after an admission 
with an acute coronary syndrome and thus its influence on outcomes. This is 
commonly  the  case  for  hospital-based  follow-up  studies,  as  secondary 
prevention is deemed to be the remit of primary care. 
The GPRD currently does not record ethnicity at the individual patient level, but 
other primary care research databases like QRESEARCH do.o QRESEARCH is a 
database derived from the anonymised health records of over 11 million patients 
from  574  general  practices  using  the  EMIS  clinical  computer  system.  The 
practices are spread throughout the UK and include data from patients who are 
currently registered with the practices as well as historical patients who may 
have  died  or  left.  Thus,  multiple  databases  may  be  linked  to  ensure  the 
availability of the necessary data fields for a research hypothesis. 
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10.4.3.2  Linking secondary care data with other secondary care data 
Linkage  of  secondary  care  databases  and  studies  with  data  sources  such  as 
Hospital Episode Statistics (HES) will allow the addition of information such as 
cause-specific future admission to databases such as MINAP. HES is the national 
statistical data warehouse for England of the care provided by NHS hospitals and 
for NHS hospital patients treated elsewhere. The two main clinical classifications 
currently  used  in  HES  are  the  International  Classification  of  Diseases,  Tenth 
Revision from which descriptions of the conditions treated or investigated can be 
obtained and the Office of Population, Censuses and Surveys: Classification of 
Interventions and Procedures, 4th Revision which records details of procedures 
or interventions performed. 
10.4.4  The influence of genetics 
Differences in genetic susceptibility may be responsible for part of the variation 
of  coronary  heart  disease  rates  between  ethnic  groups.  In  twin  studies,  the 
relative hazard of death from premature coronary heart disease (age less than 
55) when one's twin died of coronary heart disease is eight times higher in men 
and 15 times higher in women, even after taking into account other risk factors 
for coronary heart disease.196 Similar findings of familial aggregation have been 
reported in  North-Eastern Indian origin South Asian people in Mauritius, where 
a  study  has  reported  a  7.4-fold  increased  prevalence  of  coronary  disease  in 
siblings of individuals with myocardial infarction.197 
Detailed  investigation  into  the  causes  of  the  increased  incidence  of  coronary 
disease observed in South Asian populations was beyond the remit of this thesis, 
but the increased prevalence of the metabolic syndrome and diabetes mellitus in 
this population is the most widely-held explanation.198 199 Though much of this 
excess is thought to be due to environmental factors, genetic factors may play a 
role in determining the level of such risk factors. An inherited susceptibility to 
type 2 diabetes may derive from multiple genes of individual modest effect,200 
and  a  component  of  insulin  resistance,  more  prevalent  in  South  Asian 
populations,201 may be inherited.202 The thrifty gene hypothesis proposes that 
conditions of food scarcity increased evolutionary selection pressure for efficient 
metabolism,  which  then  disadvantages  those  who  become  exposed  to  the 210 
 
modern obesogenic environment, the supposed combination facing the migrant 
from  South  Asia.203  Genes  and  pathways  involved  in  the  insulin  resistance 
metabolic syndrome may underlie this.   
The recent advances in the understanding of the human genome have opened up 
possibilities for new biological insights, new clinical insights, and new clinical 
applications.  Genome-wide  association  studies  have  for  example  found  an 
association between myocardial infarction and a common sequence variant on 
chromosome  9p21.204  A  genome-wide  association  study  for  insulin  resistance 
and  related  phenotypes  in  2684  Indian  Asian  people,  with  further  testing  in 
11955 individuals of Indian Asian or European ancestry, found associations of 
the allele rs12970134 (near the Melanocortin 4 receptor MC4R, a human gene 
near which common genetic variation is associated with risk of adiposity and 
insulin  resistancep)  with  waist  circumference  and  independently  with  insulin 
resistance.205 
Such future work in genetics will help to unravel the interaction of genes with 
the environment, and may play a role in explaining the dissociation between the 
higher  incidence  of  coronary  disease  in  South  Asian  compared  to  White 
populations  and  the  similar  prognosis  between  the  two  ethnic  groups.  Such 
future  work  should  also  be  designed  to  allow  investigations  on  whether 
differences  exist  between  South  Asian  peoples  and  thus  whether  the 
heterogeneity of this group is predominately socio-economic and behavioural or 
biological.  
10.4.5  South Asians in South Asia 
In  South  Asia  today,  an  epidemiological  transition  is  taking  place  against  a 
background of economic globalisation that has greatly increased the size of the 
urban  poor  and  middle  classes,  at  the  same  time  leaving  many  millions  to 
continue living on the land at subsistence level.  There is an emerging double 
burden of disease in the countries of South Asia, characterised by a combination 
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of  pandemic  infectious  disease  and  high  rates  of  coronary  disease.  Though 
coronary risk factors tend to be concentrated in those of higher social classes,206 
the poor in India are increasingly affected. Higher levels of tobacco consumption 
are associated with low levels of education and income207 and both urban slums 
in  Delhi  and  rural  south  India  have  a  high  prevalence  of  diabetes  and 
dyslipidaemia.  The  high  prevalence  of  coronary  risk  factors  such  as  smoking, 
high blood pressure and overweight in areas of rural India are also of concern.208 
The answers to research questions surrounding ethnic differences in coronary 
health may thus increasingly come from the sub-continent. Regional endeavours 
such  as  registry  data  collection  are  already  providing  answers  on  treatment 
outcomes.209 CREATE is such an endeavour which, in a study design similar to 
MINAP, recruits eligible patients with suspected acute coronary syndrome in 89 
centres  from  10  regions  and  50  cities  in  India.  Many  of  the  data  fields  are 
common  to  MINAP  and  comparisons  can  be  made  to  CREATE.  Time  from 
symptom onset to presentation at hospital is typically longer in India than in the 
UK  for  example,  the  delay  in  presentation  being  due  to  a  lack  of  symptom 
awareness,  longer  distances  travelled  to  reach  hospital  and  problems  of 
transportation (only 5.4% of patients are brought to hospital in an ambulance, 
with the large majority using public transport (buses) and hired vehicles (taxis, 
autorickshaws).210 In addition, older people and women have been observed to 
present disproportionately late, irrespective of whether their symptoms were 
typical or atypical. Thus, there is much potential for the reciprocal exchange of 
ideas as well as collaborative work between such registries.  
10.4.6  Generational effects  
My data mostly concern ‘first-generation’ migrants from South Asia. It is unlikely 
that a large proportion of the South Asian people in my cohorts were born in the 
UK, as even the oldest second-generation South Asian people are only now in 
2009 beginning to enter their 40s. 
However, it is a pertinent question to ask whether the sons and daughters of 
first-generation South Asian migrants will be at equal risk. Decreasing mortality 
with increasing duration of residence in the new host country was observed for 212 
 
migrants from South Asia in a study in a study in Australia,155 perhaps due to 
cardio-protective behavioural practices in the Australia.  However, studies in the 
UK  have  presented  opposite  results  to  the  Australian  work,  with  increasing 
cardiovascular risk with length of residence among South Asian migrants.211  
The  interaction  of  behavioural  practices  and  socio-economic  patterns  awaits 
further  elucidation.  The  coronary  risk  of  a  group  of  educated  and  affluent 
second-generation South Asian people may more resemble that of a similarly 
educated and affluent White group, as opposed to a less educated group and less 
affluent group of second-generation South Asian people. It is here that perhaps 
the heterogeneity of the South Asian group may become increasingly important 
in  the  future.  It  is  interesting  that  apart  from  Indian  people,  minority  ethnic 
groups  (including  Pakistani/Bangladeshis)  are  found  to  be  more  likely  than 
White  majority  groups  to  engage  in  poor  dietary  behaviours  in  a  study  of 
adolescent and parental lifestyles, with those born in the UK and girls being more 
susceptible.212 Thus, some South Asian peoples may inherit (more so through 
their behaviour than their genes) the diseases of their parents, whilst others – 
like  the  offspring  of  some  professional  Indian  classes  –  acquire  the  disease 
profile of the majority White population.  
Beyond socio-economic mechanisms, the influence of biology may continue to 
adversely affect the children of South Asian migrants. South Asian populations 
have a smaller superficial subcutaneous adipose tissue compartment than White 
populations  and  a  theory  has  been  proposed  that  babies  born  to  mothers  of 
South Asian descent are smaller and have less peripheral fat, and that during 
subsequent  growth  and  development  immersed  in  the  richer  diet  of  the 
developed world, this primary compartment reaches its capacity for fat storage 
rapidly  and  the  deep  subcutaneous  and  visceral  compartments  become  more 
prominent,  with  adverse  consequences  for  risks  of  diabetes  and  coronary 
disease.213 Early evidence of ethnic differences in coronary risk has also been 
presented  in  a  cross  sectional  comparison  of  British  South  Asian  and  White 
children, with ethnic differences being present even in these children aged 8 to 
11 years – an increased tendency to insulin resistance was observed in South 213 
 
Asian children, and the authors inferred an increased sensitivity to adiposity as a 
result.51  
The finding that second-generation minority ethnic groups in England continue 
to report as poor a general health as their parents, unaffected by changes in 
health  behaviours,214  suggests  that  continuing  investigation  into  ethnic 
inequalities in health will be needed in the progeny of first-generation migrants. 
10.4.7  Ethnic inequalities in other diseases 
In a study in the UK of increasing cardiovascular risk with length of residence 
among  South  Asian  migrants,211  increased  cancer  mortality  of  South  Asian 
migrants was also shown to increase with duration of residence in England and 
Wales. Increasing adoption of the detrimental aspects of the developed world 
lifestyle is resulting in a shift of epidemiological patterns of cancers in South 
Asian  people  living  in  the  developed  world  towards  that  of  the  majority 
population. With increased time since migration and increasing life expectancy 
amongst ethnic minorities, disease patterns will start to resemble  that of the 
majority population. This was highlighted over ten years ago.215  
The heterogeneity of South Asian people becomes particularly important when 
comparing behavioural practices that may in turn determine a shift in future 
epidemiological disease patterns. 43% of Bangladeshi men smoke compared to 
the national average of 27%.216 Bangladeshis have also been found to tend to rely 
on  willpower  rather  than  health  service  interventions,  resulting  in  poor  quit 
rates217 whilst ethnic minority patients were significantly less likely to receive 
advice  on  smoking  cessation  in  one  study.218  Much  of  the  UK  Bangladeshi 
community  are  classified  as  having  low  socioeconomic  status,  high  rates  of 
unemployment and low levels of formal female employment,219 and with higher 
smoking  rates  being  found  in  inner-city  ethnic  minority  communities,220  the 
finding that those in higher social classes have higher quit rates221 is a further 
source of inequity. If lung cancer mortality reflects smoking habits of populations 
20-30  years  previously  as  has  been  proposed,11  the  likely  progression  from 
contemporary behavioural changes to future incidence and mortality data is all 
too predictable. 214 
 
 
11 Conclusions 
A systematic review of the literature revealed incidence of fatal coronary disease 
to be higher in South Asian compared to White populations, with few studies 
available on non-fatal incidence. When considering prognosis, the literature was 
unable  to  answer  whether  prognosis  was  worse  in  South  Asian  compared  to 
White populations. 
South Asian populations had a higher incidence of typical angina over long-term 
follow-up compared to White populations, but not a higher incidence of non-
exertional chest pain. Typical angina was predictive of coronary death and non-
fatal myocardial infarction on long-term follow-up, but non-exertional chest pain 
was not, in both South Asian and White populations.  
South  Asian  populations  with  typical  chest  pain,  though  at  increased  risk  of 
adverse coronary outcomes compared with those who presented with atypical 
pain, had lower rates of coronary angiography and revascularisation compared 
with White populations with typical chest pain.  
South  Asian  patients  were  less  likely  to  have  improved  angina  than  White 
patients  on  long-term  follow-up  after  undergoing  coronary  revascularisation, 
even after having taken into account appropriateness for revascularisation and 
differences in clinical characteristics. South Asian patients with chronic angina 
were not at increased risk of coronary death and non-fatal myocardial infarction. 
Survival  following  acute  coronary  syndromes  was  not  worse  in  South  Asian 
compared with White patients and this was not explained by risk factors, clinical 
management strategies or socio-environmental factors.  
On meta-analysing the studies of this thesis with previously published literature 
retrieved on systematic review, there was a higher incidence of coronary disease 
in  South  Asian  compared  to  White  populations  but  once  coronary  disease  is 
manifest, their prognosis was better.  215 
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13 Appendices 
13.1 Census 2001 - Ethnicity in England and Wales 
In the 2001 census, ethnicity categories were coded as follows: 
  
White 
British 
Irish 
Any other White background 
Mixed 
White and Black Caribbean 
White and Black African 
White and Asian 
Any other mixed background 
 Asian or Asian British 
Indian 
Pakistani 
Bangladeshi 
Any other Asian background 
Black or Black British 
Caribbean 
African 
Any other Black background 
Other ethnic groups 
Chinese 
Any other ethnic group 
 
Results on ethnicity and religion from the 2001 census revealed that 87.5 per 
cent of the population of England and Wales (seven out of eight people) gave 
their  ethnic  group  as  White  British.  The  highest  proportions  describing 
themselves as White British are in the North East, Wales and the South West (all 
over 95 per cent). 227 
 
 
Eighty-seven  per  cent  of  the  population  of  England  and  96  per  cent  of  the 
population of Wales gave their ethnic origin as White British. White Irish people 
make up 1.2 per cent of the population of England and Wales as a whole, with the 
highest  proportion  in  the  London  borough  of  Brent  (6.9  per  cent  of  the 
population). The largest proportions of White Other (that is, not White British or 
White  Irish)  people  are  in  central  London,  particularly  the  borough  of 
Kensington and Chelsea (25.3 per cent). 
London had the highest proportion of people from minority ethnic groups apart 
from more who identified themselves as of Pakistani origin, of whom there was a 
higher  proportion  in  Yorkshire  and  the  Humber  (2.9 per  cent)  and  the  West 
Midlands (2.9 per cent). Two per cent of the population of England and Wales 
were  Indian,  with  Leicester  having  the  highest  proportion  (25.7  per  cent). 
Bangladeshis formed 0.5 per cent of the population of England and Wales, with 
the highest proportion in the London borough of Tower Hamlets (33.4 per cent).  228 
 
The  largest  proportions  of  people  of  Mixed  origin  were  in  London,  with  the 
exception of Nottingham, where two per cent of people were Mixed White and 
Black Caribbean. 
The 1991 census ethnicity categories were: 
  
White 
British 
Irish 
Any other White background 
 Asian or Asian British 
Indian 
Pakistani 
Bangladeshi 
Any other Asian background 
Black or Black British 
Caribbean 
African 
Any other Black background 
Other ethnic groups 
Chinese 
Any other ethnic group 229 
 
 
13.2 International Classification of diseases 2007 version- Ischaemic 
heart disease   
 
I20     Angina pectoris  
I20.0     Unstable angina  
I20.1     Angina pectoris with documented spasm  
I20.8     Other forms of angina pectoris  
I20.9     Angina pectoris, unspecified  
I21     Acute myocardial infarction  
I21.0     Acute transmural myocardial infarction of anterior wall  
I21.1     Acute transmural myocardial infarction of inferior wall  
I21.2     Acute transmural myocardial infarction of other sites  
I21.3     Acute transmural myocardial infarction of unspecified site  
I21.4     Acute subendocardial myocardial infarction  
I21.9     Acute myocardial infarction, unspecified  
I22     Subsequent myocardial infarction  
I22.0     Subsequent myocardial infarction of anterior wall  
I22.1     Subsequent myocardial infarction of inferior wall  
I22.8     Subsequent myocardial infarction of other sites  
I22.9     Subsequent myocardial infarction of unspecified site  
I23     Certain current complications following acute myocardial infarction  
I23.0     Haemopericardium as current complication following acute myocardial 
infarction  
I23.1     Atrial septal defect as current complication following acute myocardial 
infarction  
I23.2     Ventricular septal defect as current complication following acute myocardial 
infarction  
I23.3     Rupture of cardiac wall without haemopericardium as current complication 
following acute myocardial infarction  230 
 
I23.4     Rupture of chordae tendineae as current complication following acute 
myocardial infarction  
I23.5     Rupture of papillary muscle as current complication following acute myocardial 
infarction  
I23.6     Thrombosis of atrium, auricular appendage, and ventricle as current 
complications following acute myocardial infarction  
I23.8     Other current complications following acute myocardial infarction  
I24     Other acute ischaemic heart diseases  
I24.0     Coronary thrombosis not resulting in myocardial infarction  
I24.1     Dressler's syndrome  
I24.8     Other forms of acute ischaemic heart disease  
I24.9     Acute ischaemic heart disease, unspecified  
I25     Chronic ischaemic heart disease  
I25.0     Atherosclerotic cardiovascular disease, so described  
I25.1     Atherosclerotic heart disease  
I25.2     Old myocardial infarction  
I25.3     Aneurysm of heart  
I25.4     Coronary artery aneurysm  
I25.5     Ischaemic cardiomyopathy  
I25.6     Silent myocardial ischaemia  
I25.8     Other forms of chronic ischaemic heart disease  
I25.9     Chronic ischaemic heart disease, unspecified  
 231 
 
 
13.3 Rose angina questionnaire  
1.  Have you ever had any pain or discomfort in your chest?    Yes  No 
                  ￿  ￿ 
a)Do you get this pain or discomfort when you walk uphill or in a hurry?  Yes  No 
                  ￿  ￿ 
b)Do you get it when you walk at an ordinary pace on the level?    Yes  No 
                  ￿  ￿ 
c)When you get any pain or discomfort in your chest, what do you do?   
Stop   ￿   Slow down   ￿    Continue at the same pace  ￿ 
d)Does it go away when you stand still?          Yes  No 
                  ￿  ￿ 
e)How soon?    in 10 minutes or less  ￿    More than 10 minutes  ￿ 
f)Where do you get this pain or discomfort?  Mark the place(s) with an X on the diagramq 
 
 
                                                        
q In the Rose angina questionnaire, angina is defined as being present in subjects who answer as 
follows: Q1: yes; Q1a or Q1b: yes; Q1c: stop or slow down; Q1d: relieved; Q1e: 10 minutes or less; 
Q1f: either (a) sternum (upper or middle or lower) or (b) left anterior chest and left arm 232 
 
13.4 Incidence of coronary disease MEDLINE literature search strategy 
 
1. MEDLINE; exp CORONARY DISEASE/; 148892 results. 
2. MEDLINE; "coronary disease$".af; 122799 results. 
3. MEDLINE; "coronary heart disease$".af; 30935 results. 
4. MEDLINE; coronary$.af; 308926 results. 
5. MEDLINE; exp MYOCARDIAL INFARCTION/; 119450 results. 
6. MEDLINE; "myocardial infarction$".af; 149432 results. 
7. MEDLINE; exp MYOCARDIAL ISCHEMIA/; 286602 results. 
8. MEDLINE; exp CARDIOVASCULAR DISEASES/; 1471574 results. 
9. MEDLINE; 2 OR 3 OR 4 OR 6 OR 8; 1542777 results. 
10. MEDLINE; exp INCIDENCE/; 119216 results. 
11. MEDLINE; Incidence.af; 422668 results. 
12. MEDLINE; 9 and (10 or 11 ); 72317 results. 
13. MEDLINE; exp ASIAN CONTINENTAL ANCESTRY GROUP/; 18210 results. 
14. MEDLINE; exp INDIA/eh (eh=Ethnology); 2540 results. 
15. MEDLINE; india$.ti,ab; 56482 results. 
16. MEDLINE; exp SRI LANKA/eh (eh=Ethnology); 86 results. 
17. MEDLINE; "sri lanka$".ti,ab; 2497 results. 
18. MEDLINE; exp BANGLADESH/eh (eh=Ethnology); 324 results. 
19. MEDLINE; "bangladesh$".ti,ab; 4610 results. 
20. MEDLINE; exp PAKISTAN/eh (eh=Ethnology); 618 results. 
21. MEDLINE; "pakistan$".ti,ab; 6191 results. 
22. MEDLINE; exp EUROPE/eh (eh=Ethnology); 7364 results. 
23. MEDLINE; exp EUROPEAN CONTINENTAL ANCESTRY GROUP/; 35109 results. 
24. MEDLINE; european$.ti,ab; 73839 results. 
25. MEDLINE; White$.ti,ab; 166506 results. 
26. MEDLINE; 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21; 86227 results. 
27. MEDLINE; 22 OR 23 OR 24 OR 25; 264106 results. 
28. MEDLINE; 12 and 26 and 27; 137 results. 
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1. MEDLINE; exp CORONARY DISEASE/; 148892 results. 
2. MEDLINE; "coronary disease$".af; 122799 results. 
3. MEDLINE; "coronary heart disease$".af; 30935 results. 
4. MEDLINE; coronary$.af; 308926 results. 
5. MEDLINE; exp MYOCARDIAL INFARCTION/; 119450 results. 
6. MEDLINE; "myocardial infarction$".af; 149432 results. 
7. MEDLINE; exp MYOCARDIAL ISCHEMIA/; 286602 results. 
8. MEDLINE; exp CARDIOVASCULAR DISEASES/; 1471574 results. 
9. MEDLINE; ("coronary disease$".af) OR ("coronary heart disease$".af) OR (coronary$.af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/); 1542777 results. 
10. MEDLINE; (exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR (exp MYOCARDIAL 
ISCHEMIA/) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/)); 
192810 results. 
11. MEDLINE; (exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) or ("myocardial infarction$".af) OR (exp MYOCARDIAL 
ISCHEMIA/) or (exp CARDIOVASCULAR DISEASES/) or (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/)); 
237093 results. 
12. MEDLINE; (exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) or ("myocardial infarction$".af) OR (exp MYOCARDIAL 
ISCHEMIA/) or (exp CARDIOVASCULAR DISEASES/) or (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/)); 
63612 results. 
13. MEDLINE; exp ASIAN CONTINENTAL ANCESTRY GROUP/; 18210 results. 
14. MEDLINE; exp INDIA/eh; 2540 results. 
15. MEDLINE; india$.ti,ab; 56482 results. 
16. MEDLINE; exp SRI LANKA/eh; 86 results. 234 
 
17. MEDLINE; "sri lanka$".ti,ab; 2497 results. 
18. MEDLINE; exp BANGLADESH/eh; 324 results. 
19. MEDLINE; "bangladesh$".ti,ab; 4610 results. 
20. MEDLINE; exp PAKISTAN/eh; 618 results. 
21. MEDLINE; "pakistan$".ti,ab; 6191 results. 
22. MEDLINE; exp EUROPE/eh; 7364 results. 
23. MEDLINE; exp EUROPEAN CONTINENTAL ANCESTRY GROUP/; 35109 results. 
24. MEDLINE; european$.ti,ab; 73839 results. 
25. MEDLINE; White$.ti,ab; 166506 results. 
26. MEDLINE; (exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp INDIA/eh) OR (india$.ti,ab) OR (exp 
SRI LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR ("bangladesh$".ti,ab) OR (exp 
PAKISTAN/eh) OR ("pakistan$".ti,ab); 86227 results. 
27. MEDLINE; (exp EUROPE/eh) OR (exp EUROPEAN CONTINENTAL ANCESTRY GROUP/) OR 
(european$.ti,ab) OR (White$.ti,ab); 264106 results. 
28. MEDLINE; ((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR (exp MYOCARDIAL 
ISCHEMIA/) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp INDIA/eh) OR (india$.ti,ab) OR (exp SRI 
LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR ("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) 
OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN CONTINENTAL ANCESTRY GROUP/) OR 
(european$.ti,ab) OR (White$.ti,ab)); 98 results. 
29. MEDLINE; ((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR (exp MYOCARDIAL 
ISCHEMIA/) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp INDIA/eh) OR (india$.ti,ab) OR (exp SRI 
LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR ("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) 
OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN CONTINENTAL ANCESTRY GROUP/) OR 
(european$.ti,ab) OR (White$.ti,ab)); 253 results. 
30. MEDLINE; ((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR (exp MYOCARDIAL 235 
 
ISCHEMIA/) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp INDIA/eh) OR (india$.ti,ab) OR (exp SRI 
LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR ("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) 
OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN CONTINENTAL ANCESTRY GROUP/) OR 
(european$.ti,ab) OR (White$.ti,ab)); 316 results. 
31. MEDLINE; exp PROGNOSIS/; 639740 results. 
32. MEDLINE; prognosis.af; 356881 results. 
33. MEDLINE; (exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) or ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) or (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/)); 
1560108 results. 
34. MEDLINE; ((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af)); 136554 results. 
35. MEDLINE; (((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af))) AND ((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp 
INDIA/eh) OR (india$.ti,ab) OR (exp SRI LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR 
("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN 
CONTINENTAL ANCESTRY GROUP/) OR (european$.ti,ab) OR (White$.ti,ab)); 59 results. 
36. MEDLINE; ((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af)); 138044 results. 
37. MEDLINE; (((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 236 
 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af))) AND ((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp 
INDIA/eh) OR (india$.ti,ab) OR (exp SRI LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR 
("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN 
CONTINENTAL ANCESTRY GROUP/) OR (european$.ti,ab) OR (White$.ti,ab)); 59 results. 
38. MEDLINE; exp FOLLOW-UP STUDIES/; 378507 results. 
39. MEDLINE; follow-up.af; 642761 results. 
40. MEDLINE; exp TREATMENT OUTCOME/; 365669 results. 
41. MEDLINE; (disease AND outcome).af; 206093 results. 
42. MEDLINE; ((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af) OR (exp FOLLOW-UP STUDIES/) OR (follow-up.af) OR (exp TREATMENT 
OUTCOME/) OR ((disease AND outcome).af)); 237774 results. 
43. MEDLINE; (((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af) OR (exp FOLLOW-UP STUDIES/) OR (follow-up.af) OR (exp TREATMENT 
OUTCOME/) OR ((disease AND outcome).af))) AND ((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp 
INDIA/eh) OR (india$.ti,ab) OR (exp SRI LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR 
("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN 
CONTINENTAL ANCESTRY GROUP/) OR (european$.ti,ab) OR (White$.ti,ab)); 133 results. 
44. MEDLINE; ((((exp CORONARY DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR 
(coronary$.af) OR (exp MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial 
infarction$".af) OR (exp CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart 
disease$".af) OR (coronary$.af) OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND 
((exp PROGNOSIS/) OR (prognosis.af) OR (exp FOLLOW-UP STUDIES/) OR (follow-up.af) OR (exp TREATMENT 
OUTCOME/) OR ((disease AND outcome).af))) AND ((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp 237 
 
INDIA/eh) OR (india$.ti,ab) OR (exp SRI LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR 
("bangladesh$".ti,ab) OR (exp PAKISTAN/eh) OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN 
CONTINENTAL ANCESTRY GROUP/) OR (european$.ti,ab) OR (White$.ti,ab))) NOT ((((exp CORONARY 
DISEASE/) OR ("coronary disease$".af) OR ("coronary heart disease$".af) OR (coronary$.af) OR (exp 
MYOCARDIAL INFARCTION/) OR ("myocardial infarction$".af) OR ("myocardial infarction$".af) OR (exp 
CARDIOVASCULAR DISEASES/) OR (("coronary disease$".af) OR ("coronary heart disease$".af) OR (coronary$.af) 
OR ("myocardial infarction$".af) OR (exp CARDIOVASCULAR DISEASES/))) AND ((exp PROGNOSIS/) OR 
(prognosis.af))) AND ((exp ASIAN CONTINENTAL ANCESTRY GROUP/) OR (exp INDIA/eh) OR (india$.ti,ab) 
OR (exp SRI LANKA/eh) OR ("sri lanka$".ti,ab) OR (exp BANGLADESH/eh) OR ("bangladesh$".ti,ab) OR (exp 
PAKISTAN/eh) OR ("pakistan$".ti,ab)) AND ((exp EUROPE/eh) OR (exp EUROPEAN CONTINENTAL 
ANCESTRY GROUP/) OR (european$.ti,ab) OR (White$.ti,ab))); 74 results. 
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13.6 Search Strategies for prognosis in MEDLINE in Ovid Syntax and the 
PubMed translation 
For prognosis, the following data are shown: the single term with the highest 
sensitivity  while  keeping  specificity  at  50%; the  single  term  with  the  highest 
specificity while keeping the sensitivity at 50%; the single term with the least 
(minimal) absolute difference between sensitivity and specificity; and then the 
same data for multiple terms (the single term strategy may be shown again if it 
performs at least as well as multiple terms). In the second column of the table the 
search strategies are shown in Ovid syntax followed by the PubMed translation. 
In the third column of the table: sens = sensitivity; spec = specificity; prec = 
precision; acc = accuracy. 
Prognosis  
Ovid Strategy 
Strategy type 
PubMed Translation 
Sens / spec / prec / acc  
(%) 
exp epidemiologic studies  1 term  
high sensitivity 
epidemiologic studies(MeSH term) 
65 / 79 / 1 / 79 
exp epidemiologic studies  1 term 
high specificity 
epidemiologic studies(MeSH term) 
65 / 79 / 1 / 79 
exp epidemiologic studies  1 term  
min difference 
epidemiologic studies(MeSH term) 
65 / 79 / 1 / 79 
incidence.sh. OR exp mortality OR  
follow-up studies.sh. OR  
prognos:.tw. OR  
predict:.tw. OR  
course:.tw. 
2 or more terms  
high sensitivity 
incidence(MeSH:noexp) OR 
90 / 80 / 2 / 80 239 
 
mortality(MeSH Terms) OR  
follow up studies(MeSH:noexp) OR  
prognos*(Text Word) OR  
predict*(Text Word) OR  
course*(Text Word) 
prognos:.tw. OR  
first episode.tw. OR  
cohort.tw. 
2 or more terms  
high specificity  prognos*(Title/Abstract) OR  
(first(Title/Abstract) AND  
episode(Title/Abstract)) OR  
cohort(Title/Abstract) 
52 / 94 / 3 / 94 
prognosis.sh. OR  
diagnosed.tw. OR  
cohort:.mp. OR  
predictor:.tw. OR  
death.tw. OR  
exp models, statistical 
2 or more terms  
min difference 
prognosis(MeSH:noexp) OR  
diagnosed(Title/Abstract) OR  
cohort*(Title/Abstract) OR  
cohort effect(MeSH Term) OR  
cohort studies(MeSH:noexp) OR  
predictor*(Title/Abstract) OR  
death(Title/Abstract) OR  
"models, statistical"(MeSH Term) 
83 / 84 / 2 / 84 
 
With  thanks  to  Bridget  Cole,  Trust  Librarian,  Sir  Thomas  Browne  Library, 
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13.7 Deprivation scores  
13.7.1  Indices of Multiple Deprivation 
The Indices of Multiple Deprivation are measures of deprivation for every area in 
England. The Index consists of 33 indicators of need which have been statistically 
condensed into six themes with some given more importance or weight than 
others:  
•  Income deprivation (two and a half times the importance of the lowest).  
•  Employment  deprivation  (two  and  a  half  times  the  importance  of  the 
lowest).  
•  Health deprivation/disability (one and a half times the importance of the 
lowest).  
•  Education/skills  and  training  deprivation  (one  and  a  half  times  the 
importance of the lowest).  
•  Housing deprivation (joint lowest importance).  
•  Geographical access to services (joint lowest importance). 
Indices of Multiple Deprivation are based on a range of administrative data and 
have the advantage that as they are not based solely on census results they can 
be  updated  more  than  once  every  ten  years.  The  indices  combine  these 
indicators into a single deprivation score for each small area in England. This 
allows each area to be ranked relative to one another according to their level of 
deprivation. In 2000, they were measured at a ward level which may not take 
into  account  heterogeneity  within  that  area.  IMD  2004  and  2007  used  the 
smaller Lower Super Output Area level, of which there are 32,482 in the country. 
13.7.2  Carstairs 
Carstairs  scores  are  an  unweighted  combination  of  four  census  variables: 
unemployment, overcrowding, car ownership and low social class (Social Class 
IV and V). The definitions used by the Office for National Statistics for the 2001 
scores are shown below:  241 
 
 
Each  variable  is  standardised  (z-scored)  to  avoid  the  score  being  unduly 
influenced by a high or low value for any one variable and to put each variable on 
the same scale, centred around zero. This is done for each variable by subtracting 
the mean of the observations for all wards in England and Wales from the value 
of that variable for each ward and dividing by the standard deviation for that 
variable. The resulting values for each variable are summed to give a single score 
for that ward. The scores can be either positive (more deprived) or negative (less 
deprived). 
13.7.3  Townsend  
The Townsend Score is derived from the following census variables: 
•  Unemployment - the percentage of economically active residents aged 16-
59/64 who are unemployed.  
•  Car ownership - the percentage of private households who do not posses 
a car.  
•  Home  ownership  -  the  percentage  of  private  households  not  owner 
occupied.  
•  Overcrowding- the percentage of private households with more than one 
person per room. 
The Townsend Score is a summation of the standardised scores (z scores) for 
each  variable  (scores  higher  than  zero  indicate  higher  levels  of  material 
deprivation).  242 
 
13.8 Terminology for description of people 
In the general description of persons who may be relevant to this work, I have 
used the terms people and populations.  
When specifically discussing those within the studies of this thesis, I used the 
term participants when referring to the healthy population of Whitehall-II and to 
those in Chest Pain Clinic study, who have yet to be diagnosed with disease.  For 
those participating in ACRE and MINAP, I have used the term patient. For general 
discussion  of  these  participants,  I  continue  to  use  the  terms  people  and 
populations.  
Towards the end, I discuss all people – whether describing those in general or 
those in the studies of this thesis - as part of populations or as patients rather 
than as participants of studies. 
13.9 Fonts 
The text is written in Cambria, the figures/tables in Calibri 243 
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